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 The purpose of this study was to convey the experiences of nurses who care for or 
have cared for patients with lung cancer in different settings and to discover how these 
experiences relate to the stigma associated with lung cancer. The study was conducted 
using a narrative approach.  Two stigma theories were used to guide this study; 
Goffman’s theory, which describes stigma at the micro level, and Link and Phelan’s 
theory, which describes stigma process at the macro level.  The main theoretical concepts 
used to guide this study are the stigma process as a downward trajectory for the disease 
and the people who have the disease, which begins with labeling, associating labels with 
negative stereotypes, separation, status loss, and structural discrimination. “Normals” 
contribute to this process and the “wise”, or nurses, counteract this process.   
 Thematic analysis of nurses’ experiences caring for patients with lung cancer 
yielded four themes: addiction in action, cancer of a functioning organ, jumping through 
hoops, and securing the journey. The subthemes of addiction in action were stigma-
related thoughts, struggle, and frustration; for cancer of a functioning organ the 
subthemes were dyspnea, sick, and secretions, for jumping through hoops the subthemes 
were push back, attitude barriers, and system level barriers; and for securing the journey 
the subthemes were progressing, following, connecting, and challenges to the journey.     
At the micro level of the stigma process, nurses are considered to be “wise” 
persons who have knowledge of the difficulties of people who have a stigmatized illness 
and are positioned to help the stigmatized counteract stigma, but the “wise” are also 
   
 
 
“normals”. Nurses’ experiences, communicated through narratives, further informed the 
characteristics of “wise” persons so that these qualities can be known and taught in 
nursing. This study added a more nuanced understanding of the experiences of nurses as 
the “wise” and nurses as “normals”, and the actions they take to help deal with struggles 
they have when caring for patients with smoking addiction, and lung cancer. Maintaining 
integrity of the nursing profession requires in depth knowledge of how nurses embody 
the expectations of their profession and the care they provide, and when they struggle to 
do so, or when they see the struggles of other health care professionals.  
Conditions that are commonly stigmatized, like smoking addiction, were at times 
transformed by the “wise” as something that can protect the person who has addiction 
from further judgement, which adds complexity to the identity of nurses and other health 
care professionals as “normals” and “wise”, and the process of labeling. However, nurses 
had a fragmented understanding of smoking addiction that contributed to their difficulties 
in witnessing smoking behaviors, and frustration with effectively addressing smoking 
cessation. This fragmented understanding allows for the continuation of extant negative 
stereotypes and labels in the health care setting. The “wise” thoughts and “wise” actions 
that nurses had and did can be used to build a framework for approaching patients with a 
stigmatized disease, and it also provides guidance for what additional research needs to 
be done. 
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CHAPTER I 
 
INTRODUCTION 
 
In The Scarlet Letter, Nathaniel Hawthorne wrote of the character Hester Prynne 
after her release from jail “On the breast of her gown, in fine red cloth surrounded with 
an elaborate embroidery and fantastic flourishes of gold thread, appeared the letter ‘A’” 
(Hawthorne, 1983, p. 49). The letter on her chest represented her crime of adultery.  
Some members of the town thought this an unfitting punishment and suggested branding 
the letter on her skin (Hawthorne, 1983).  The “A” on her clothing was part of her stigma, 
a way to distinguish Hester from everyone else in the town, to cast her out socially, and 
to ensure her crime would be known wherever she went.  
Stigma is one consequence of humanity’s struggle to discover, define, and 
describe what is normal, and what to do about what is not normal. Examples of this 
struggle can be found in history, literature, religion, science, and health care, from the 
Greeks who branded their criminals, to Nathaniel Hawthorne’s tale of a marked woman 
who was openly stigmatized while her co-adulterer concealed his deviance, but suffered 
inwardly from shame and self-stigma (Hawthorne, 1983).  In the Old Testament, some 
illnesses were considered to be a “curse from God” (Chitando & Gunda, 2007, p. 192) as 
punishment for immoral behavior; and punishments extended beyond the original deviant
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like the mark put upon Cain by God for murdering his brother Abel; hence all 
descendants of Cain were doomed from the depravity of their progenitor.  
While science might appear to be separate from religion, medicine at times 
struggled to find the cause for diseases that religious and moral views were quick to 
supply (Herek, 1990). Before it was known that cholera was caused by bacteria in water, 
outbreaks of the disease in the United States incited fear and blame directed at the poor, 
prostitutes, blacks, and immigrants because it was thought that these groups had certain 
innate characteristics like laziness, drunkenness, and sexual promiscuity, that predisposed 
them to cholera (Rosenberg, 1962). Ironically, those who drank alcohol likely had an 
advantage due to the sterilization processes in alcohol production. When the cause was 
finally linked to poor sanitation, it was determined that the aforementioned groups were 
the most vulnerable to the disease and the stigma attached to it (Rosenberg, 1962).  
Certain diseases, even today, still carry a stigma due to their link to behaviors that 
are deemed immoral or deviant by society. The HIV/AIDS epidemic is a near repeat of 
the cholera outbreaks because, again, moral judgments were more expedient than science.  
Morality, extant in most aspects of culture including government, religion, and social 
interactions, already guided how people should judge a new disease and those who have 
it – particularly when said people are outside the parameters of normal. When at first it 
seemed as though the disease was restricted to gay men, not only did those who fell 
within the normal parameters of a heterosexual group feel safe, but the existence of the 
disease seemed to indicate that judgment had finally fallen upon the morally corrupt 
(Herek,1990). 
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Unfortunately, this inaccurate, premature view of the disease greatly contributed to the 
spread of it and the many stigmas involved linger today (Balaji, Bowles, Hess, Smith, & 
Paz-Bailey, 2016), further delaying access to treatment (Golub & Gamarel, 2013).  
While the stigma of HIV/AIDS was most prevalent among already stigmatized 
and marginalized groups, some behaviors related to diseases undergo a transformation 
from normal and accepted to deviant and socially unacceptable. Smoking is one such 
behavior, and the disease it is most strongly linked to, lung cancer, has also undergone a 
transformation among the people who have it. When cigarette consumption was 
increasing in the early twentieth century, early attempts to counteract consumption were 
led by religious and secular organizations who focused less on health as a reason to stop 
smoking and more on moral degradation (Brandt, 1990; U.S. Department of Health and 
Human Services, 2014). These efforts could not stop the tide of mass production and 
advertising of cigarettes, but the moral argument would be used again to decrease 
smoking behavior. Some of the results of this transformation of smoking behavior from 
popular to aberrant, are the social construction of smoking behavior and lung cancer into 
a behavior and disease, respectively, that are burdened with issues of stereotyping, status 
loss, and discrimination. These issues place an additional social and psychological burden 
on patients with lung cancer and the people who care for them.  
Problem Statement 
 Nurses are key people among health care professionals that care for people with 
lung cancer. Nursing is one of the most rapidly expanding healthcare professions in the 
United States; with a projected increase of 16% over the next eight years (U.S. 
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Department of Labor, 2014). Most patients have multiple and sometimes prolonged care 
encounters with nurses, making them the most critical and pivotal members of the 
healthcare team, and the most likely, other than close family and friends, to detect social 
and psychological burdens among their patients (Abrahamson, 2010).  
At the center of most care related decisions made for and with patients are nurses, 
and they must coordinate with multiple other health care professionals in order to provide 
safe, effective care. Nurses who work with patients that have conditions which carry a 
stigma can undo the nurse patient relationship when they exhibit a negative attitude 
(Dickinson & Hurley, 2012). One study provided a glimpse of such attitudes when nurses 
from China were surveyed and the results indicated that some diseases, like lung cancer, 
are worthy of more blame than other cancers (Wang, Zhan, Zhang, & Xia, 2015).  
The attitudes, perspectives, and beliefs of nurses toward stigmatizing conditions 
have been studied. Only one study examined their attitudes toward lung cancer with a 
cross-sectional survey design (Wang et al., 2015). Other studies interviewed nurses about 
their perspectives on obesity and stigma using a qualitative design, but the perspective 
was from nurses who had the stigmatized condition (Aranda & McGreevy, 2014; I. 
Brown & Thompson, 2007). The obesity studies revealed that nurses are aware of extant 
stereotypes about stigmatized diseases and the damage that they do, yet they still 
expressed negative emotions about their patients who had weight problems (Aranda & 
McGreevy, 2014).  
In addition, it has been theorized that nurses may act as a buffer against the 
negative impact of stigma (Goffman, 1963; Hamann et al., 2014). However, few studies 
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have examined what actions nurses take to counteract stigma. Studying the experience of 
the nurse, in detail, using qualitative methodology with a narrative approach, would 
contribute to completing the knowledge of the impact of stigma on patient care and hence 
ways to improve the care of patients with lung cancer.  
There are key national goals related to lung cancer, namely reducing the death 
rate, increasing the number of cancer survivors living five years or longer to 72.8%, and 
improving overall well-being of all cancer survivors (U.S. Department of Health and 
Human Services, 2014).  Learning more about how nurses perceive the care of patients 
with lung cancer will provide the information on how to improve their care and treatment 
outcomes.  Considering that patients with lung cancer can have poor five-year survival 
rates (National Cancer Institute,  2016), their psychosocial issues must be detected and 
addressed early in order to provide the best and most holistic care. 
Purpose of the Study  
 The purpose of this study is to explore the experiences of nurses who care for 
patients with lung cancer in a variety of settings to better understand their perspective of 
issues related to care of the patient with lung cancer and stigma. The perspectives of 
nurses are underrepresented in the literature on lung cancer and stigma, however the 
perspectives of patients, physicians, clinical social workers, and lay caregivers have been 
represented. Studying nurses is also key to the conceptual development of stigma because 
theoretically they are considered a counteracting force against stigma (Goffman, 1963), 
yet they can also perpetuate it. Nurses are integral to improving the quality of care for 
patients with lung cancer. A qualitative study will provide the needed contextual 
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information to design interventions that help patients have the best outcomes. Without 
supportive context, any interventions to mitigate stigma and improve the psychosocial 
issues surrounding it will have little meaning for the patients and nurses engaged in these 
interventions (Munhall, 2007).  
Background and Significance   
Lung cancer has the highest mortality rate of all the major, most prevalent cancers 
(National Cancer Institute, 2016), yet it has low public support and low funding. When 
comparing 2016 funding for three major cancers: congressional appropriations for breast 
$120 million (a total of 3.6 billion from 1992-2015), prostate $80 million (1.45 billion 
from 1997-2015), and lung $12 million (89.5 million from 2009-2015); lung cancer 
continues to be underfunded in spite of the high prevalence and mortality (Department of 
Defense, 2014). Furthermore, in 2013 the National Cancer institute spent $559.1 million 
on breast cancer and only $285.9 million on lung cancer (National Cancer Institute, 
2014). Funding is a proxy for public support because it increases awareness and 
education about diseases which are necessary precursors for support.  
National Statistics 
Cancer is the second leading cause of death in the United States (Heron, 2016), 
with an estimated 1,685,210 deaths for 2016 (National Cancer Institute, 2016). Medical 
costs for cancer in 2013 were $74.8 billion (National Cancer Institute, 2016). Lung 
cancer is the leading cause of cancer death for men and women (American Cancer 
Society, 2017), and the fifth leading cause of death worldwide at 1.7 million deaths in 
2015 (World Health Organization, 2017). Lung cancer prevalence in 2013 was over 
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415,500, which was less than prostate, breast, or colon cancers but the death rate was 
higher (National Cancer Institute, 2016). 
Lung Cancer  
Of the four cancers that have new cases over 100,000 per person in 2016, lung 
and bronchus (224,390), breast (246,660), prostate (180,890), and colon (134,490); lung 
and bronchus cancers have the highest number of deaths at 158,080 people, and the 
lowest five-year survival rate at 17.7% (National Cancer Institute, 2016). The five-year 
survival rate is based on the Surveillance, Epidemiology, and End Results Program 
(SEER) data from 2006-2012. Over half of the people who are diagnosed with lung 
cancer will die from the disease before one year has passed (American Lung Association, 
2017). While the survival rates of lung cancer have increased slightly for men and 
women from 1977 to 2010; the incidence and mortality decreased for men while these 
rates increased for women, indicating momentum in fighting cancer for the former but 
not the latter (Cho, Mariotto, Schwartz, Luo, & Woloshin, 2014).  
Like the aforementioned cancers, lung cancer is most frequently diagnosed late in 
life with 32.4% of new cases in the 65-74 age group, 27.4% in the 75-84 age group, and 
21.5% in the 55-64 age group. Incidence rates of lung cancer are higher in men than 
women, 67.9% versus 49.4%; and the highest incidence and mortality is seen in black 
men at 90.9% and 73.1% respectively; although not uniformly for gender in the black 
race/ethnicity category because white women have higher mortality rates than black 
women, per 100,000 persons (National Cancer Institute, 2016). However, lung cancer is 
also typically diagnosed at a late stage (American Cancer Society, 2016) which in 
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addition to diagnosis late in life, contributes to the poor five-year survival rate. The type 
of lung cancer, the stage, how quickly it spreads, treatment options that are partly based 
on co-morbidities, and health behaviors before, during, and after treatment also impact 
survival and treatment outcomes (American Cancer Society, 2016). The health behavior 
that has been most closely linked with lung cancer is cigarette smoking.  
Cigarette Smoking  
Cigarette smoking overshadows all causes of preventable death because it is 
linked to many leading causes of death such as heart disease and cancer (Jamal et al., 
2015); it is also the primary cause of lung cancer (U.S. Department of Health and Human 
Services, 2014). Smoking prevalence data tends to be congruent with lung cancer 
incidence data; for example, men have a higher prevalence of smoking and smoke more 
cigarettes than women, and people between the ages of 45 and 74 smoke on average more 
cigarettes per day than any other adult age group (Schoenborn, Adams, & Peregoy, 
2013).  However, over 30% of current smokers in their early 20s started smoking before 
age 16 (Schoenborn et al., 2013), and most smoking initiation occurs before age 18 (U.S. 
Department of Health and Human Services, 2014); early initiation adds to the risk of 
young people becoming lifelong smokers (National Center for Chronic Disease 
Prevention and Health Promotion (US) Office on Smoking and Health, 2012). This 
information also indicates that people who have smoking related diseases likely started 
smoking at a time in their lives when they were susceptible to peer pressure, advertising, 
and the desire to belong, and therefore vulnerable to initiating risky behaviors, and when 
they are addictive, maintaining them (Shadel & Cervone, 2011).  
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The trend of smoking initiation in early adolescence diverges when examining 
data on smoking incidence in Blacks, who smoke fewer cigarettes than whites and start 
smoking later in life (Schoenborn et al., 2013); yet they have the highest rate of lung 
cancer incidence (31.8) in the 40-49 age group when compared to: Whites (21.7), 
American Indians/Alaska Natives (AIs/ANs) (13.4), Asian/Pacific Islander (As/PIs) 
(10.8), and Hispanics (8.5) (Underwood et al., 2012). These numbers are also regionally 
dependent in that Whites have higher incidence of lung cancer in the South (75.6), Blacks 
in the Midwest (88.9), and AIs/PIs in the West (40.0) (Underwood et al., 2012). 
Differences in mortality of lung cancer are also noted among certain groups examined 
with county-level data (Rubin, Clouston, & Link, 2014). There is support that mortality 
rates of lung cancer are higher among people in areas that have higher rates of low 
education attainment, lower number of people in white collar jobs, and fewer people 
above the federally-defined poverty level (Rubin et al., 2014).  
Smoking prevalence has similar socioeconomic ties. Although there has been a 
marked decline in smoking prevalence over the past five decades, from 42.4% in 1965 
(Lavinghouze et al., 2015) to 16.8% in 2014 (Jamal et al., 2015); the rates are still high 
for people who have low education attainment and low income (Jamal et al., 2015). 
Specifically, for people with a general education development certificate the rate was 
43.0% compared to people with a graduate degree, 5.4%, and those living below the 
federal poverty level, 26.3%, compared to those living above, 15.2%, in 2014 (Jamal et 
al., 2015).   
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The metrics on lung cancer and smoking indicate that there are differences in 
death, survival, incidence, and prevalence rates among different cancers, and specifically 
for lung cancer, by gender, by race, and by socioeconomic status (SES). Differences in 
prevalence rates for smoking by SES are also present. Theorists and researchers have 
hypothesized that the decrease in smoking prevalence among higher educated and higher 
income individuals and hence the lower levels of lung cancer incidence in these groups, 
is due to their potential greater ability to understand health information and respond to it 
(Rubin et al., 2014). In general, this thesis indicates that both disease development and 
health risk behaviors are not just biological, they are imbued with larger social 
implications.  
Lung cancer has a strong association to smoking not only with regard to disease 
causality, but also with social perception (Rohan, Boehm, Allen, & Poehlman, 2016). 
Smoking was socially acceptable and widely prevalent in the early to mid-twentieth 
century (Brandt, 2007). Over the past five decades, science and policy have not only 
provided overwhelming support that smoking is unhealthy, it has also been deemed 
deviant (Bayer, 2008; Markle & Troyer, 1979). Patients with lung cancer who never 
smoked feel that they must explain their non-smoking status when they reveal their 
diagnosis (Conlon, Gilbert, Jones, & Aldredge, 2010). There is also support that stigma 
for patients with lung cancer is related to psychosocial issues such as a decrease in 
quality of life (Brown Johnson, Brodsky, & Cataldo, 2014; Cataldo, Jahan, & Pongquan, 
2012), increase in depression (Gonzalez & Jacobsen, 2012), increase in self-blame and 
decrease in self-esteem (Else-Quest, LoConte, Schiller, & Hyde, 2009) and delays in 
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seeking care (Carter-Harris, 2015; Carter-Harris, Hermann, Schreiber, Weaver, & Rawl, 
2014; Tod & Joanne, 2010).  
The perspectives of health care professionals have revealed that patients with lung 
cancer delay seeking care because of vague symptoms (Dunn et al., 2016), shame related 
to smoking (Dunn et al., 2016; Tran et al., 2015), and stigma (Dunn et al., 2016). Further, 
health care professionals note that people with lung cancer think they are at fault 
regardless of smoking status (Conlon et al., 2010; Dunn et al., 2016); there is nihilism 
and pessimism among professionals and people who smoke (Dunn et al., 2016; Scott, 
Crane, Lafontaine, Seale, & Currow, 2015; Tran et al., 2015) which also contributes to 
delays in care and negative attitudes.  
 Nurses are considered to be, professionally, the epitome of impartiality and 
acceptance; however, their therapeutic relationships with the myriad of patients they 
encounter can involve a mosaic of complicated thoughts and feelings (Peternelj-Taylor, 
1989). Ignoring this complexity, and failing to acknowledge that “nurses are people first 
and nurses second” (Peternelj-Taylor, 1989, p. 745) creates an environment that increases 
the challenges of fully understanding and adhering to professional practice standards. 
Examples of current practice standards for nurses from specialties like oncology, home 
health, and the overall standards from the American Nurses Association (ANA), that are 
pertinent to stigma, indicate that nurses are expected to self-examine, reflect, and 
inventory their beliefs, values, and culture that could impact patient care (American 
Nurses Association, 2015; Brant & Wickham, 2013), that the home health nurse 
“advocates for equitable care” (American Nurses Association, 2014, p. 61), and that all 
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nurses examine the influence of discrimination on the care of those who are vulnerable 
(American Nurses Association, 2015).  
Nurses have been studied exclusively in only one study in China, which examined 
their different attitudes toward diseases that carry stigma such as lung cancer, obesity, 
liver cancer, colon, and breast cancers; more nurses assigned blame to lung cancer than 
any other cancer presented.  However, attitudes toward a disease are influenced by 
cultural norms, which may be different in China than the United States. Nurses have also 
been included in mixed samples of clinicians in qualitative studies, but their perspective 
is seldom distinguishable from other clinicians. When their perspective is presented, 
nurses express awareness of patients’ potential self-blame and perceived stigma related to 
smoking (Tod & Joanne, 2010). Lastly, qualitative studies of nurses’ attitudes toward 
obesity elicited complex beliefs and feelings about their own body size and education for 
overweight and obese patients (Aranda & McGreevy, 2014; Brown & Thompson, 2007). 
These complex attitudes included: awareness of stereotypes such as ‘fat’, ‘lazy’, and 
unhealthy, counteracting stereotypes by asserting that thin people have health problems 
too and body size is not about health but social norms and acceptance, and their negative 
attitudes sometimes overruled empathy when educating patients about weight reduction 
(Aranda & McGreevy).  
In order to counteract pessimism and avoid emotions, nurses hid behind their 
professional role or noted the hypocrisy of educating about risk factors they themselves 
had (Aranda & McGreevy, 2014). In another study nurses were uncomfortable talking 
about obesity, avoided the word obesity with their patients because it was deemed a 
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disagreeable label, and used rapport and a neutral attitude to offset stigma (Brown & 
Thompson, 2007). Other nurses asserted that personal responsibility was key to behavior 
change and judgement is a constant (Brown & Thompson). Nurses also expressed 
frustration with patient requests for quick fixes and noncompliance (Brown & 
Thompson). All of these studies were in other countries, China and England respectively, 
so the perspectives presented reflect, to some degree, the culture of that country and the 
health care system. 
Since so little is known about nurses’ perspectives about lung cancer and stigma, 
a qualitative approach is warranted. Moreover, prior research into nurses’ perceptions of 
stigmatized conditions reveals complex attitudes toward both the condition and their 
patients. Narrative inquiry allows for the exploration and analysis of complex, layered 
experiences (Frost, 2011). Narratives are drawn from cultural and social experiences 
which can also reveal aspects of the teller’s identity and personality (Lieblich, Tuval-
Mashiach, & Zilber, 1998), making it an ideal approach to study nurses’ experiences of 
caring for people with lung cancer and how these experiences relate to stigma.  
Theoretical Framework  
The purpose of this study is to explore the experiences of nurses who care for 
patients with lung cancer, using stigma theory as a guide. Two stigma conceptual 
frameworks will guide the study. The first framework is Erving Goffman’s theoretical 
analysis of the micro-level interactions among individuals where stigmatization occurs 
(Goffman, 1963). Stigma is defined as a label that is linked to a stereotype that discredits 
the person who has it (Goffman).  The individual interactions surrounding stigma involve 
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those who have a stigmatized condition, or “the stigmatized”, those who do not, 
“normals”, those who understand the stigmatized and work to advocate for them, the 
“wise” who are also “normals”, and those who share the experience of having the 
stigmatized condition, the “own”. (Goffman).  
Examples of “wise” people provided by Goffman are nurses, physical therapists, 
relatives, and friends, however, there is little description in his theory or in studies about 
how “wise” people, specifically health care professionals, counteract stigma and advocate 
for those who have a stigmatized disease. Learning more about nurses as “wise” people 
through research is important because they are part of a profession for which there are 
expectations of caring, empathy, knowledge, understanding, advocacy for equitable care, 
and examination of the impact of discrimination on vulnerable people. Maintaining 
integrity of the profession requires in depth knowledge of how nurses embody these 
expectations and when they struggle to do so, or when they see the struggle of other 
health care professionals.  
Other concepts in Goffman’s theory are social and psychological consequences of 
stigma such as social exclusion, avoidance, stereotyping, and decreased empathy from 
“normals” (Goffman, 1963). Additional consequences experienced by the stigmatized are 
self-blame, shame, self-isolation, and concealment from internalizing, perceiving, or 
actually experiencing negative attitudes, social exclusion, and stereotyping from 
“normals” (Goffman). Actions to counteract stigma are also described as self-advocacy, 
collective advocacy, rejecting the stigma, and rejecting other stigmatized individuals.  
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Goffman (1963) defined stigma as an “attribute that is deeply discrediting” (p. 3); 
the attribute can be visible, like weight or height, or invisible, like some diseases. 
Attributes are objectively constructed as a way to identify objects and people and 
communicate about them. Attributes are also socially constructed in which the label takes 
on connotations, subtext (Volinn, 1983), and stereotypes (Goffman; Link & Phelan, 
2001). For example, lung cancer is an objective diagnosis and can also be associated with 
a behavior, smoking, or label, smoker.  People who smoke have been described by people 
who do not smoke as lacking intelligence (McCool, Hoek, Edwards, Thomson, & 
Gifford, 2013), selfish and ignorant (Wigginton & Lee, 2013), having a weak character 
and personal failings (Stuber, Galea, & Link, 2008), and being dirty (Greaves, Oliffe, 
Ponic, Kelly, & Bottorff, 2010). 
There are psychological, behavioral, and social consequences of stigma. Affective 
responses to stigma include shame, depression, and anxiety. Psychological and 
behavioral responses include internalization of negative attitudes and stereotypes or 
internalized stigma, self-blame, anticipation of stigma, and rejection of the stigma and 
others who have it. Social consequences include concealment of the stigmatized 
condition, self-induced isolation, avoidance, and advocacy.   
The second conceptual framework presents stigma as a macro-level process of a 
downward social trajectory (Link & Phelan, 2001). In addition to Goffman’s description 
of stigma that is a label-stereotype link that discredits a person, Link and Phelan further 
describe stigma as a process that leads to separation, status loss, and limited access to 
resources in the context of power.  There are five main concepts in the Link and Phelan 
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theory that describe a downward social trajectory: labeling, stereotyping, separation, 
status loss, discrimination, and power. Power is the driving force behind the stigma 
process that helps create and perpetuate negative stereotypes that are linked to labels, and 
power differences exacerbate separation, status loss, and discrimination (Link & Phelan). 
Indeed, this theory is distinguished from other stigma theories and even Goffman’s 
because the creators assert that “[s]tigma is entirely dependent on social, economic, and 
political power – it takes power to stigmatize” (Link & Phelan, p. 375).  
For the purposes of this study, stigma is a process whereby labels of individuals 
or groups are linked to negative stereotypes that can be used to separate that individual or 
group from the rest of society or from comparable groups, diminish their social status, 
and withhold, divert, or decrease their access to resources (Link & Phelan, 2001). Stigma 
is also described as a characteristic used to identify an individual that can disgrace and 
dehumanize them in certain situations, and is temporally dependent (Goffman, 1963; 
Link & Phelan). Social, cultural, and political components of society determine which 
labels and characteristics fall within normal parameters and which do not (Link & 
Phelan); those that do not, acquire negative focus and stereotypes (Goffman).  
Assumptions 
 
 The following assumptions were retained for the planning and conduct of the 
research study:  
• Nurses are attuned to and willing to talk about the psychological and social issues 
surrounding the diagnosis of lung cancer.  
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• Nurses are able to recognize and willing to talk about the psychosocial issues of 
their patients with lung cancer. 
• Nurses recognize and are willing to talk about their own experiences with 
stereotyping, status loss, and discrimination.  
Research Questions 
 
This study answers the following broad, qualitative research question: what are 
the experiences of nurses who care for patients with lung cancer? The other question is, 
how are these experiences related to the stigma associated with lung cancer? The two 
stigma theories mentioned and a narrative inquiry approach will provide guidance toward 
answering this question. Using a narrative inquiry approach to study nurses’ experiences 
of caring for patients with lung cancer will provide rich experiences that are oriented to 
the narrator’s identity and personality, are drawn from culture, and are socially 
contextual.  
Definition of Terms  
This study employed the following terms and definitions: 
1. Label: Diseases and diagnoses are labels. For this study, the label of interest is 
lung cancer. 
2. Stereotype: Negative characteristics linked to a label (Link & Phelan, 2001) that 
are cognitively expedient but have low accuracy (Volinn, 1983).  
3. Separation: The mental, physical, political, and social processes of placing 
individuals or groups into separate categories based on labels and stereotypes, or 
excluding them socially. 
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4. Status Loss: The social sequelae of labeling, stereotyping, and separation (Link & 
Phelan, 2001). A diminished position of a group, disease, or individual in a 
hierarchical structure.  
5. Discrimination: The social sequelae of labeling, stereotyping, separation, and 
status loss which leads to a reduction in access and opportunities.  
6. “Normals”: Health care professionals, lay caregivers, and members of the general 
public who create a “virtual identity” of the person with lung cancer (Goffman, 
1963, p.2).  
7. “Stigmatized”: People with lung cancer and people who smoke and who know 
their “actual social identity” or the array of characteristics they know they possess 
(Goffman, 1963, p. 2).  
8. The “Wise”: “Normals” who have knowledge of the plight of the stigmatized and 
have empathy for them.  
9. The “Own”: Other people with lung cancer who have empathy for the shared 
experience of having a stigmatized form of cancer.  
10. Shame: A psychological consequence of internalizing stereotypes, separation, and 
status loss.   
11. Psychological Consequences of Stigma – experiences of the stigmatized that 
include anticipation of or actual instances of stereotyping, negative attitudes, 
status loss, separation, and discrimination that includes feelings of shame, self-
blame, anxiety, depression, and decreased self-esteem.  
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12. Social Consequences of Stigma – alterations in social contacts that include 
avoidance, exclusion, concealment, and decreased empathy from “normals”. 
13. Counteracting Stigma- Actions taken by the “stigmatized”, “normals”, and/or the 
“wise” that decrease the negative perception of the stigmatized condition and 
support those who have it.  
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CHAPTER II 
REVIEW OF LITERATURE 
The following chapter is both an explanation of two theoretical frameworks that 
are used to organize the review of literature and underpin the study, and a review of the 
literature on stigma and lung cancer. First there will be an overview of the concepts in 
each theory. Second there will be a review of the literature organized by some of the 
major concepts in each theory. Finally, sections of the literature review will be concluded 
by tying them back to the concepts in the theories.  
Stigma Theories 
The two stigma frameworks that will be used to guide this study are Erving 
Goffman’s (1963) micro-level theory of stigmatization that occurs during interactions of 
individuals, and the second theory, by Link and Phelan (2001), describes stigma as a 
macro-level process involving labeling, stereotyping, separation, status loss, and 
discrimination; with power as the driving force behind the process.  The first stigma 
theory, Goffman’s (1963), was chosen because it is the most frequently used theory in 
studies of stigma and lung cancer, the concepts and processes within are supported by the 
literature, it is useful for understanding social and psychological aspects of stigma at the 
individual level, and includes the concept of the “wise” as knowledgeable advocates for 
the stigmatized
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The second theory, by Link and Phelan (2001), was chosen because it has 
conceptual overlap and basis with Goffman’s theory, and is useful in understanding the 
driving force behind stigmatization which is not explained in Goffman’s theory. For 
those who have a disease that carries stigma, both of these conceptualizations are 
pertinent. Patients experience stereotyping and status loss with one on one interactions 
with people and they are also aware of and susceptible to larger processes that negatively 
impact society’s perception of the disease (Bell, 2014; Chapple, Ziebland, & McPherson, 
2004; Hamann et al., 2014; Rohan et al., 2016; Tod, Craven, & Allmark, 2008). The 
literature also supports that health care professionals are aware of and retain negative 
attitudes and stereotypes, and they note the structural discrimination of low funding and 
support for lung cancer given the high mortality and low five-year survival rates.  
The review of literature will be organized under the following concepts from Link 
and Phelan’s (2001) theory: discrimination, separation, and status loss. Concepts from 
Goffman’s theory will be grouped under psychological and social consequences of 
stigma. There will be subheadings under concepts that refer to the main theme of the 
studies starting with delays in care, comparisons of lung cancer to other cancers and 
stigmatized conditions, comparing smoking behaviors of patients with lung cancer, then 
narratives and measurements of psychological and social aspects of stigma.  
Stigma  
Stigma is a process whereby labels of individuals or a group are linked to negative 
stereotypes (Goffman, 1963) that can be used to separate that individual or group from 
the rest of society or from comparable groups, diminish their social status, and withhold 
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or divert resources from them (Link & Phelan, 2001). Stigma is also described as a 
characteristic used to identify an individual that can disgrace and dehumanize them in 
certain situations, and is contextually and temporally dependent (Goffman; Link & 
Phelan). Social, cultural, and political components of society determine which labels and 
characteristics fall within normal parameters and which do not (Link & Phelan); those 
that do not, acquire negative focus and stereotypes (Goffman). Members of society who 
determine what is normal are referred to as “normals”, and those who are not are the 
“stigmatized” (Goffman). For the purposes of this study, the label is a diagnosis, lung 
cancer, and the stereotypes are smoker, self-inflicted disease, personally responsible, 
pessimism, and nihilism. The negative qualifiers for these stereotypes are deviant, stupid, 
unclean, lazy, dirty, and ‘leper’. While the discipline of medicine created the label of lung 
cancer, society attaches additional meanings to this label so that the disease becomes not 
only biologically defined, but socially defined.  
Goffman. The concept of stigma also contains the various people who interact to 
create it, realize it, counteract it, perpetuate it, receive it, and endure the consequences of 
it. People who determine what is normal and what is different, or outside normal 
parameters, are called “normals” (Goffman, 1963, p. 5), and they also fall within said 
parameters. “Normals” hold expectations of social situations regarding what should and 
should not be, and with these expectations create a “virtual identity” of the stigmatized. 
“Normals” retain judgements, attitudes, beliefs, biases, and stereotypes about people with 
lung cancer which may or may not be damaging. The “Own” and the “Wise”, are those 
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who share the stigma and are empathetic and knowledgeable about the plight of the 
stigmatized respectively (Goffman).  
The “stigmatized” are the recipients of these judgements, attitudes, beliefs, biases, 
and stereotypes because they have a label that not only places them outside the 
parameters of normal, but can become an all-encompassing identifier when examined by 
“normals”. Labels that are judged range from visible abnormalities, to ethnicity, to 
“blemishes of individual character” such as “addiction” (Goffman, 1963, p. 4). The 
“stigmatized”, at times, endure several social and psychological continuums (a) their 
status may move from “discreditable” to “discredited” (Goffman, p. 4) in which their 
stigma is not known and becomes known; (b) accepted to rejected when they interact 
with others who are stigmatized and then with normals; (c) self-blame, self-stigma, and 
shame to defiance when they absorb society’s perceptions of their condition or reject it.  
What is normal and what is different is determined by personal values, beliefs, 
and knowledge which stem from larger social values and the culture in which a group or 
individual is situated (Link & Phelan, 2001). Determination of what is normal and what is 
not helps a society and individuals within to organize their social world (Jones et al., 
1984) such that labels become background, are seldom questioned, and are “…taken for 
granted as being just the way things are” (Link & Phelan, p. 367). Labels and stereotypes 
are also permeated with moral meanings that validate them and have the potential to elicit 
strong reactions from individuals and groups (Jones et al.). The process of labeling and 
stereotyping begins as a way to organize and categorize information to simplify cognitive 
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processes (Volinn, 1983), yet the consequences of this process are detrimental socially 
and psychologically for individuals and groups.  
Stigma has also been distinguished as a “…language of relationships, not 
attributes…” (Goffman, 1963, p.4), meaning that stigma is lessened or amplified 
depending on the social context and what comparisons are being made. For diseases that 
carry a stigma, there is also a language of associations. The disease acquires stereotypes 
and status loss before the person develops it, then the person inherits the stigma 
associated with the disease as well as having to cope with physical symptoms. 
Consequently, disease-related stigma creates a disparity among diseases where some are 
burdened with social, psychological, and political problems more than others. In the 
context of lung cancer stigma, this can mean that certain diseases that also carry a stigma 
seem normal in comparison or that those who have had diseases that are more stigmatized 
may not notice the stigma associated with lung cancer. For example, a patient with lung 
cancer who also has HIV notices the stigma associated with HIV but not with lung cancer 
(Rohan et al., 2016). Likewise, when lung cancer is compared to a disease that carries 
minimal negative stereotypes, the stigma is amplified.  
Psychological and Social Consequences of Stigma  
 The psychological consequences of stigma include anticipation of or actual 
instances of stereotyping, negative attitudes, status loss, separation, and discrimination 
that yields experiences of shame, self-blame, anxiety, depression, and decreased self-
esteem. Shame is an awareness of being a lesser person based on knowledge of societal 
norms (Goffman, 1963). In this sense, shame is linked to status loss, because the 
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experience of it is associated with diminution of a person’s own status in addition to the 
negative perceptions from society.  
Social Consequences of Stigma 
 The social consequences of stigma are alterations in social contacts that include 
avoidance, exclusion, concealment, and decreased empathy from “normals” (Goffman, 
1963). Avoidance behaviors may be initiated by either “normals” or the “stigmatized” in 
order to decrease the chances of an awkward interaction (Goffman). For the 
“stigmatized”, avoidance to a certain degree may lead to self-isolation, not only to 
decrease awkwardness, but to avoid stigmatizing attitudes from others (Goffman). 
Exclusion can be actual or anticipated, for example, a patient with lung cancer may 
anticipate feeling out of place at a breast cancer support group or may have actually 
experienced such a feeling.  
Counteracting Stigma 
The “stigmatized” may reject stereotypes linked to their label, and may even 
reject other people with the same stigmatized label (Goffman, 1963). For example, when 
people who have never smoked reveal their diagnosis of lung cancer they quickly 
reinforce that they have never smoked (Conlon et al., 2010) and that “…normal people 
who weren’t smokers…do get lung cancer” (Brown & Cataldo, 2013, p. 358). People 
with a stigmatized status may also react with antagonism in order to place “normals” in 
the defensive position (Goffman). In contrast, self and group advocacy occur as another 
mechanism to offset stigmatization, emphasize normal characteristics and labels, and 
provide support to those who have similar characteristics or the “own” (Goffman, p.33).   
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There are members of society who already know the struggles of those who have 
conditions that carry stigma. These are the people who work closely with those who are 
stigmatized, yet do not place emphasis on the undesirable labels and stereotypes. 
Goffman referred to these individuals as the “wise” who provide support, help, sympathy, 
and advocacy; he provided examples of health care professionals; yet health care 
professionals may also perpetuate the stigma consciously or unconsciously. A “wise” 
person can also be someone who is related or a friend to the person with a disease that 
carries stigma.  
A person or group can also have other labels in addition to their disease that carry 
stigmas, or multiple stigmas. For example, people with lung cancer may also have the 
stigmatized label of smoker, low income or poor, and low education attainment, which in 
turn are linked to multiple negative stereotypes. Stigma researchers have given this 
problem different names such as “stacked stigma” (Conlon et al., 2010, p. 99), “multiple 
disadvantaged statuses” (Stuber, Meyer, & Link, 2008, p. 353), and “compound[ded]” or 
“layered” stigma (Jain & Nyblade, 2012, p. 3). Whatever the nomenclature, a person who 
has multiple labels that are linked to stereotypes has an increased chance of subsequent 
social problems, such as social exclusion, diminished social status, and discrimination. 
Stereotyping and Status Loss  
 For stigma, stereotypes are a set of “undesirable characteristics” (Link & Phelan, 
2001, p. 369) that are linked to labels as a cognitively expedient process that may happen 
without full awareness. The negative nature of the stereotypes contributes to the process 
of separation, and the process of separation is not necessarily physical or spatial but 
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social demarcations of “us” versus “them” (Link & Phelan, p. 370). The group with the 
greater negative valence from stereotypes loses the most in social standing and 
acceptance. Separation is also initiated with diagnostic labels when people are referred to 
as their disease or behavior, for example: ‘diabetic’, ‘epileptic’, and ‘smoker’ (Link & 
Phelan).  
Discrimination  
 Discrimination, according to Link and Phelan (2001) is not confined to one 
person limiting the chances of another. There are broader forces that contribute to 
structural discrimination, or practices, policies, and barriers that work toward creating a 
disadvantaged status (Link and Phelan). They provide funding disparities for certain 
diseases, like schizophrenia, noting that it creates a disadvantage for the people who work 
with patients who have a stigmatized disease and the patients themselves (Link & 
Phelan). The authors assert that stigma “…affect[s] the structure around the person, 
leading the person to be exposed to a host of untoward circumstances” (p. 373). A 
downward social status trajectory from a label-stereotype link is another form of 
discrimination because the new lower status further limits opportunities and access to 
resources (Link & Phelan). 
Funding. Lung cancer is a diagnosis and label that simultaneously links those 
who have it to other patients with cancer yet differentiates them as having a unique form 
of cancer. The ‘why’ of this uniqueness is not just cellular or biological. Lung cancer has 
a strong link to social and psychological issues such as high mortality, socially and 
morally reprehensible behaviors, and disparate funding. The differences in funding have 
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been noted by several prominent scholars in nursing, public health, and psychology. 
These scholars assert that the stigmatization of smoking and lung cancer are responsible 
for low funding and that: 
A number of factors have contributed to this inequity. First, a large and vocal 
group of breast, prostate, and colon cancer survivors have raised the public profile 
of these cancers and successfully lobbied for increased funding. This pressure has 
translated into important budget earmarks and research emphases. Unfortunately, 
survivors of lung cancer are relatively few and thus underrepresented in the voices 
clamoring for more research support (Gritz, Sarna, Dresler, & Healton, 2007, p. 
860).  
 
Other scholars offer a similar perspective, noting that many famous women have 
talked openly about their experiences with breast cancer, creating a powerful force in 
support for breast cancer, while lung cancer has not benefitted from such support (Gulyn 
& Youssef, 2010). A journalist, and friend of Peter Jennings who died of lung cancer, 
recounted that he quit smoking when he heard of Jennings’ death and that the 
“…relatively paltry funding for lung cancer research suffers from the impact of smoker’s 
guilt — the "we bring it on ourselves" lament that even Peter referenced in his very last 
broadcast, saying he’d “been weak” and had gone back to smoking after 9/11.” (Taibbi, 
2007, para. 13). 
Power  
Power is the driving force behind stigma that allows it to be created, perpetuated, 
and maintained (Link & Phelan, 2001). Sources of power are social, political, and 
economic, but they may not be obvious since observations of differences tend to focus on 
characteristics, not the myriad of forces contributing to a lack of equity (Link & Phelan). 
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Stigma can involve links to many stereotypes, which can in turn consume the person’s 
identity (Goffman, 1963; Link & Phelan; Volinn, 1983) leading others to see them as a 
lesser person and threaten their social status. Part of the power of stigma is that it may not 
be detected until the consequences have damaged a person’s identity, for example a 
person who never smoked can get lung cancer and subsequently be included in the 
stereotype of a ‘self-inflicted’ disease (Conlon et al., 2010).  
Health care professionals and other “normals” have power first and foremost 
because they typically do not have lung cancer, and because of their status as trusted 
professionals that the public has become reliant on for knowledge about health (Starr, 
1982). This status allows them to create labels in the form of diagnoses, form judgements 
about causes and behaviors past or present, plan care based on those judgements (at the 
individual level or population level), and they are aware of and can carry forward extant 
stereotypes, negative attitudes, and beliefs about diseases that are stigmatized because 
they occur in the culture in which they practice (Volinn, 1983).  
All health care professionals have power in relation to the people they care for 
because patients interact with the health care system when they are at their most 
vulnerable or progressing toward that state, and at times, their naiveté of the health care 
system contributes to powerlessness in being active agents in their care. More 
importantly, patients, due to their more vulnerable position as an ill person in a large and 
complicated health care system, are less able to offset negative stereotypes. Because there 
is a power difference between patients and health care professionals, if patients were to 
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stereotype health care professionals this would not result in stigma because it does not 
originate from the same status or knowledge level.  
This vulnerable position is compounded, in part, by labeling processes that are in 
the control of health care practitioners (Volinn, 1983). Health care professionals, nurses 
specifically, also control the patterns and routines of care, which stem from facility 
policies, and impacts communication and interactions with patients (Hewison, 1995). 
While retaining the intention to help and promote health, health care professionals are 
also positioned to set the goals and interventions for health promotion, requiring little 
input from patients; yet when the interventions are not successful there are negative 
physical, social, and psychological consequences for patients (Tengland, 2016). 
While health care professionals may or may not be able to transmit stereotypes 
and negative attitudes to the broader public, they can do so within their professions 
because they are responsible for teaching and mentoring students in their respective 
disciplines. They also transmit their attitudes to other health care workers during day to 
day interactions with patients in the form of slang, games, and derogatory humor (Wear, 
Aultman, Varley, & Zarconi, 2006). Third and fourth-year medical students, n =58, who 
participated in focus groups where they were asked to describe cynical or derogatory 
humor about patients, students described the people who were the object of humor who 
were mostly obese patients, and anyone who is at fault for their disease including people 
who smoke, drink, use drugs, have unsafe sex, practice illegal behaviors, and those who 
are noncompliant (Wear et al.). The status of an experienced professional which includes 
their advanced knowledge, stable status in the profession, and expertise, means they may 
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not be questioned about the way they choose to express their beliefs, attitudes, or 
stereotypes, particularly from their students, mentees, or supposed subordinates (Wear et 
al.).   
The stigmatized alternate between two identities, one that contains their actual 
characteristics, and the other which consists of imputed characteristics from society and 
“normals” (Goffman, 1963). Hence, actual characteristics that carry a stigma and are 
known make the stigmatized a “discredited” person; when they are not known, a 
“discreditable” one (Goffman, p. 41). Extant stereotypes, labels, and characteristics are 
also an expedient method of organizing and simplifying information in order to mitigate 
uncertainty in encounters; health care encounters are no exception (Puhl & Suh, 2015; 
Sriram et al., 2015; Volinn, 1983); however, such methods potentially have low accuracy 
and a high degree of adverse psychosocial outcomes (Goffman; Volinn).  
Psychological and social processes occur for “normals” and “stigmatized” alike 
with regard to stigma. Social construction of diseases means, in part, that people form 
“lay theor[ies]” about the illness and how it fits within the social hierarchy; are people 
with the disease welcomed, empathized with, or judged harshly and excluded (Link & 
Phelan, 2001, p. 373). Psychological processes of stigma for the stigmatized can include 
incorporating the negative attitudes of “normals” in the form of self-blame, shame, and 
essentially stigmatizing oneself (Goffman, 1963). Figure one is a diagram of the major 
concepts in both Link and Phelan’s theory and Goffman’s Theory.  
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Figure 1.  Diagram of Concepts in Stigma Theories.  
 
This study focuses specifically on stigma as it relates to lung cancer and the 
nurses who care for patients with lung cancer. Society, health care professionals, and lay 
caregivers of people with lung cancer have been studied as the perspective of “normals” 
and potential stigmatizers. Stigma frameworks have also been used to study patients with 
lung cancer. Nurses as a distinct profession within health care have not been studied 
qualitatively except in studies of obesity-related stigma (Aranda & McGreevy, 2014; 
Brown & Thompson, 2007), and HIV/AIDS and stigma (Greeff & Phetlhu, 2007). There 
is one quantitative study that examines the perspectives of nurses in relation to lung 
cancer stigma (Wang et al., 2015).   
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The following review of the literature is organized by concepts from Goffman’s 
theory of stigma (1963) and those from the Link & Phelan (2001) conceptualization. 
Other concepts that emerged from the literature will also be discussed with regard to 
studies that tested or explored them. The process of stigma begins with links that are 
made between labels and stereotypes, then progresses to separation of the stigmatized 
from other groups in society that are considered normal, and finally discrimination; with 
power as the social, political, and economic force behind the stigmatization process (Link 
& Phelan).  
Stereotypes, Bias, Negative Attitudes, and Therapeutic Nihilism 
The social construction of disease that includes connecting stereotypes to labels 
can contribute to biased perceptions that are in favor of or against an illness (Dovidio & 
Fiske, 2012). For example, some diseases may be favored by health care professionals 
because they have a clearer treatment course, and some patients may be favored because 
they are viewed as curable or treatable (Ford, Liske, & Ort, 1962; Wear et al., 2006). 
Diseases that are difficult to treat typically have sequelae or outcomes that do not return 
to normal parameters. For example, most of the cancers with high incidence rates also 
now have high five-year survival rates, except lung cancer (American Lung Association, 
2017).  
Knowing that a patient with lung cancer has a higher likelihood of dying than 
surviving may not only foster an anti-lung cancer bias (Sriram et al., 2015), but create 
room for therapeutic nihilism, or the belief that because the disease has poor treatment 
outcomes it is not treatable (Schroen, Detterbeck, Crawford, Rivera, & Socinski, 2000), 
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and only natural, or nonmedical, forces could lead to good outcomes (Starr, 1982). 
Encounters with patients who have a disease such as lung cancer that has a high mortality 
rate may imbue people with a fear of dying; a powerful existential crisis that pushes 
against the boundaries of normal parameters (Jones, 1984).  
Smoking and Stigma 
History of Lung Cancer and Smoking Stigma  
Lung cancer has been linked to smoking since the mid twentieth century when 
scientists, statisticians, and physicians suspected the link, but could not study the problem 
until there was appropriate funding for such research (Mukherjee, 2011), and the extreme 
doubt and ridicule of other scientists and physicians of the proposed link was overcome 
(Brandt, 2007).  This effort and the overwhelming scientific evidentiary support that 
followed the initial link were so controversial that other causes of lung cancer did not 
have the same strong connection in the public’s mind (Mukherjee). Moreover, an existing 
struggle at the time, to find the cure and cause of cancer, made lung cancer both famous 
and infamous because finally there was a known cause for a type of cancer and it could 
be prevented (Mukherjee).  
The 1964 Surgeon General’s report on the dangers of smoking solidified the 
science – yet politically the report was downplayed so as not to offend tobacco 
companies and politicians who supported them (Mukherjee, 2011). However, the report 
led to important policies to limit the impact of tobacco advertising on the public which to 
that point was mostly unfettered and unregulated (U.S. Department of Health and Human 
Services, 2014). Meanwhile, people who smoked were having a difficult time quitting, 
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because the scientific focus was on epidemiology not physiology, or addiction (U.S. 
Department of Health and Human Services). When scientific focus moved toward 
smoking and addiction, again propaganda thwarted efforts to address the problem of 
smoking realistically. Smoking was advertised to be not only a personal choice, but a 
matter of freedom (Brandt, 2007). There was additional reluctance to proclaim that 
smoking was addictive because the association to ‘addict’ was considered to be too much 
of a negative connotation.  
Other stereotypes and judgements that were propagated at this time were that 
smoking was a choice (Mukherjee, 2011), smokers were selfish, immoral with character 
flaws (Brandt, 2007), and that lung cancer was self-inflicted (Mukherjee). In addition, 
since non-smokers were “innocent victims” of second-hand smoke, it was their health 
concerns, not those of people who smoked, that garnered widespread attention and 
cigarette smoke was soon on par with industrial level air pollution (Brandt, p. 281). 
Smoking, at the time, was also linked to heart and vascular disease and heart disease was 
termed “tobacco heart” (Brandt, p. 146); yet this stereotype (for there are now many 
hypotheses about the cause of heart disease) did not have the same lasting link as 
smoking to lung cancer. Although there is almost no comparable link to smoking and 
other cancers, the behavior is by no means uncommon to other cancers. For example, a 
recent study of people diagnosed with breast cancer revealed that of the 975 breast cancer 
patients who participated, 20% were current smokers and 29% were former smokers. 
(Izano, Satariano, Hiatt, & Braithwaite, 2015). 
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Social. Smoking underwent a dramatic change from socially acceptable to deviant 
over the past century to the present (Brandt, 2007). Social forces that discourage smoking 
are often the same entities that link the behavior to disparaging stereotypes such as all 
people who smoke are lazy, stupid, careless, and selfish. These stereotypes are based on 
taken for granted ideas that extant knowledge of the dangers of smoking should be an 
automatic stimulus for immediate behavior change (Brandt, 1990) – therefore those who 
have not responded have inherent character flaws. This belief, that widely disseminated 
health information is synonymous with lasting behavior change, has largely been 
debunked (Rollnick, Mason, & Butler, 1999), and does not apply only to smoking 
cessation – behavior change and adherence to that change is difficult and complex, and 
does not occur only with advice (Rollnick et al.).  
Political. The social influences on stigma and smoking, and hence stigma and 
lung cancer stem in part from policy and politics. Political power allowed tobacco 
companies to advertise, campaign, and lie about cigarettes for many decades (Brandt, 
2007). Policies that counteracted the negative influence of tobacco companies led to 
broad sweeping public health initiatives such as tobacco denormalization. These 
initiatives were a direct counter measure to the powerful propaganda and advertising 
from the tobacco companies, but did little to address the complex issues of dependence. 
Furthermore, there was delayed recognition of the negative consequences of 
denormalization campaigns such as marginalization of vulnerable groups of people who 
smoke like those with low education attainment, mental illness, low income, and minority 
ethnic groups (Brandt, 1990).   
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Throughout the enactments of policies and positions, and counter policies and 
positions about smoking and lung cancer, there are descriptions of the process that allude 
to a battle or war (Mukherjee, 2011). Since one side of the battle, the tobacco companies, 
had enormous economic, political, and social influence – not to mention consumers who 
were addicted to their product – they had to be met from opposing sides with an equal 
force which was directed both at tobacco companies and the behavior of smoking in the 
public realm. Two main goals of this battle were to decrease the influence of tobacco 
companies and their ability to retain customers and lure new ones, and the other was to 
change public perception about smoking.  
These negative stereotypes linked to smoking, make people who smoke and 
smoking related diseases a politically weak, negatively constructed deviant group that is 
more likely to be punished than given advantage politically and with public policy 
(Schneider & Ingram, 1993). The attorneys general of 46 states sued the largest four 
tobacco companies in the Master Settlement Agreement (MSA) for billions of dollars to 
be paid to the states over several decades, ideally for smoking related illnesses and 
tobacco use prevention; this may seem like a politically powerful and strong advocacy 
effort on behalf of those who smoke and have smoking-related illnesses. However, use of 
the money for tobacco use prevention and tobacco-related illnesses was never specified in 
the settlement, consequently, over the years the money has been used to fund various 
budgets that were not even health related (U.S. Department of Health and Human 
Services, 2014).  
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Smoking now is not only a risky health behavior, but a deviant behavior since it is 
banned in most public places. These policies to restrict smoking have interacted with 
individuals’ struggles with nicotine dependence, leading to social situations fraught with 
conflict (Greaves et al., 2010; Ritchie, Amos, & Martin, 2010). Deviance has also been 
attached to smoking via clean air policies that were initiated in response to anti-smoking 
advocacy groups asserting that people who smoke are endangering the lives of others 
intentionally (Markle & Troyer, 1979). Markle and Troyer presaged the stigmatization of 
smoking when they noted that “[c]igarette smokers, who in increasing numbers see 
themselves as deviant actors, have been labeled as drug addicts and neurotics as well as 
air polluters and fire hazards” (p. 622). 
Political and social power have worked both for and against lung cancer due to 
their influential attachment of the disease to smoking. The link to smoking stimulated 
policies to reduce smoking and counteract the tobacco companies, but it also 
dehumanized people who smoke by portraying them with grotesque images and as 
engaging in horrific acts (Thompson, Barnett, & Pearce, 2009; The Real Cost, 2016). 
While there are arguments both for and against fear-based smoking denormalization 
campaigns, the target groups for these messages are already vulnerable and marginalized 
groups where smoking prevalence is high such as low income, low education attainment 
(Garrett, Dube, Winder, & Caraballo, 2013), people with mental illness (Centers for 
Disease Control and Prevention, 2013), lesbians, gays, and bisexuals, and ethnic minority 
groups such as American Indians/Alaska Natives (Martell, Garrett, & Caraballo, 2016). 
The disgusting images portrayed in these campaigns gives tacit permission to further 
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stigmatize these groups who are already struggling with multiple stigmas. The 
denormalization campaign was effective with high income, high education attainment 
smokers and less so with people on the other end of the sociodemographic spectrum. In 
addition, vulnerable and marginalized groups, today, have high smoking prevalence and 
more difficulty with quitting.   
The U.S. Department of Health and Human Services 2014 report on smoking and 
health consequences notes that when smoking was first linked to lung cancer and other 
diseases, there was little knowledge on how addictive it was. While this information was 
eventually gathered and disseminated in a 1988 report, there is still a significant lag in 
bringing this information and the clinical practice guidelines for tobacco cessation to the 
patient who smokes to provide the best opportunity for tobacco cessation. There were 
powerful efforts to convince people to stop smoking, and minimal support for people who 
smoke to achieve smoking cessation and maintain the behavior change (Leventhal & 
Cleary, 1980). The denormalization of smoking, the lag in wide dissemination of 
cessation support, the political ties of the tobacco companies to the U.S. Government, and 
ambiguous advocacy efforts in the form of the Master Settlement Agreement have all 
contributed to a general pall over smoking behavior and expressions of distrust by some 
people who smoke toward screening for lung cancer (Carter-Harris, Ceppa, Hanna, & 
Rawl, 2015).  
 The stigmatization of smoking has been studied and examined since the 1970s. 
Even then, scholars were concerned that the battle to decrease smoking prevalence 
among the public would change into a fight between smokers and non-smokers (Markle 
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& Troyer, 1979). Further investigations in the late 90s indicated that smoking was no 
longer only viewed as a health concern, 16.8% of a sample of 715 students, their parents 
and grandparents agreed that smoking was immoral, and the feelings of disgust expressed 
by non-smokers is more closely correlated with morality (r = 0.40) than health (r = 0.14) 
and this difference remained significant across six subsamples (p <0.02) (Rozin & Singh, 
1999).  
 While there is some support that the anti-smoking attitudes push people toward 
behavior change when they feel shame (p = 0.043), stereotypes of smokers having a weak 
character was not a predictor of behavior change (Kim & Shanahan, 2003). In addition, 
most studies that examine the impact of stigma on behavior change are cross sectional, so 
there is no way to determine the direction of this relationship: does a failed attempt at 
behavior change lead to shame and thoughts about trying again, or the reverse? Even less 
apparent is how long shame is useful as a stimulus for behavior change. The most telling 
outcome of years of shaming citizens through public health campaigns is that none of the 
clinical practice guidelines or behavior change techniques endorse shaming or stigma as a 
way to interact with a patient; as a matter of fact, this is considered to be 
counterproductive and damaging (Kim & Shanahan). Unfortunately, public health 
initiatives regarding denormalization of cigarette smoking set the stage for how smoking 
cessation should be viewed, that it is the individual’s responsibility (Brandt, 1990). These 
initiatives conflict with current cessation guidelines that are underpinned with 
motivational interviewing techniques that use a partnership model for behavior change 
assistance (Miller & Rollnick, 2013).   
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While judgements of intelligence by the public toward smokers might seem 
justified, since the harms of smoking have been widely disseminated for many decades, it 
also demonstrates a stereotype that if something is known to be harmful and is done 
anyway, the person must lack intelligence. The stereotype negates the complex 
dimensions of cigarette dependence, and the person, not the behavior, is criticized.  
Delays in Care 
Delays in seeking care for symptoms of lung cancer represent the concepts of 
stereotyping, status loss, and discrimination. Patients delay seeking care for symptoms 
related to lung cancer because of extant stereotypes about the causes of lung cancer, their 
symptoms are vague, they have fear, and there are nihilistic attitudes retained by patients 
and physicians. There is also a desire to improve their status by quitting smoking before 
they go to their doctor, something Goffman (1963) referred to as attempting to mitigate 
faults in order to obtain “…fully normal status…” (p.9), but only achieving partial 
acceptance as someone with a history of stigma.  
Delays in Care, Studies of “Normals” 
Delays in care emerged as an issue in the care of patients with lung cancer in four 
qualitative studies with mixed samples of health care professionals and one quantitative 
study of physicians.  One qualitative study design was specific to creating a health 
advertisement for people at risk for lung cancer so they would not delay getting care (Tod 
& Joanne, 2010), the other studies explored outcomes and support (Dunn et al., 2016), 
how practitioners perceive symptoms and referrals (Scott et al., 2015), and barriers to 
care, for patients with lung cancer (Tran et al., 2015). The perceptions of physicians, and 
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the potential impact on referral and knowledge of patients with breast cancer versus lung 
was represented in one quantitative study (Wassenaar et al., 2007).  
In a qualitative study with a purpose of creating a health advertisement to prevent 
delay in care seeking for people at risk for lung cancer, Tod and Joanne (2010) 
interviewed 14 health care professionals (nurses and pharmacists).  The participants 
reported that delays in care-seeking behavior occurred because the patients were afraid of 
being blamed, shamed, judged, and not being treated well because of continued smoking.  
Additionally, health care professionals noted that people at risk for lung cancer fear a 
potential diagnosis of cancer, have fatalistic beliefs that are exacerbated by negative 
advertisement campaigns against smoking, try to manage the symptoms themselves, or 
wait until they are severe.   
Similarly, in another study of physicians, nurses, therapists, and health workers in 
Australia, n = 31, delays in receiving care occurred when a patient’s symptoms were 
immediately linked to smoking by the practitioner, without further investigation or 
screening for lung cancer, patients attribute their own symptoms to other causes, they feel 
like they do not deserve care, they have shame related to smoking, and they do not want 
to be blamed by health care professionals (Dunn et al., 2016). Health care professionals 
also noted that smokers and nonsmokers experience the stigma associated with lung 
cancer, and engage in self-blame. Fear, again, spurred by negative public health 
advertisements was noted to be a deterrent to timely care (Dunn et al.).  
Two other qualitative studies had themes related to barriers or delays in care for 
patients with lung cancer from the perspective of general practitioners in Australia, n = 
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10 (Scott et al., 2015), and anther sampled health care professionals and non-healthcare 
professionals, n = 74, who work for lung cancer nonprofit organizations in Canada (Tran 
et al., 2015). General practitioners noted that there is more compassion for patients who 
get lung cancer and never smoked, and those who never smoked have a delayed path to 
diagnosis because lung cancer is not factored into the differential diagnosis (Scott et al.). 
One general practitioner remarked: 
Because it presents so late, there’s not much you can really do except to tell 
people “If you get it because you were smoking, well we told you, you shouldn’t 
have smoked. If you didn’t smoke at all and you still got it, you’re just really 
unlucky” (Scott et al., p. 620).  
 
Patients at risk for lung cancer who sense or experience these attitudes from their 
physicians may not only delay returning for worsening or repeating symptoms, they lose 
trust in health care professionals.  
Of the 74 participants in the Tran et al. (2015) study, 28% endorsed that there is a 
general unfavorable view toward lung cancer. A radiologist indicated that the shame and 
self-blame that patients experience diminishes their self-agency, and they do not take 
action related to their symptoms. A thoracic surgeon and oncology social worker asserted 
that nihilism related to lung cancer is still a problematic attitude among health care 
professionals and impacts care decisions and referrals to cancer centers. A physician 
recalled discussions with other physicians about lung cancer screening and arguments 
against it for people who smoke (Tran et al.). Fifty-eight of the 74 participants in this 
study did not see stigma as a problem related to barriers in lung cancer care, however, the 
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authors only provide two examples of this response, one from a health administrator and 
the other participant had no title attached to their quote.  
 Delays in care may also occur after a diagnosis of lung cancer. A cross-sectional, 
experimental, factorial study of 672 internal medicine and family physicians who were 
randomly assigned to one of four vignettes of patients with lung cancer or breast cancer 
in which the smoking status and tumor stage were manipulated, revealed that perceptions 
of lung cancer differ from those of breast cancer in the context of referral decisions, 
therapy benefit, and follow up (Wassenar et al., 2007). Patients with lung cancer and 
metastatic disease were significantly less likely to be referred to an oncologist than breast 
cancer patients (p < 0.001), less likely than breast cancer patients to receive follow up 
every one to two weeks (p < 0.0256), and knowledge about adjuvant therapy and the 
survival benefits were less for lung cancer than breast cancer (p = 0.001).  Although these 
findings might be attributable to lack of knowledge there was no statistical difference 
between physicians who saw fewer cancer patients than those who saw more (Wassenar 
et al.). 
Critique 
The studies discussed above have limitations.  First, the qualitative studies all 
have mixed samples of health care professionals and do not always identify the 
profession of the person quoted.  Second, some of them did not adequately describe their 
analytic rigor (Tod & Joanne, 2010, Scott, 2015).  None of the studies addressed 
saturation of the sample.    
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While all of the studies provided diverse viewpoints among the different health 
care professions, all of the studies were also conducted in places with socialized 
medicine, which is different from the United States; however certain psychosocial issues 
related to lung cancer likely span health care cultures. Most of the studies did not ask 
about stigma directly, but used broad open ended questions about practices, barriers, and 
support for lung cancer. One study asked the main interview questions first, then asked 
about stigma and nihilism with prompts (Dunn et al., 2016).  
The instrument used in the Wassenar et al., 2007 study was not an established 
instrument, although it was partially validated with feedback from the research group and 
medical oncologists, and was piloted. Despite this limitation, some of the findings in the 
study are congruent with comments from participants in more recent qualitative studies.  
Summary 
Overall, the perceptions of health care professionals are that patients with lung 
cancer experience stigma. While one study found that the majority of people interviewed 
did not see lung cancer as a stigmatized disease (Tran et al., 2015), the other studies 
found that this was the minority perception. Since these different perceptions will likely 
occur in future studies, it would be useful to obtain a richer description of how people 
view lung cancer if they do not see any stigma attached to it; perhaps not only the label of 
lung cancer, but the stereotypes, status loss, and discrimination have become “…taken for 
granted as being just the way things are” (Link & Phelan, 2001, p. 367).  
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Delays in Care, Studies of Patients  
 Delays in care can also be examined from the perspective of people at risk for 
lung cancer and people who have been recently diagnosed. Three qualitative studies 
explored delays in seeking care for symptoms related to lung cancer (Tod et al., 2008), 
trajectories of being diagnosed with lung cancer (Carter-Harris, Hermann, & Draucker, 
2015), and perceptions of screening for lung cancer (Carter-Harris, Ceppa, et al., 2015). 
These studies represent patients with lung cancer and patients at risk for lung cancer.  
 A qualitative study of 18 patients who had been diagnosed with lung cancer in the 
past six months (n=16), and two who were 18 month survivors in the United Kingdom, 
revealed congruency with statements made by health care professionals about potential 
delays in seeking care (Tod et al., 2008). When recounting their symptoms prior to 
diagnosis, participants noted that they would attribute new symptoms to changes in their 
environment or their age, but not a serious illness. Participants also stated that there was 
more information about breast cancer than lung cancer noting "You’re more likely to 
think of yourself getting breast cancer than lung cancer, even as a smoker" (Tod et al., 
p.340), and that advertisements that use scare tactics were deterrents to wanting to find 
out about health problems.  
Negative advertisements that link lung cancer to smoking also portray the idea 
that smoking is the only cause of lung cancer. Participants who quit smoking believed 
they were no longer at risk for lung cancer, and those who smoked and did not quit 
anticipated blame related to their behavior and were questioned repeatedly about their 
smoking behavior (Tod et al., 2008). Beliefs about when to see a doctor, when the 
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problem is severe, and how much it would cost (prior to universal health care) also 
contributed to delays (Tod et al.).   
 Another qualitative study of patients with lung cancer who smoked, n = 11, in the 
United States, sought to discover how patients with lung cancer become diagnosed 
(Carter-Harris, Hermann, et al., 2015). All of the participants in this study sought care 
when they noticed their symptoms persisted or were accompanied by other symptoms 
such as weight loss, exhaustion, and chest pain. However, their stories of finally getting 
diagnosed with lung cancer reveal experiences of frustration and duress because the 
prescribed treatments for the supposed problems of pneumonia, high blood pressure, and 
sinusitis never worked; one woman was told by her physician that it was “all in her head” 
and this delayed her seeking care again when her symptoms became more severe (Carter-
Harris, Hermann, et al., p. 579). She was finally diagnosed when she went to the 
emergency room and a chest x-ray was done. Another participant spoke of her many 
visits to a health care provider because the antibiotics were not working, she started 
crying in frustration during an office visit where she had a CT scan and was diagnosed 
with stage IV non-small lung cancer. Other participants, who had more drastic symptoms 
such as hemoptysis, a better rapport with their physician, or had tests related to another 
problem, had a quicker pathway to diagnosis.  
 The patients in this study were all at high risk for lung cancer, yet the screening 
process for some of them was not triggered despite having a smoking history and 
indicative symptoms. Moreover, patients had further delays due to the attitudes of their 
providers who did not believe the problem was serious or who did not take their patients’ 
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concerns seriously. Delays in diagnosis are further complicated by the perceptions of 
people at risk for lung cancer.  
In a mixed method study, 163 people from communities of low socioeconomic 
status in England who currently smoked or had a history of smoking revealed their own 
sense of pessimism regarding lung cancer screening (Quaife, Marlow, McEwen, Janes, & 
Wardle, 2016). Among participants who smoked, 20% believed that there was no benefit 
to screening for a prolonged history of smoking or current smoking, and 30% thought a 
negative screening result meant they could continue smoking without further risk of lung 
cancer. Lung cancer was thought to be a “death sentence” by 48%, and 20% thought that 
people who perform the screening would be rude to people who smoke (Quaife et al., p. 
5). These results further amplify the belief among smokers that they have to quit before 
they seek treatment or screening, instead of viewing health care professionals as people 
who can help with quitting. Comments from participants also revealed anticipated stigma 
and blame from health care professionals and feelings of guilt and regret.  
Similar results emerged in another mixed methods study in Australia (Crane et al., 
2016). Data from 16 focus groups were compared to survey information from 1,000 
randomly sampled people who answered a telephone survey. From the survey results, 
participants who had higher SES, were older and female had better knowledge of the 
symptoms of lung cancer. Some of the participants who were current smokers offset the 
link of smoking to lung cancer by attributing the risk to air pollution (28.1%) and 
aerosolized chemicals (30.8%). A participant who was a current smoker noted “We know 
the facts, yet we still smoke. So we’re obviously in denial about a lot of things. We can 
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accept one point of view and another, because we’re playing mind games with ourselves” 
(Crane et al., p. 6). Other participants noted barriers to going to the doctor such as 
delaying for a long as possible because the problem is “self-inflicted” and another noted 
“Possibly a feeling that the doctor is going to focus on your smoking “don’t bother 
coming back until you’ve fixed your smoking” (Crane et al., p. 5). 
 The last qualitative study included 26 long-term smokers who were recruited for 
four different focus groups; two focus groups included people who had been screened for 
lung cancer and two groups were comprised of those who had not been screened (Carter-
Harris, Ceppa et al., 2015). During the focus groups, participants discussed potential 
obstacles to screening and ways it can help people at risk for lung cancer. Consistent with 
comments from health care professionals, people at risk for lung cancer, and current and 
former smokers, pictured having lung cancer as a fearful, horrible experience that 
inevitably results in death, and that health care professionals blame them for smoking and 
treat them as if they are “stupid” for doing so (Carter-Harris, Ceppa, et al., p. 7). While 
participants thought that current and former smokers should be screened, they also 
expressed poor knowledge of the existence of lung cancer screening and how it is done, 
even those who had been screened, and there was mistrust of both tobacco companies and 
the government for supporting and profiting from them. These suspicions carried over to 
screening which was seen as a way to make money – a way to get people in for one test 
then order more tests. One participant noted that the historical timing of lung cancer 
screening seemed suspicious:  
I hate to be kind of skeptical of modern technology…all of a sudden now we’re 
hearing about lung screening. All of these years, how long have cigarettes been 
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around, and how many people have died from lung cancer or whatever, now we 
have the screen (Carter- Harris, Ceppa et al., 2015, p. 6).  
 
Critique 
 All of the studies above provided explanations of analytic rigor as far as using an 
analytic plan, multiple coders, and discussion of codes, but again did not address 
saturation or an audit trail. Samples for these studies were mostly White, so they 
underrepresent minority views on these issues, and it is not clear from the quotes which 
people expressed what opinions. It cannot be ruled out that while breast cancer appears to 
dominate the cancer discourse, White participants, so far, dominate the discourse on 
perceptions of lung cancer in the literature. One study, Tod et al. (2008), did not report 
the ethnicity of their participants or the education level, and another study, Carter-Harris, 
Ceppa, et al. (2015), reported the mean education level but did not include this category 
in their demographic table. However, one study, Carter-Harris, Hermann, et al. (2015) 
had a near even split between low and high education attainment participants. Low 
education attainment is one of the key demographics for high smoking prevalence.  
Summary 
Many of the comments made by patients in these qualitative studies are consistent 
with what health care professionals have said about problems with perceptions of lung 
cancer. Patients note the fear surrounding smoking and lung cancer from public health 
advertisements, that breast cancer and other cancers are more prominent in the media and 
have more support, symptoms of lung cancer can be vague or not taken seriously due to 
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smoking, and that people who smoke anticipate, or are actually blamed and made to feel 
small.  
Comparing Lung Cancer to Other Cancers  
 
  The comparison of lung cancer to other cancers is a form of separation and 
discrimination. While this comparison is sometimes prompted by the research design, 
there is support that lung cancer is not treated like any cancer and not just because of 
biological processes, but because it is linked to a behavioral cause which is not as 
perceptually prevalent for other cancers.  
 Perspective of “Normals”  
  Lung cancer is compared to breast cancer by both patients with lung cancer, the 
public, health care professionals, and as part of study designs as a non-stigmatized 
disease referent. Breast cancer is used as a referent because there is no widely known 
behavioral cause of the disease. Patients with lung cancer note that a lump in the breast is 
treated more seriously by health care professionals than a persistent cough (Chapple et 
al., 2004). In other qualitative studies breast cancer is perceived to have more support and 
funding (Conlon et al., 2010; Scott et al., 2015), more overall public awareness (Conlon 
et al.; Tod & Joanne, 2010), and this is fueled in part by longer five-year survival which 
contributes to self-advocacy among breast cancer survivors (Conlon et al.).  
Oncology social workers, n = 18, from 17 different hospitals in 13 different states 
were interviewed for their perspectives on differences between lung cancer and other 
cancers and differences among patients with lung cancer (Conlon et al., 2010). Among 
other themes such as smoking status and poor outcomes, participants noted the difference 
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between advocacy for breast cancer and for lung cancer stating “there seems to be so 
much awareness and advocacy at a national level and in the media that really helps 
women to understand this cancer” and “…the resources are just not there for people 
diagnosed with lung cancer. Susan G. Komen has this nice $1,000 grant that they are 
giving to people with breast cancer but there is nothing like that for lung” (Conlon et al., 
p. 106). Other participants note the differences in support and funding saying:  
[w]ith the more common cancers, such as prostate and breast cancer, there is more 
information, support, and money for patients—especially for breast cancer. 
There’s more grant funding. I meet breast patients in outpatient radiation. There 
seems to be so many resources for them. It’s a shame because with brain and 
lung, especially lung, there seems to be so much less available (Conlon et al., p. 
107).  
 
Another participant notes the impact on patients, saying: 
And, there’s the frustration that there are not as many resources for lung cancer. 
There’s not as many walks and talks and volunteering. My patients would get 
things about this breast cancer run and that leukemia and lymphoma event. There 
was just nothing for them. There wasn’t that same kind of outpouring for lung 
cancer. Patients would be frustrated with that, with the lack of resources. That 
played into that feeling of this disease being stigmatized. They struggled with that 
(Conlon et al., 2010, p. 107). 
 
The comments are supported by a quantitative experimental, factorial design 
study that examined the funding choices of 462 and 299 college students in two separate 
studies (Knapp-Oliver & Moyer, 2012). In the first study, participants were randomly 
assigned to a scenario that was high or no risk and either lung cancer (caused by 
secondhand smoke or smoking) or breast cancer. In the first study, participants preferred 
less risky programs to fund and the cause of the cancer did not change the direction or 
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strength of the relationship between how the disease was presented and provision of 
funding (Knapp-Oliver & Moyer, 2012). In the second study, lung cancer and breast 
cancer were presented as being in competition for funding. Findings for this study 
indicate that even among college students, who are theoretically not involved in real 
funding decisions, the behavioral cause of the cancer led them to choose funding breast 
cancer over lung cancer when the two cancers were in competition for funding. When 
participants were exposed to scenarios where the cause of lung cancer was not the 
patient's fault, lung cancer funding was preferred. When students were asked to explain 
their funding choice, the majority of responses (27.6%) involved noting the behavioral 
cause of lung cancer, and one participant noted specifically that lung cancer is caused by 
"lifestyle choices" while breast cancer "occurs naturally" (Knapp-Oliver & Moyer, p. 
2378). While other participants (11.2%) noted that lung cancer patients have a lower 
survival rate and should therefore receive more funding − however these views were in 
the minority. 
Similarly, in a cross-sectional study of 1,071 participants who were randomly 
sampled from the general public, 18% reported being involved in a breast cancer support 
organization and only 8% reported this for lung cancer, and future monetary support was 
29% and 18% respectively (Weiss, Stephenson, Edwards, Rigney, & Copeland, 2014). 
The results of this study also indicate that people have mixed views about the cause of 
lung cancer, while 94% believed that a person can get lung cancer even if they do not 
smoke, most participants also indicated that the cause of lung cancer is due to "lifestyle 
choices"- echoing the participants in the Knapp-Oliver and Moyer (2012) study. While 
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only 23% of participants believed that all lung cancer is caused by smoking, 43% thought 
that prevention of lung cancer could be achieved by prohibiting smoking, and 59% noted 
that people with lung cancer can be blamed in part for their disease. People who 
attributed the cause of lung cancer to genetics and thought that it could be cured when 
detected early were more likely to monetarily support the disease. The dominant reason 
for supporting one cancer over another was knowing someone who had the cancer and 
thinking that one might get the cancer (Weiss et al.).  
Lung cancer also has implicit negative associations among cancer patients (N = 
243), caregivers (N = 677), health care providers (N = 142), and members of general 
public (N = 716) (Sriram et al., 2015). The majority of participants, 75%, associated lung 
cancer with despair, and 66% with shame versus 9% and 17% respectively for breast 
cancer (p<0.001) (Sriram et al., 2015).  The association of shame to lung cancer is, 
psychosocially, a potentially powerful link; shame is not part of the epidemiological data 
of lung cancer (mortality, incidence, prevalence, and survival), indicating that people are 
associating aspects of their moral judgements with the disease. The shame association 
could also stem from the lack of public awareness campaigns for lung cancer; indicating 
that a disease that carries shame should stay silent.  
When lung cancer is compared to several other cancers such as cervical, breast, 
skin, and colorectal, a convenience sample of 1,205 people from an online survey panel 
in England responded with similar negative perceptions (Marlow, Waller, & Wardle, 
2015). Participants were randomly assigned to one of five cancers to rate on 
awkwardness, severity, avoidance, policy opposition, personal responsibility, and 
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financial discrimination; lung cancer was rated higher than breast and cervical cancers in 
all six dimensions, but skin cancer scored higher on financial discrimination (Marlow et 
al.). In a similar experimental study design, a sample of women, n = 1,620, who were 
randomly selected from a pool of potential participants, 15% attributed blame to people 
with breast cancer, while 70% assigned blame to lung cancer which was less than blame 
assigned to chlamydia (87%), and obesity (96%) (Marlow et al., 2010). When 
participants knew the behavioral causes related to a disease, like chlamydia, they were 
more likely to endorse blame (p<0.001) (Marlow et al.). However, only one item was 
used to assess blame, the variable was dichotomized to no blame and some blame, and 
higher cutoffs for the blame score yielded smaller differences among cancer groups.  
Oncology nurses in China responded slightly differently to the same survey used 
in the Marlow et al. (2010) study. Among 317 oncology nurses in a hospital in Beijing, 
82% attributed some blame to lung cancer patients for their condition versus 67.5% to 
patients with breast cancer (Wang et al., 2015). This was the only study that sampled 
nurses exclusively. While the percentage who blamed patients with breast cancer is 
higher than other studies, the results in this study are still consistent with other studies 
where blame was highest for diseases linked to behaviors that are considered to be 
controllable. In this study, the most blame went to patients with obesity at 88.6%. 
Participants were mostly female, young, and educated. Additionally, causes of illness in 
China are likely viewed differently. An ethnographic study of 15 Chinese-Australians 
with different degrees of acculturation, revealed that participants retained biomedical and 
traditional beliefs about cancer (Yeo et al., 2005). Karma and retribution, in particular, 
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are belief systems that link illness to bad behaviors by ancestors or in a previous life (Yeo 
et al.).  
A cross-sectional analysis of existing data from a prospective study was done to 
compare clinicians (physicians, advanced practice nurses, and physician assistants) 
ratings of 3,106 lung, breast, prostate and colon cancer patients on quality of life (QOL), 
care challenges, and symptoms (Hamann, Lee et al., 2013). Responses by clinicians, most 
of which were from the patients’ attending physicians, indicated that the odds of 
reporting care challenges were five times higher for lung cancer patients than for other 
cancer patients (p < 0.001), yet statistical significance did not remain when covariates 
were included in the model. However, poor QOL and challenges with weight changes 
ratings were 3.6 and 3.2 times greater for patients with lung cancer than other cancers 
after adjusting for covariates (p < 0.0001, p = 0.0002). For QOL and weight changes, the 
model was adjusted for patients’ own ratings of these issues; 47% and 33% of patients 
with lung cancer rated their QOL as good or fair. 
Critique  
The Conlon et al. (2010) study had the limitation of no explanation of analytic 
rigor, however the origins of their sample were diverse, and like the Weiss et al. (2015) 
study, participants contributed actual experiences versus responding to a hypothetical 
stimulus. Participants in the quantitative studies are often presented with minimal or 
acontextual stimuli about a disease they are prompted to judge therefore, attitudes could 
be different in a less controlled settings. The Knapp-Oliver et al. (2012) study sampled 
from university students, which while more diverse than most of the samples discussed so 
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far, are still limited by less life experience and a narrow age range; however, validity of 
the design was enhanced by participants providing an explanation for their funding 
choice. The two Marlow et al. (2010; 2015) studies used instruments that are well 
supported by theory but the 2010 study did not report reliability, and the 2015 study 
found low reliability for the policy opposition subscale but high reliability for the other 
subscales (Marlow et al., 2015). While the Hamann, Lee et al. (2013) study had a large 
sample size, it was mostly female, and mostly White.  
Summary  
These studies had sampling, design, and measurement limitations, yet there is 
support across the studies that lung cancer and the people who have it attract blame from 
the general public and from health care professionals, more so than other cancers. 
Clinicians may view lung cancer with more pessimism, poorer quality of life, and more 
care challenges than other prominent cancers, and with more pessimism than their 
patients do (Hamann, Lee et al., 2013), and associate it with shame (Siriam et al., 2015). 
Other diseases, like obesity and chlamydia, that also have behavior-related causes, can 
attract more blame than lung cancer because the former is more visible (Jones, 1984) and 
the latter is linked to sexual behavior.  
Perspectives of Patients with Lung Cancer  
Stigma is not exclusive to one type of cancer. Studies that compare the level of 
stigma among patients with different cancers helps to distinguish the degree to which 
lung cancer patients experience stigma more than other patients with other cancers such 
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as breast, prostate, head, and neck cancers. Breast and prostate cancers have high 
incidence rates compared to other cancers but are rarely linked to behavioral causes.  
In a longitudinal study, 172 patients with stage IV lung, breast, or prostate cancer 
answered survey questions at three time points, baseline, two and six months (LoConte, 
Else-Quest, Eickhoff, Hyde, & Schiller, 2008). Perceived cancer-related stigma was 
significantly greater among patients with lung cancer than the comparison groups (p < 
.01). Shame, embarrassment, perceived family shame, and behavioral self-blame were 
endorsed more by patients with lung cancer than comparison groups (p < .001, p < .05, p 
< .05, p < .001); these comparisons did not remain significant at the two and six-month 
time points. Patients with lung cancer did not endorse the statement that they deserved 
their type of cancer or ‘people judge me for my type of cancer’ more than the comparison 
groups. While other patients with cancer may experience stigma, patients with lung 
cancer have a unique experience in that they may suffer shaming from others as well as 
directing it at themselves; though these perceptions and experiences may change over 
time.  
Patients with lung, n = 107, and head and neck cancers, n = 99, who were 
survivors less than three years were compared on positive health changes, stigma, and 
self-blame (Lebel, Feldstain et al., 2013). Overall, there was no significant difference 
between groups on stigma scores; however, self-blame was significantly more prevalent 
in patients with lung cancer than in patients with head or neck cancers (p < .001). While 
self-blame was a predictor of positive health changes, p = 0.02, stigma was not, p = .12. 
Most of the patients in this study endorsed engaging in positive health changes, which 
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may explain why average stigma scores were low. Positive health changes may indicate 
that participants were already coping with any perceived stigma and this mitigated the 
perception. In addition, the stigma instrument was adapted for this study, maintaining 
good reliability, but limitations in validity must be considered. This sample was also 
mostly middle to high income, post-secondary and higher education, and former and 
never smokers.  
In a similar study of the same participants the authors examined the impact of 
stigma on depression and well-being, and found significant positive and negative 
correlations respectively (Lebel, Castonguay, et al., 2013). Again, these participants 
reported low levels of stigma, however, even at low levels there is still significant 
relationships in the expected directions for variables such as depression and well-being 
which has been supported in other studies of patients with lung cancer (Cataldo & 
Brodsky, 2013; Cataldo et al., 2012).  
In a sample of 96 lung, 30 breast, and 46 prostate cancer patients, lung cancer 
patients were significantly more likely to endorse that their behavior caused their cancer, 
or self-blame (Else-Quest et al., 2009). Among all the groups there was a significant 
negative relationship between perceived stigma and self-esteem and a positive significant 
relationship to self-blame, depression, anger, and anxiety. Regression models revealed a 
significant, negative relationship between perceived stigma and self- esteem that was 
mediated by self-blame, a model that explained 40.1% of the variance among patients 
with lung cancer versus 24.1% in a combined group of breast and prostate cancer 
patients. These findings support the presence of perceived stigma among different 
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patients with different cancers, but more so in patients with lung cancer. However, for 
this study, stigma was measured with one item derived from patients in support groups. 
The rest of the instruments were established with good reliability and validity.   
In a qualitative study described earlier (Tod et al., 2008), the participants with 
lung cancer noted that the prominence of breast, testicular, and prostate cancers meant 
that knowledge of the risks of lung cancer were not known, and thought to be nonexistent 
if a person does not smoke (Tod et al.). In another qualitative study of 21 patients with 
lung cancer in the United States, a participant asserted “If it’s not pink and on an M&M, 
well God help you because there’s just not a lot of sympathy or money out there for 
you… [with lung cancer] we have people dying. You know, where should our attention 
be? …and that frustrates me. So, if I could become a poster child, I certainly would…I 
want to write a book that says, “Don’t judge me.” (Rohan et al., 2016, p. 177). This 
participant represents the difficulty in not feeling judged when compared to a disease, 
breast cancer, which has widespread commercial and public support. Many other 
participants talked about the lack of support locally and nationally.  
These feelings are not restricted to people with lung cancer. ‘Pink envy’ is a 
descriptor used by people with other cancers to describe an inferior identity in relation to 
breast cancer (Chelsea, 2011). Barbara Ehrenreich, a survivor of breast cancer, critically 
noted that it overshadows other prominent diseases that kill women, like heart disease 
and lung cancer, and that the positive attitude portrayed by women with breast cancer 
overpowers other viewpoints (Ehrenreich, 2001). Responses she received from other 
women with breast cancer after posting a comment to an online support group about the 
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challenges she was facing during her illness and eschewing the pink ribbons were that she 
had a “bad attitude” and from another person that she needed “counseling” (Ehrenreich, 
p. 50).  
Perspectives of “Normals” on Smoking Behavior and Lung Cancer 
Patients with lung cancer who never smoked, are former smokers, or current 
smokers are viewed differently by society and at times by health care professionals and 
their caregivers. Lung cancer and people with the disease are also portrayed differently in 
the media, magazines and television news, based on behaviors related to the disease. The 
following section of the literature review represents the concepts of separation and 
discrimination.  
Several studies examined the difference in attitudes toward patients with lung 
cancer by using an experimental, factorial design and presenting participants with a 
vignette of a patient with lung cancer where the smoking status was manipulated 
(Bresnahan, Silk, & Zhuang, 2013; Hamann, Howell, & McDonald, 2013; Stump, 
LaPergola, Cross, & Else-Quest, 2016). Participants in the first study, 224 undergraduate 
students, responded to a vignette of a person with lung cancer who was a heavy, 
moderate, occasional, or non-smoker (Bresnahan et al., 2013). The participants also had 
different smoking behaviors:113 nonsmokers, 111 occasional smokers, 22 heavy 
smokers, and 38% knew someone who died of lung cancer. Participants assigned 
significantly less blame to the condition where the person with lung cancer was a non-
smoker (p < 0.001), moreover when non-smoking and smoking participants were 
compared, non-smoking participants assigned significantly more negative stereotypes to 
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people with lung cancer such as “selfish” and lack “willpower” (p < .001), and assigned 
more blame to tobacco companies and cigarette advertisements than to a person with lung 
cancer (p < .01, p < .001) (Bresnahan et al., 2013, p. E135). Participants who did not 
smoke and did not know someone with lung cancer assigned significantly more blame 
than non-smokers who did know someone (p < .001). Those that perceived smoking to be 
a highly controllable behavior and had confidence in their ability to quit assigned more 
negative stereotypes to people with lung cancer. 
The second study had a similar sample of 147 undergraduate students where they 
responded to a vignette of a person with lung cancer who smoked, had a genetic 
predisposition, and had both (Hamann, Howell, et al., 2013). There were significant 
differences in perception between the smoking and genetic condition. Participants who 
responded to the smoking condition perceived that the person had more control over, 
could have “easily avoided” getting their cancer, was at fault, more responsible, deserved 
less pity and more anger, than those in the genetic condition. Participants who reported a 
family history of lung cancer assigned greater responsibility and control to the person in 
the vignette. There was also a significant negative relationship between wanting to help 
the person in the vignette and assignment of responsibility and a positive relationship 
with feelings of pity.   
Another study used a similar design and sample, 242 psychology students, but the 
manipulation of the vignettes included a smoking, nonsmoking, and unknown condition 
(Stump et al., 2016). Participants who responded to the smoking vignette assigned more 
blame and anger, and less sympathy than to the nonsmoking condition; sympathy 
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mediated the relationship between blame, assignment of responsibility and desire to help 
the person at an individual or institutional level (p = .01).  
Another study used a similar experimental design with a random sample of 486 
general practitioners (GPs) and pulmonologists in France, where participants responded 
to a vignette of a person with lung cancer who worked in a shipyard and the smoking 
status was manipulated (Verger et al., 2008). Participants were asked if they would make 
a recommendation for filing a worker’s compensation claim, which was significantly 
higher among GPs who were presented with vignette of a nonsmoker. Pulmonologists did 
not differ by smoking condition.  
Similar outcomes have been measured among lay caregivers of patients with lung 
cancer (Lobchuk, McClement, McPherson, & Cheang, 2008, 2012; Lobchuk, McPherson, 
et al., 2012); analyses used were exploratory factor analysis (EFA) and structural 
equation modeling (SEM). All the studies surveyed patients with lung cancer and the 
people who cared for them as a unit. In the first study n = 100 dyads (50 caregivers and 
50 patients), significantly higher levels of anger, fault, blame, aggravation and annoyance 
were reported among caregivers who cared for someone with lung cancer who was a 
current smoker versus those who cared for someone who had quit (p < .05) (Lobchuk et 
al., 2008). There was no statistical difference among caregivers in their reported helping 
behaviors toward current versus former smokers; yet their feelings of anger and 
annoyance were significantly, negatively correlated with empathic communication (p = 
.029, p = .004). However, overall, the average scores for positive feelings such as pride, 
satisfaction, and hope were higher than average scores for negative feelings.  
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In a later study with 304 dyads, a SEM analysis revealed that anger was 
significantly, negatively correlated with the caregiver knowing the patient’s thoughts and 
feelings (p < .05) and aggravation and annoyance were significantly (p = .01, p = .02), 
negatively correlated with open communication toward the patient with lung cancer, but, 
mean scores for blame, fault, responsibility, anger, annoyance, and aggravation were very 
low (Lobchuk, McClement, et al., 2012).  In the last study, the authors studied the same 
304 dyads, but wanted to determine how family caregivers and patients view control over 
disease (Lobchuk, McPherson, et al., 2012). Linking the control of lung cancer to 
external factors such as fate was associated with caregivers directing anger and blame at 
themselves. Linking control to a team effort was associated with more self-blame 
(caregivers blamed themselves), open communication, and more coping assistance for the 
patient. Conversely, when patients attributed control to fate, this was associated with 
more attempts at stopping smoking and feelings of satisfaction in their own disease 
management. 
Qualitative ethnographic studies that have analyzed online comments (Luberto, 
Hyland, Streck, Temel, & Park, 2016), news stories in magazines (Clarke & Everest, 
2006) and on television (MacKenzie, Chapman, & Holding, 2011) regarding beliefs 
about lung cancer and smoking behavior provide support for pessimistic and nihilistic 
beliefs about smoking and lung cancer, and blame directed at tobacco companies. Media 
frames endorse medical and lifestyle descriptions of cancer and emphasize fear and battle 
metaphors (Clarke & Everest), and emphasize the smoking status of people who die of 
lung cancer (MacKenzie et al.).  
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Document analysis of 139 online comments in response to an article about 
smoking prevalence for lung and colorectal cancers revealed stigmatizing attitudes, 
fatalistic, nihilistic, and pessimistic beliefs about quitting smoking, from people with and 
without lung cancer. The authors developed a conceptual framework from the comments 
that indicated a relationship between smoking beliefs such as “smokers should be able to 
quit”, those that do not are stupid and this is what keeps them from quitting, tax money 
should not go to smoking-related illnesses, and stigmatizing attitudes (Luberto et al., 
2016). One participant expressed nihilism by saying “So what? I mean if you’ve already 
got cancer, why quit?” (Luberto et al., p. 2196). Pessimistically, another commenter 
noted “[y]ou smoke, you get cancer, your fault, no treatment, you die. Simple as that” 
(Luberto et al., p. 2196). Some participants noted the fault of tobacco companies and the 
Food and Drug Administration “…they all know they are selling a product that is 
addictive and has the potential to kill. Only an immoral, unethical person would do such a 
thing,” and “[t]hat the FDA has not classified it as a narcotic or a controlled substance is 
bewildering ... smoking kills—just ban it” and this was associated with sympathetic 
attitudes in the framework (Luberto et al., p. 2197).  
Analysis of 23 magazines and a total of 131 articles about cancer revealed that 
breast cancer dominated cancer news, medical followed by lifestyle description frames 
were most prominent, and fear was a common theme among articles (Clarke & Everest, 
2006). The theme of fear, represented by 70 references, reflected the aforementioned 
nihilistic beliefs that cancer is “inevitable” “growing silently and secretly” (Clarke & 
Everest, p. 2595) and the related statistics impart a grim picture. Analysis of 2,042 
66 
television reports about cancer in Australia revealed that only 45 were about lung cancer, 
and 68% of the relevant content of the reports relayed the smoking behavior of the people 
who had lung cancer (MacKenzie et al., 2011). Of the 33 news reports on celebrities with 
lung cancer, mostly Dana Reeves, 24 highlighted her non-smoking behavior. Articles on 
treatment frequently emphasized high mortality and invasiveness of lung cancer, and 
articles on causes were dominated by smoking. Lastly news reports pitted non-smokers or 
“tragic victims” (p. 68) and those with mesothelioma against people with lung cancer 
who smoked.  
The lifestyle frame of cancer news provides some reassurances to the public that 
cancer is preventable and controllable, yet confusion can also occur when people who 
have quit many years ago receive a diagnosis of lung cancer. Portraying lung cancer as a 
controllable disease related mostly to lifestyle has the potential to reinforce the notion 
that smoking is and was a choice for current and former smokers. However, as Dackis 
and O’Brien (2005) assert, addictive drugs alter the brain by “activating and 
dysregulating endogenous reward centers, addictive drugs essentially hijack brain circuits 
that exert considerable dominance over rational thought, leading to progressive loss of 
control over drug intake in the face of medical, interpersonal, occupational and legal 
hazards.” (p. 1431).  
While experimental studies provide an idea of how people perceive a vignette of a 
person with lung cancer, they do not provide empirical data about actual behavior and 
their controlled nature limits external validity and real world applicability. Perhaps one of 
the most compelling studies is one that consists of recorded conversations between 
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physicians, oncologists and thoracic surgeons, and their encounters with patients with 
lung cancer (Morse, Edwardsen, & Gordon, 2008). When patients with lung cancer make 
statements, or ask questions that require the use of empathy, 384 instances from 20 
conversations, physicians rely heavily on medical explanations and empathy is used only 
10% of the time, but more empathy occurred with oncologists than with surgeons (p = 
.02). Moreover, physicians make blaming statements directly linking the patient’s 
smoking behavior to their lung disease (Morse et al.).  
Critique  
Most of the studies had convenience samples of university students in the United 
States who were mostly White, young, and believe they have low risk for developing a 
smoking related disease, yet the experimental designs of these studies enhanced internal 
validity. Internal validity is also supported by the instruments and scales which had good 
reliability, α > .70, and validity was supported by theory (Bresnahan et al., 2013), or 
theory and replication of findings (Hamann, Howell, et al., 2013; Stump et al., 2016). 
External and internal validity were threatened by convenience sampling, and external 
validity is limited by the controlled, experimental conditions of the studies. The 
ethnographic studies of television news and magazine articles had analytic rigor, yet they 
were short on thick descriptions of their findings such as descriptions of image content as 
well as text and verbal content. Description of the tone surrounding the online comments 
in the Luberto et al. (2016) study would have provided thicker description and better 
context.  
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Summary 
 A combination of experimental and qualitative design research studies have 
provided support that people with lung cancer who smoke are viewed differently than 
those that do not smoke, incurring more blame and negative stereotypes, particularly 
from people who do not smoke or see it as a controllable behavior. These beliefs and 
attitudes are, at times, related to emotions such as annoyance and aggravation that can 
interfere with open, interpersonal communication. Some attitudes and beliefs about lung 
cancer come from how it is portrayed in the media; highly fatal, related to lifestyle (a 
controllable cause), and that smokers and nonsmokers are unfairly competing for 
resources. 
Patients with Lung Cancer Who Have Different Smoking Behaviors  
 
 People with lung cancer also provide perspectives on smoking, lung cancer, and 
stigma. Researchers to date have done psychometric testing on a lung cancer stigma 
scale, the Cataldo Lung Cancer Stigma Scale (Cataldo, Slaughter, Jahan, Pongquan, & 
Hwang, 2011), an instrument that has been used in other studies (Brown Johnson et al., 
2014; Cataldo & Brodsky, 2013; Cataldo et al., 2012), all of which compared perceived 
stigma among patients with lung cancer and different smoking histories. Different 
perspectives based on smoking behaviors have also been reported in qualitative studies 
(Brown, & Cataldo, 2013). Other researchers used different psychometrically tested 
instruments such as the Cancer Responsibility and Regret Scale (CRRS) (Criswell, 
Owen, Thornton, & Stanton, 2016), an adapted version of the Shame and Stigma Scale 
previously tested in head and neck cancer patients (Shen et al., 2015). People at risk for 
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lung cancer and who have different smoking histories have been surveyed on beliefs 
about screening and risk for lung cancer (Crane et al., 2016; Quaife et al., 2016). 
The psychometric testing of the Cataldo Lung Cancer Stigma Scale (CLSS) 
included administering the instrument online to a convenience sample of 186 people with 
lung cancer, factor analysis of the data, and correlation analyses with related concepts 
such as depression, measured by the Center for Epidemiological Studies–Depression 
Scale (CES-D); anxiety, measured by the Rosenberg Self-Esteem Scale (RSES); self-
esteem measure by the Rosenberg Self-Esteem Scale (RSES), social support and social 
conflict, measured by the Social Support Indices; and quality of life, measured by the 
Quality of Life Inventory (Cataldo et al., 2011). Factor analysis yielded 31 items divided 
among four subscales (stigma and shame, social isolation, discrimination, and smoking) 
with a reliability alpha coefficient of .96. Lung cancer stigma was significantly and 
negatively correlated with QOL, self-esteem, social support, and being involved in one’s 
own social network (p = .01). Positive and significant correlations of lung cancer stigma, 
depression, and social conflict (p = .01) were found.  
 In a similar study, a convenience sample of 190 patients with lung cancer 
recruited from online support networks revealed an overall average CLCSS score of 
102.6 with a range of 46 – 184, which was slightly lower among never smokers, 99.5, 
and slightly higher among ever smokers, 103.7 (Cataldo et al., 2012). Again, lung cancer 
stigma (LCS) was significantly and negatively correlated with QOL, and significantly 
and positively correlated with depression. A regression model with five covariates 
including smoking status, age, gender, and depression explained 62.5% of the variance in 
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QOL (p < .001), with LCS and depression contributing to 2.1% and 22.5% of the 
explained variance respectively (p < .001).  
 A third study of 144 people with lung cancer revealed a mean CLCSS score of 
75.7 with a possible range of 31 – 124 (Cataldo & Brodsky, 2013). This study also 
examined the relationship between LCS and symptom severity (fatigue, dyspnea, pain, 
cough, appetite loss, and hemoptysis) where the average score for symptom severity was 
17.8, range of 9 – 45. Correlation analyses supported a strong positive relationship 
between LCS and anxiety, depression, and each aspect of symptom severity (p < .001). 
Regression modeling of the impact of LCS on symptom severity, controlling for age, 
anxiety, and depression, explained 53% of the total variance (p < .001) with LCS 
accounting for 1.3% (p < .05) of the variance. While the authors collected information on 
smoking history, comparisons were not made for this variable.  
 Similarly, 149 people with lung cancer had a mean QOL score of 5.6, with a 
possible range of 1 – 10 (Brown Johnson et al., 2014). Lung cancer stigma was included 
in a model controlling for age, gender, anxiety, and depression which explained 71.0% of 
the variance in QOL with LCS explaining 1.2% (p = .015). None of these variables 
differed by smoking behavior when comparing current and former smokers as one group 
to never smokers.  
 A recent study examined 141 patients with lung cancer with different categories 
of smoking history: never smokers, quit before diagnosis or after diagnosis, and current 
smokers (Shen et al., 2015). A higher number of participants achieved less than a college 
degree than in the previous studies and education level had a significant inverse 
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relationship and stigma had a significant positive relationship with psychological distress, 
measured by the Hospital Anxiety and Depression Scale (HADS). Positive self-appraisals 
from having a cancer diagnosis or post-traumatic growth (PTG), moderated the 
relationship between stigma and psychological distress only among people who had quit 
smoking after their diagnosis, but there was no statistical difference between pre and post 
diagnosis cessation and levels of stigma.   
A study of 213 patients with lung cancer revealed that current and former smokers 
report significantly higher levels of personal responsibility, self-blame, and regret when 
compared to never smokers, but being older was associated with lower levels (Criswell et 
al., 2016). However, the strongest relationships between personal responsibility and other 
outcomes such as depression (r = .49), care satisfaction (r = -.57), and avoidance coping 
(r = .37) were significant only among never smokers (Criswell et al.). Regret and the 
same outcomes, except care satisfaction, were significant among current and former 
smokers (Criswell et al.).  
Among 174 people with lung cancer, current smokers, compared to former and 
never smokers, were significantly more likely to report that health care providers and 
society treat patients with lung cancer differently than patients with other cancers, and 
overall 25% thought that they were treated differently by insurance companies (Weiss et 
al., 2016). Current smokers also had significantly higher stigma scores than former or 
never smokers, but never smokers perceived less satisfaction with care compared to 
former and current smokers combined (Weiss et al.). 
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Lastly, a qualitative study of eight women with lung cancer with different 
smoking histories elicited themes of people’s attitudes toward lung cancer, encounters 
with health care professionals, diagnosis, alterations in social connections, experiences 
with stigma, and coping with stigma (Brown & Cataldo, 2013). Former smokers noted 
how strong smoking addiction is, growing up with the Marlboro Man and no knowledge 
of smoking dangers, that general practitioners have a pessimistic view of lung cancer, 
oncology staff were generally more hopeful and supportive and do not focus on smoking. 
Nonmedical encounters, however, always included the question ‘did you smoke?’ when 
finding out about lung cancer (Brown & Cataldo, p. 357). Also, advocacy efforts from 
supportive organizations have focused on young nonsmoking people with lung cancer 
leading one woman to remark “But, frankly, the rest of us survivors who were at the 
run/walk last year, felt a little belittled, because we are, too. That’s the fact. You know, as 
a sixty-year-old ex-smoker, I, too, am the face of lung cancer.” (p. 357). A nonsmoking 
woman remarked that she likes to share her diagnosis with people because “I think 
sharing is important to make people aware that normal people who weren’t smokers…do 
get lung cancer” (Brown & Cataldo, p. 357).  
Critique 
 Again, convenience sampling is a limitation for internal and external validity, 
particularly since the samples tended to be White, female, educated with some or more 
college, and former smokers for the first four studies. Internal validity was supported 
with valid and reliable instruments used in the studies. Lung cancer stigma scores tended 
to be at the midpoint of the possible range of values which is higher than stigma scores in 
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other studies that had a higher mean age for their participants and used different stigma 
instruments (Lebel, Feldstain, et al., 2013; LoConte et al., 2008). One study examined 
response shift regarding fatigue among 23 people with non- small cell lung cancer as part 
of a quality of life instrument (Westerman et al., 2007). Participants reported their fatigue 
as minimal, in an effort to appear positive and not sick when surveyed, but the same 
participants, when interviewed, indicated more severe fatigue on a regular basis. While 
this study only examined fatigue, there are implications that patients with lung cancer 
may want to present themselves in research as feeling or coping better than they are in 
order to control their cancer narrative and maintain a positive outlook which can result in 
response bias due to social desirability. Reporting actual severity of symptoms or feelings 
may also be perceived as complaining (Westerman et al.).  
Summary  
People with lung cancer have different experiences which, in part, stem from the 
stereotype of a self-inflicted disease. Nonsmokers want to distinguish themselves as 
“normal” lung cancer patients, and at times are less satisfied with their care because they 
may endure a “courtesy stigma” (Goffman, 1963, p. 30) in that they are assumed to be 
people who smoke and have a difficult time with self-advocacy due to their illness, the 
perceived reputation of their disease, and low social support and funding. For current 
smokers, studies provide less clear data about from where their perceptions of blame and 
stigma originate. If they first direct stigma and blame at themselves, it may be easier for 
them to perceive that others think poorly of them. Studies that provide examples of 
enacted stigma (Morse et al., 2008), stigmatizing behaviors from others toward patients 
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with lung cancer, do not close the communication loop by asking the patient about what 
the experience meant to them. Some of these experiences will be represented in the 
following section about the psychological, social, and health consequences of stigma. 
There is also support that different medical specialties have different attitudes toward 
lung cancer. However, what is not known is how active these clinicians are in public 
advocacy for lung cancer considering that they are aware of the disparities. 
Psychological and Social Consequences of Stigma 
 
The psychological and social consequences of stigma are represented in the 
literature mostly from the patient perspective in both qualitative and quantitative studies. 
The perspectives of “normals” on this issue were addressed in previous sections of this 
review of the literature. Thus far, there is support in the literature that lay people and 
health care professionals associate negative stereotypes and shame to lung cancer, and 
assign blame to those who have it. In studies of patients with lung cancer, psychological 
consequences of stigma are depression, anxiety, fear, shame, and self-blame. Social 
consequences are restricted social networks due to diagnosis concealment, avoiding 
awkward or potentially judgmental interactions, and not wanting people to express worry 
or pity.  
 Among 95 patients with non-small cell lung cancer there was a significant 
positive correlation between perceived stigma, measured with the Social Impact Scale 
(SIS), and depressive symptoms, measured using the CES-D (p < .001) (Gonzalez & 
Jacobsen, 2012). However, two dimensions of the SIS, social rejection and internalized 
shame, did not have significant correlations with the CES-D. A regression model that 
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controlled for history of depression, time since diagnosis, avoidant coping, social support, 
and dysfunctional attitudes, revealed that perceived stigma accounted for 3% (p = .043) 
of the variance in depressive symptoms. The regression model was conducted using the 
separate dimensions of the SIS scale, financial insecurity and social isolation accounted 
for 3% (p < .036) and 7% (p < .001) of the variance in depressive symptoms respectively.  
Shame in this study was measured as a dimension of stigma and included 
statements related to blame from others, self-blame, and hiding an illness. Framing an 
illness positively included statements about what one says to oneself about one’s illness 
to make things better. Possibly, patients feel shame and self-blame related to their lung 
cancer but also want to control the narrative of their disease and avoid negative 
comments from others. This supposition is echoed in the comments of people who care 
for patients, one nurse remarked “Some of them don’t want to go to their GP to be told 
that it’s because of their smoking” and another said “Well, I think smokers 
especially…they’ll not present themselves with problems because they think it’s self-
inflicted, and they think medical professionals look down on them for that” (Tod & 
Joanne, 2010, p. 41).  
 Concealment is a way of coping with a stigmatized disease that places a cognitive 
and social burden on the person with lung cancer. They must decide to whom they will 
reveal their diagnosis which potentially restricts their social interactions and relationships 
(Hamann et al., 2014). In the qualitative studies discussed earlier, participants have said 
that they have bone cancer instead of lung cancer to make social interactions easier 
(Rohan et al., 2016), not tell their family or only tell certain people to avoid judgment, 
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and avoid telling their oncologist they have started smoking again so they don’t “let them 
down” (Hamann et al., p. 85).   
 A quantitative study of 117 patients with non-small cell or small cell lung cancer, 
participants were asked to report if they had concealed their diagnosis in the past month 
from either family, friends, or coworkers (Gonzalez et al., 2015). Overall, 26% of 
participants reported concealing their diagnosis mostly from informal friends, 67%, and 
close friends, 40%, and less frequently from relatives who were not close, 27%. 
Concealment from more than one person occurred for 33% of participants who reported 
it, and the most frequently reported reasons were they did not want the person to worry 
about or pity them. Compared to those who did not conceal, those who did, reported 
higher levels of internalized shame (p < .01). The reasons for concealment are congruent 
with the reported higher levels of shame because people who feel shame do not think 
they deserve to have others worry about or pity them.  
 Among newly diagnosed patients with lung cancer, n = 151, 49% and 41% had 
moderate levels of anxiety and depression respectively, measured by the Hospital 
Anxiety and Depression Scale (HADS), however older participants, > 60 years, had 
lower levels of anxiety and depression (Chambers et al., 2015). Age, gender, and stigma, 
measured with the CLCSS, were entered into a regression model which accounted for 
28% (p < .001) of the variance in anxiety; age and gender alone accounted for 10% of the 
variance. Stigma and age explained 30% of the variance in total psychological distress 
(anxiety and depression).  
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 Similar responses are found in qualitative studies. Among 45 patients with lung 
cancer in England, emergent themes were fear, stigma, and opposing blame and stigma. 
Participants experienced restricted social networks because of increased awkwardness of 
interactions, fear of stigma because of prior experience with it from a different disease 
(epilepsy), and family members telling them they felt “dirtied” being near cancer 
(Chapple et al., 2004, p. 1471). Fear was also experienced in relation to distressing public 
health announcements related to smoking and lung cancer, and for people who smoke, 
not being taken seriously by health care professionals.  
Research on the social aspects of stigma has also focused on measures of social 
support such as the Social Support Indices (O’Brien, Wortman, Kessler, & Joseph, 1993), 
two components of which were used in the Cataldo et al. (2011) study; perceived 
availability of support, α = 0.87, and social conflict, α = 0.82 (O’Brien et al.). 
Additionally, the same study examined the construct validity of the Cataldo Lung Cancer 
Stigma Scale with factor analysis and one of the subscales measures social isolation, with 
an alpha coefficient of 0.98 (Cataldo et al.). There were significant positive correlations 
between lung cancer stigma (LCS) and social conflict (0.619), and significant negative 
correlations between LCS and perceived availability of social support (-0.547), social 
support validation (-0.512), and subjective integration (-0.627). Lastly, there was a 
strong, significant negative correlation between social isolation and self-esteem (-0.738) 
(Cataldo et al., 2011). 
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Critique  
 While there is support that patients with lung cancer experience depression and 
stigma, due to the cross-sectional nature of the studies it is difficult to know which comes 
first; depression may make someone more susceptible to self-blame and isolation or 
possibly the reverse. Patients with lung cancer also must decide to whom they will reveal 
their disease, but these people may not be prominent in their social network, nonetheless 
social encounters are more awkward when one person feels the need to hide something. 
Although sampling in the Chapple et al. (2004) study was designed to represent people 
with different social backgrounds, the people represented in quotes are all from a support 
group, though it is not clear what kind. The authors used methods to increase analytic 
rigor, and performed member checks.  
Summary 
 While concealment of a lung cancer diagnosis or smoking behavior is a form of 
coping with stigma, the negative impact on social interactions and participation in care 
means it can be a dysfunctional form of coping. There are also health-related sequelae for 
the psycho-social problems of stigma. People with lung cancer are at risk for smoking 
relapse from the stress of their diagnosis and treatment (Simmons et al., 2013), however 
if they have too much shame to tell their health care provider they cannot receive 
comprehensive help with quitting. Smoking can interfere with treatment, exacerbate 
symptoms, and increase risk for cancer recurrence. While the studies mentioned so far do 
not examine stigma and therapy adherence, an inference can be made that additional 
79 
psychological and social problems such as fear, self-blame, shame, and concealment have 
the potential to disrupt the illness trajectory. 
Nurses and Stigma 
The perspective of nurses in the literature on lung cancer and stigma is 
represented in one study (Wang et al., 2015) which was discussed earlier in this chapter. 
Nurses’ perspectives regarding stigma have also been studied with obesity and stigma 
(Aranda & McGreevy, 2014; Brown & Thompson, 2007; Peternelj-Taylor, 1989) and 
HIV/AIDS and stigma (Greeff & Phetlhu, 2007). Qualitative studies of nurses’ attitudes 
toward obesity have highlighted complex beliefs and feelings about their own body size 
and education that they provide for overweight and obese patients (Aranda & McGreevy; 
Brown & Thompson). These complex attitudes included: awareness of stereotypes such 
as ‘fat’, ‘lazy’, and unhealthy, counteracting stereotypes by asserting that thin people 
have health problems too, and body size is not about health but social norms and 
acceptance. Their negative attitudes sometimes overruled empathy when educating 
patients about weight reduction (Aranda & McGreevy).  
In order to counteract pessimism and avoid emotions, nurses hid behind their 
professional role or noted the hypocrisy of educating about risk factors they themselves 
had (Aranda & McGreevy, 2014). In a similar qualitative study, nurses were 
uncomfortable talking about obesity, avoided the word obesity with their patients because 
it was deemed a disagreeable label, and used rapport and a neutral attitude to offset 
stigma (Brown & Thompson, 2007). Other nurses asserted that personal responsibility 
was key to behavior change and judgement is a constant (Brown & Thompson). Nurses 
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also expressed frustration with patient requests for quick fixes and noncompliance 
(Brown & Thompson). Yet these studies also represent nurses who work in countries that 
have socialized medicine, so the perspectives are representative of the medical and 
general culture of those nations.  
HIV/AIDS is mentioned as another disease that is stigmatized, but it carries a 
negative valence of a different origin within social and cultural values. Since it is a 
primarily sexually transmitted disease, originally thought to only occur among gay men, 
there is a strong association with high risk sex behaviors and sexual deviance (Herek, 
1990). A qualitative study that analyzed focus group discussions of patients living with 
AIDS (PLWA) (n = 18), nurses who care for them (n =16), and volunteers who care for 
them (n = 6) in South Africa revealed themes of received stigma, internal stigma, 
associated stigma, results of stigma, and disclosure (Greeff & Phetlhu, 2007). Nurses 
reported that PLWA experienced social and physical separation from their family, other 
health care professionals would not hire PLWA to work in their home, and people in the 
community did not understand why nurses cared for these patients. Other problems that 
were reported were: a counseling room for PLWA was dubbed the “AIDS room”, AIDS 
was largely considered a self-inflicted disease, there was pessimism surrounding the care 
of PLWA, and the patients enacted self-imposed isolation.  
Although the authors of these studies report analytic rigor, the Greeff and Phetlhu 
(2007) study did not always provide rich context for their quotes and the same quote was 
used in multiple themes. The authors also reported that they asked the participants to 
describe their own understanding of discrimination and stigma, but they do not provide 
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the results for this question in a way that helps the reader to distinguish it from other 
questions. If the authors had provided descriptions of how their participants perceived 
concepts related to stigma, there would be a better understanding of how their personal 
descriptions of the concepts matched or did not match what they experienced while 
caring for PLWA.  
Thus far, both qualitative and quantitative studies have retained the assumption 
that participants share the researchers’ understanding of concepts used in instruments and 
interviews. While psychometric analysis provides support for confidence in such 
assumptions, there are discrepancies among what patients with lung cancer report to be 
their level of stigma in various quantitative studies and their reported perceptions in 
qualitative studies. If nurses were to be surveyed about concepts related to stigma, the 
survey would perform better if nurses’ descriptions were used to construct it. Also, from 
qualitative studies of nurses concerning obesity, there is little professional biographical 
background context for their perceptions of issues related to their own body size and that 
of their patients, which would provide context for not only who the participant is, but 
how their perspective as a nurse has changed over time, given that stigma is a temporal 
construct.  
We still do not know how any of the “normals” in the studies examined thus far, 
define or describe major concepts related to stigma such as self-blame, shame, 
discrimination, stereotyping, status loss, separation, being judged, and personal 
responsibility; particularly as they relate to lung cancer. There is also minimal 
information on what nurses know or perceive about the stigma related to lung cancer and 
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the patients who have it. Furthermore, there is only a small glimpse of what impact these 
issues have on patient outcomes and nursing care. 
Feasibility Study 
A qualitative feasibility study conducted in preparation for this study (Abrams, 
2015) revealed that nurses who care for patients with lung cancer in the oncology setting, 
n = 3, noted the difference in support and funding for breast cancer versus lung cancer. 
For one nurse this difference was noted when recounting conflicts expressed by the lung 
cancer nurse navigator; that stigma reduces the funding for lung cancer, and breast cancer 
“gets all the money because there’s a negative stigma against lung cancer patients that 
they do it to themselves because they smoke.” However, this nurse also noted that stigma 
related to lung cancer is “it’s just a general public stigma and donation wise and money 
wise.” Poor survival was also noted and a form of joking was developed to cope with 
this: 
I mean there’s kind of this joke um… about the we’ve shared with the nurse who 
works at the desk with the lung cancer doctor about how she doesn’t get close to 
her patients because they’re not around long enough. I mean it’s just it’s kind of 
one of those things you just come to accept like in the doctor’s constantly taking 
on new patients and the joke is he’s always got room for new patients because his 
patients are always dying. I mean it’s just something that’s known that the lung 
cancer patients definitely have a shorter survival period from diagnosis like where 
you’ve got breast cancer patients who have like been patients for 20 years versus 
you know your lung cancer patient who will probably be around a year or two. 
 
The nurses who were interviewed all worked in oncology settings, both inpatient 
and outpatient, and might be insulated from understanding how stigma impacts patients 
since they tended to refer to it in vague or general terms, but not as something that 
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impacts the illness trajectory. One nurse noted something another nurse said about 
unequal funding but did not validate this comment and said it was a “general public 
stigma” not something that impacts the health care system, yet funding supports research 
and research supports care. Potentially, nurse navigators are exposed to aspects of stigma 
related to lung cancer because they have a broader perspective of the patient’s trajectory. 
Another nurse noted the support for breast cancer versus lung cancer when she said:  
all these wonderful runs and support groups and things for breast cancer patients 
you know and everybody wears pink and you know life is support breast cancer 
and you don’t see as much of that for the lung cancer and I don’t know if it’s just 
that general thought that they did this to themselves. 
 
This nurse expresses ambivalence by saying a common stigmatizing belief, “they 
did this to themselves”, but not knowing if this is the reason for differences in support. 
Yet another nurse noted that patients with lung cancer believed “that they had it coming 
to them anyway ‘cause they smoked.” The joking about survival may indicate a way to 
cope with caring for people with lung cancer who have poor survival and the oncology 
staff either do not feel empowered to advocate to change this or they do not see the need 
to do anything, a ‘this is just the way things are’ type of mentality. Two of the nurses 
noted the stark contrast between lung and breast cancer patients, similar to qualitative 
studies discussed earlier.  
Summary 
Within the broader narratives in the literature on stigma and stigma and lung 
cancer, are the stories of people who have lung cancer and the people who care for them 
as well as quantitative studies that have provided psychometric, correlational, and 
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modeling of stigma and related concepts. The two stigma theories presented posit that 
stigma occurs at the macro and micro levels and that the people involved in the stigma 
process have overlapping identities with extant and emerging statuses that promote or 
prevent a downward social trajectory related to a stigmatized condition. People who are 
“normals” or “wise” may also have a stigmatized condition, however their status in 
society can determine how easily they can conceal their stigmatized condition and what 
they can do to counteract the stigma (Goffman, 1963). For health care professionals, their 
status as a professional engenders assumptions that they are empathic, impartial, social 
justice activists and advocates, which may cloak their personal judgements and attitudes 
about what is normal while simultaneously informing their more “wise” approach to care.  
A major gap among the perspectives presented in the literature is that of nurses 
who are not only considered to be “wise” persons; they are positioned at the center of 
care with the patient who has lung cancer. Their experience, communicated through 
narratives, further informs the identity of “wise” persons so that these qualities can be 
known and taught in nursing. Maintaining integrity of the nursing profession requires in 
depth knowledge of how nurses embody these expectations and when they struggle to do 
so, or when they see the struggle of other health care professionals. 
A feasibility study of nurses’ experiences with caring for patients with lung 
cancer (Abrams, 2015) also revealed broader conflicts about the disease such as unequal 
funding, and a milieu of pessimism that is at times offset with humor as a possible form 
of coping with these issues. Responses in the feasibility study also indicate that oncology 
nurses are aware of the stigma associated with lung cancer but believe it is external to the 
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health care setting and the care that is provided. The participants were not asked further 
about their ambivalence regarding the knowledge of differences in support and general 
stigmatizing attitudes and not knowing if this is related, and what impact this has on 
people with lung cancer. There is also no sense of who these nurses are and how their 
perspective of lung cancer has changed over time, which would add to the knowledge of 
who ‘wise’ persons are, particularly in health care.  
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CHAPTER III 
METHODOLOGY 
The history of stigma reveals humanity’s past struggles to discover, define, and 
describe what is normal, and what to do about what is not normal. Throughout this 
history people have grappled with the coexistence and intermingling of scientific and 
social explanations of health-related phenomena. These struggles, at times, yield social 
constructions of diseases that result in stigmatization of the disease and those who have 
it. Socially, stigma is often portrayed as a grand conflict, a narrative with key characters, 
a setting (time and place), and pivotal events. A disease is discovered and people in 
different settings, scientific and social, take action to discover the cause.  
The narrative of the discovery of lung cancer has a similar story arc; it begins 
with an increase in the number of lung cancer cases and several conflicts in the scientific 
community about how to address it, and ends with a disease that is powerfully and 
inextricably linked to a stigmatized behavior, smoking. The story arc of smoking involves 
the transformation from a socially desirable, therapeutic, commercially successful, 
politically protected behavior and product to a deviant, unhealthy, polluting “habit”. 
When these two narratives collided, it yielded a behavior that went from ubiquitous and 
socially desirable to tainted and dwindling, and a disease that is set apart from most 
cancers because it has a strong link to a discredited behavior, smoking. Researchers are 
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still studying the consequences of this collision, while simultaneously working to 
denormalize smoking behavior in order to decrease prevalence.  
Stigma is a psycho-social, cultural phenomenon that, in the literature, is linked to 
delays in diagnosis (Carter-Harris, 2015; Carter-Harris, Hermann, et al., 2015) and care 
(Dunn et al., 2016; Scott et al., 2015; Tod & Joanne, 2010; Tran et al., 2015; Wassenaar 
et al., 2007). The delays, in turn, are related to psychological and social sequelae of 
stigma like perceived blame and shame by people at risk for lung cancer (Chapple et al., 
2004; Crane et al., 2016; Tod et al., 2008), nihilistic and pessimistic attitudes (Carter-
Harris et al., 2015a; Quaife et al., 2016; Siriam et al., 2016), and blame (Wang et al., 
2015) and shame from health care professionals (Siriam et al., 2016; Wang et al.).  
Currently, there is no clear understanding of the experiences of nurses who care 
for patients with lung cancer and how these experiences relate to the phenomenon of 
stigma; a qualitative study is not only most appropriate when there is little known about a 
perspective, but also provides a rich, in-depth description of this perspective.  
Research Design 
Qualitative research is a subjective, inductive form of inquiry that is conducted to 
answer broad questions about a phenomenon that is not well known (Streubert & 
Carpenter, 2011).  Specifically, a narrative, qualitative approach allows for the 
exploration and understanding of the “experienced reality” through the natural 
communication style of personal narrative (Lieblich, Tuval-Mashiach, & Zilber, 1998, 
p.7). Telling of experiences using narration reveals the speaker’s identity, personality, 
and the cultural and social meaning of the telling (Lieblich et al., 1998, p. 7). As Lieblich 
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et al. (1998) note “[p]eople are meaning-generating organisms; they construct their 
identities and self-narratives from building blocks available in their common culture, 
above and beyond their individual experience” (p. 8).  
Research Question  
 The broad research question for this study is: what are the experiences of nurses 
who care for patients with lung cancer? The secondary question is how are these 
experiences related to the stigma associated with lung cancer? The two stigma theories 
described in Chapter Two and a narrative inquiry approach provided guidance toward 
answering these questions. Using a narrative inquiry approach to study nurses’ 
experiences of caring for patients with lung cancer provided rich experiences that were 
oriented to the narrator’s identity and personality, drawn from culture, and socially 
contextual.  
Sample  
Registered nurses who have practiced for at least two years, have cared for 
patients with lung cancer at least six months of their career, and are currently practicing 
in the Southeastern United States, were recruited for this study. A minimum of six 
months caring for patients with lung cancer was needed as an inclusion criterion to ensure 
that participants had enough experience to be good informants. Narrative studies that 
have used experience in a clinical area as an inclusion criterion used six months for 
nurses in any setting (Chan, Jones, & Wong, 2013), two years for cardiovascular nursing 
(Lapum et al., 2016), and four months for nurse practitioners (Hernandez & Anderson, 
2012). The focus of this study was not on a specific specialty, but nurses in different 
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settings who have cared for, or are caring for patients with lung cancer. A pilot study 
revealed that while oncology nursing is an obvious specialty from which to recruit, home 
health and hospice nurses also care for patients with lung cancer (Abrams, 2015). 
Exclusion criteria were nurses who are not registered nurses, who have cared for patients 
with lung cancer less than six months of their career, and who have not cared for patients 
who have been diagnosed with lung cancer.  
A combination of purposive and snowball sampling was used. Purposive 
sampling includes directing recruitment at groups or people who have “had experience 
with or are part of the culture of the phenomenon of interest” (Streubert & Carpenter, 
2011, p. 29) and snowball sampling is “using one informant to find another” (Streubert & 
Carpenter, p. 29). Nurses who care for patients with lung cancer include, but are not 
limited to, nurses who work in inpatient and outpatient oncology, acute care, lung cancer 
nurse navigators, home health nurses, hospice nurses, and palliative care nurses.  
Incentive. Participants signed for and were provided a $15.00 Target gift card at 
the end of the first interview and a $10.00 Target gift card for the follow-up interview. 
The gift cards were provided in an unsealed envelope that contained a ‘thank you’ card 
for their participation with three of the researcher’s information cards. The information 
card was a business-type card that has the University logo, the researcher’s name, e-mail, 
a contact number, current student status, and the title of the study. Participants were also 
given three recruitment flyers to give to people they knew who were eligible for the study 
as part of snowball sampling. Participant were instructed not to post the flyer anywhere 
without permission; this statement was also in the recruitment flyer.  
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Data Collection Procedures 
Interviews 
The main data collection method employed was the semi-structured interview 
with the researcher as the instrument of analysis. All participants who consented were 
interviewed at least once. Those who agreed to be contacted again for a second interview, 
on the consent form, were contacted via e-mail to schedule an interview. Participants who 
did not respond to the first request to schedule a follow- up interview were contacted one 
more time then considered as lost to follow-up.  All participants were interviewed in-
person in an agreed upon location that was relatively private, quiet, with few 
interruptions. This type of setting was necessary to ensure confidentiality, quality of the 
data, and sound quality for the recording of the interviews. The researcher recommended 
places that were away from the participant’s place of work to ensure privacy and 
confidentiality. After the consent was signed, the PI began data collection by asking 
participants a series of demographic questions which included age, gender, ethnicity, 
where they grew up, state of prelicensure education, number of years as a registered 
nurse, highest education level obtained, current clinical setting and setting, shift and how 
long they cared for patients with lung cancer, tobacco use, and if a family or friend had 
ever been diagnosed, and or died of lung cancer.  
Follow-up Interviews. Follow-up questions were developed to further probe 
issues that were unfolding during the analysis. Questions specifically about stigma were 
reserved until the very end of the interview unless the participant mentioned stigma first; 
this was done to mitigate bias during the interview so the participant’s experience could 
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be freely described. The questions on the interview guide were derived from the two 
stigma theories, and the review of the literature.  
Interview Questions. The free association questions at the beginning of the 
interview were asked to elicit initial impressions and potential extant stereotypes about 
people and objects (patients who smoke and cigarettes, respectively, as an example). 
Questions about lung cancer were derived from other qualitative studies about health care 
professionals who care for patients with lung cancer (Conlon et al., 2010; Tran et al., 
2015). These studies addressed differences between lung cancer and other cancers, 
people who smoke and those who do not smoke, and support for patients with lung 
cancer. The background biographical questions were designed to provide contextual 
background of the narrator related to nursing, the profession in which they care for 
patients with lung cancer, lung cancer and smoking behavior, and prior exposure to 
smoking behavior and lung cancer, before becoming a nurse. Of the few qualitative 
studies that investigated nurses’ views on diseases that carry stigma such as obesity 
(Aranda & McGreevy, 2014; Brown & Thompson, 2007), participants provided 
background information about their own struggles with weight gain which provided 
context for the care they provided for their patients who were obese (Aranda & 
McGreevy, 2014).   
Interviews were audio recorded with a digital audio recorder, and uploaded to a 
secure cloud space. Interview recordings were then transcribed verbatim by either the PI 
or a transcriptionist. Field notes were completed after the interview in which the PI made 
notes about date, time, and setting of the interview and the length of data collection. Field 
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notes also included overall impressions, non-verbal behavior, and interruptions during the 
interview. For interviews transcribed by a transcriptionist, the PI listened to the entire 
interview recording to verify the transcript and make notes of audible non-verbal 
occurrences such as laughter and pauses, and verbal occurrences such as self-
interruptions, interruptions by the PI, and when the participant spoke as if they were 
another person (such as a patient).  
After the initial interview, participants were sent a copy of the transcript with a 
member check form so they could indicate whether or not they agreed with the transcript 
and any questions or comments they had. The copy of the transcript had continuously 
numbered lines that the participant could refer to when making a comment. Three 
participants participated in verification of their initial transcript, and three participants 
participated in verification of their follow-up interview transcript.  
Data Management 
Data were transcribed into a word processing document by the PI, de-identified, 
and saved on a secure hard drive and backed up in secure cloud space, using UNCG 
BOX, both of which are password protected. All raw data were assigned a number that 
corresponded with a participant. Near the conclusion of analysis, pseudonyms were 
created that corresponded with the numbers. Recordings that were transcribed by a 
transcriptionist or needed to be verified by the PI’s committee chair were shared using 
functions in the secure cloud space. Any words that could potentially identify the 
participant such as locations and names were removed from the transcript and in brackets 
the PI put [name of place] or [name of person]. Forms, such as consent forms, with 
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participant signatures were kept in a locked box throughout the study. Other forms with 
no personal identifiers, such as demographic forms, were kept in a separate locked box.  
Protection of Human Subjects  
Institutional review board (IRB) approval was obtained from the University of 
North Carolina at Greensboro IRB before recruitment and data collection. Potential 
participants who expressed an interest in participating contacted the PI by e-mail or 
phone. The PI set up a time and place to meet with the interested person, then presented 
and discussed informed consent before beginning data collection. The participant was 
provided with a copy of their consent and the PI kept the signed copy.  
Participant Rights. The PI explained to the potential participant, from the 
consent form, that they had the right to refuse to participate or to withdraw at any time, 
without penalty. If they did withdraw, it would not affect them in any way. If they chose 
to withdraw, they may request that any of their data which had been collected be 
destroyed unless it was in a de-identifiable state. The investigator had the right to stop 
their participation at any time. This could occur because they have had an unexpected 
reaction, or have failed to follow instructions, or because the entire study had been 
stopped.  
Participant Risks. The risks to the potential participant were explained in the 
consent form and read to the participant. These risks that were explained were: because 
their voice will be potentially identifiable by persons who hear the recording, their 
anonymity cannot be guaranteed. The PI will limit access to the audio recording to the 
following persons: the PI, who will need to listen to and verify each interview and may 
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need to transcribe some of the interviews, one committee member who will need to verify 
the interview, and a transcriptionist unless the participant wishes to have the access to the 
recording limited to the PI only. In the event that the interview becomes emotionally 
distressing, the researcher would pause the interview so that the participant can take a 
break, get some water, and/or walk around the room. The researcher would ask them if 
they want to take a longer break or resume the interview at a later time, or not participate 
in the study. If the emotional distress persists then the researcher would offer the 
participant the option of withdrawing from the study. If withdrawing from the study, the 
participant would be provided with the incentive at that time and a list of counseling 
services if needed. None of the participants experienced emotional distress or withdrew 
from the study.  
Number of Participants and Rationale  
The final sample size of six was determined by the principles of saturation, or 
when no new themes were interpreted in the data (Streubert & Carpenter, 2011). An 
estimated sample size of 10 was based on other studies that used a similar sample, nurses, 
and methodology, narrative. A narrative study that recruited a heterogeneous sample of 
nurses from eight different specialties achieved saturation at 11 participants (Jackson et 
al., 2010). In a study of acute care nurses’ experiences caring for patients with COPD, the 
sample size was 10, but the authors did not discuss saturation (Bailey, Colella, & Mossey, 
2004). Another study interviewed seven nurses about the discharge process for patients 
who had heart surgery and noted that their sample size was supported by their 
methodology [Lieblich et al., (1998)] (Lapum et al., 2016). Nurses’ experiences with 
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humor was studied with a sample size of four, which the authors noted was adequate to 
address their research question (Haydon & van der Riet, 2014). Qualitative studies that 
have the following design characteristics require smaller sample sizes: studies that are 
informed by theory, studies with “good interview dialogue” versus “weak interview 
dialogue”, studies that recruit a specific type of participant, and studies that have more 
narrow aims (Varpio, Ajjawi, Monrouxe, O’Brien, & Rees, 2017).  
Rigor for Narrative Inquiry 
Several techniques can be employed by the qualitative researcher to enhance the 
rigor of their findings regardless of the methodological approach. Rigor is enhanced with 
the use of member checks, maintaining an audit trail, and reflexive analysis. Member 
checking allows participant involvement in analysis of the data to the extent that they can 
respond to the accuracy of the transcript or analytic summary (Birt, Scott, Cavers, 
Campbell, & Walter, 2016). In this study, participants were sent a copy of their transcript, 
with numbered lines, along with a form for them to indicate whether they agreed or 
disagreed with the transcript and a space to make comments.  
An audit trail provides a detailed description of the analytic process that could be 
used to audit the research process (Streubert & Carpenter, 2011). The audit trail provides 
a ‘road map’ of “evidence and thought processes that led to the conclusions” (Streubert & 
Carpenter, p. 49) reached by the qualitative researcher. In narrative inquiry, Lieblich et al. 
(1998) refers to the audit trail as “width”, or the quality of both the data collection and 
analytic methods, which includes multiple quotes and different explanations to allow for 
others to evaluate this criterion (p. 10).  Lastly, unlike quantitative research, generating 
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qualitative research data is a combined effort between the researcher, the participant, and 
their interactions (Finlay, 2002). Through a structured process of reflexive analysis, the 
researcher seeks to determine ways in which their “position, perspective, and presence” 
affects the research (Finlay, 2002, p.532). While it is assumed in narrative inquiry that the 
researcher does influence the research, reflexive journals assist with documenting how 
this influence evolved. In addition, narrative inquiry also requires coherence, 
insightfulness, and parsimony (Lieblich, 1998). Coherence is the way the analytic 
components come together to form a “picture” (Lieblich, p. 10) and is evaluated either 
during the process or by comparing the analysis to extant research and theories which 
was done as part of the discussion of this dissertation, Chapter Five. Insightfulness refers 
to the ability of the researcher and others to glean new understandings from the analyses 
of the narratives. Parsimony is achieving an analytic outcome with as few concepts or 
themes as are necessary.  
Audit Trail 
An audit trail was maintained in several ways. The interviews were recorded with 
a digital recorder and transcribed, and the transcriptions were checked for accuracy, 
errors, and personal information that is a threat to confidentiality and anonymity. Field 
notes were written after the interview to record impressions about the overall interview, 
reactions to questions and the tone of responses, and interruptions during the interview 
and why they occurred. The demographic form was filled out by the researcher before the 
interview. The recorded interview, transcription, and field notes are considered the “raw 
data” for the audit trail (Lincoln & Guba, 1985, p. 382). The process of data analysis and 
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reduction, and related processes such as reflexive notes, were likewise documented 
throughout the steps of coding, analytic thoughts, memos, comparisons, themes, 
relationships, and questions asked of the data. These aspects of analysis and reduction 
were kept with the transcript, or in a separate document in a folder with the transcript.  
Reflexivity 
Reflexive thinking and analysis, a form of thorough self-evaluation, occurs before 
the research study begins, and during data collection and analysis (Finlay, 2002). Before 
the research begins a reflexive journal was kept, and has already been started, where the 
researcher wrote about her relationship to lung cancer, stigma, smoking, and nursing. 
During this process of reflection, the researcher considered her motivations, assumptions, 
and interests because this is what potentially “skew[s] the research in particular 
directions” (Finlay, 2002, p. 536). Lastly, during data analysis the researcher examined 
her assumptions and feelings about participants’ narratives and responses, which was also 
included in the reflexive journal (Finlay, 2002).   
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CHAPTER IV 
FINDINGS 
The purpose of this study was to explore the experiences of nurses who had at 
least six months of cumulative experience caring for patients with lung cancer, had been 
registered nurses for at least two years, and who were practicing nursing in the 
Southeastern United States. A secondary aim of this study was to explore how these 
experiences are related to the stigma associated with lung cancer. 
Recruitment 
Participants were recruited using a gradual rollout method of recruitment 
materials including an electronic flyer and brief recruitment message. First, potential 
participants were recruited through the Oncology Nursing Society Piedmont Chapter 
electronic newsletter and Facebook page by posting a recruitment flyer to both venues. 
After a week, the PI used two social media platforms, LinkedIn and Facebook, to share a 
recruitment flyer among her personal network with instructions to share among other 
networks. The original exposure to the flyer was limited to the network of the PI, with a 
request by the PI to the people in the network to use the “share” and “like” functions in 
Facebook and the “re-share” function in LinkedIn to disseminate the flyer beyond the 
PI’s network. The flyer was posted using the “create an event” function in Facebook and 
the “Share an article, update, or photo” function in LinkedIn. In the recruitment flyer was 
a statement that asked participants to consider other people they know who may be 
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eligible for the study. The PI’s e-mail and phone number were on the flyer with 
instructions for those who were interested in participating to contact the PI through the 
provided e-mail address or phone number. For those who expressed interest in 
participating, the researcher contacted them by e-mail or phone, per their preference, to 
ensure they understood the eligibility requirements for the study. This was done to ensure 
the potential participants understood the flyer before an interview is scheduled.  
After a week passed, the PI began the next phase of recruitment. A brief 
recruitment message, which was an abbreviated version of the recruitment flyer, was 
posted on the Sigma Theta Tau International Global Member Forum in “The Circle.” 
Messages posted to this forum are accessed by members’ e-mail or by logging onto the 
forum. The PI also recruited in-person through an Oncology Nursing Society local 
Chapter meeting which had approximately 20 attendees. The PI continued the next phase 
of recruitment after several weeks to provide time for coding and analysis. Next, the PI 
purchased and posted a brief recruitment message in the North Carolina Nurses 
Association electronic publication which has an estimated distribution of 5200 members.    
For recruitment flyers and messages that had a wide and variable distribution like 
social media, the PI used a separate phone number from her personal phone number and a 
secure UNCG e-mail address. This was done to ensure that research correspondence was 
kept separate from other correspondence, and that the researcher’s personal phone 
number was not widely advertised.  
 
 
100 
Analysis 
The narrative analysis was informed by a constructivist approach. A constructivist 
approach is suited for analysis in which the researcher will focus on aspects that 
contribute to the construction of narratives such as, but not limited to, themes, hidden 
meanings, and the social and power relations that bring about these meanings (Frost, 
2011). Analysis of the data was based on the four stages of thematic analysis proposed by 
Frost (2011),  and derived from Riessman (2008) which focuses more on ‘what’ 
participants say versus ‘how’ they say it. This model includes the following steps: 
selection of segments of the data; in this case codes were used to represent sections of the 
transcript, grouping the material into categories; defining thematic categories with words 
and sentence; and drawing conclusions. Structural analysis of the data was based on the 
components of a narrative proposed by Labov (1972). These components are (a) abstract, 
(b) orientation, (c) complicating action, (d) evaluation (e) result, (f) coda. The abstract is 
at the beginning of the narrative and provides a summary of the point of the narrative, the 
orientation provides the time, place, and people involved, the complicating action is the 
crisis, the evaluation is why the narrative was told, the result or resolution is the outcome 
of the story, and the coda is a clause that signals the conclusion of the narrative and may 
include information the narrator gained from the experience.  
 Analysis of data began with the first interview and continued as interviews were 
completed so that initial analyses informed subsequent interviews. For example, in the 
first interview, addiction was a code that was used several times; therefore, in subsequent 
interviews and follow-up interviews, this issue was explored further. A key component of 
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data analysis is data immersion which involved the writing of field notes, listening and 
transcribing interviews, listening to and verifying transcripts, and writing initial codes 
and notes while reading and re-reading the transcripts. The transcripts were put in a table 
format with four columns: the first column was the transcript, the second column 
contained codes, the third column contained analytic thoughts related to the transcripts 
and the codes, and the fourth column was a summary of categories and themes. Codes 
from each interview analytic table were transferred to a code book that contained three 
columns: categories with codes, supporting quotes, and summary explanations of 
categories to assist with theme development. A reflexive journal was maintained 
throughout the research process in which the PI wrote about biases, thoughts, questions to 
be asked of the data, and to track analysis as a way to form an analytic audit trail to 
enhance rigor of the findings.  The analytic process was reviewed by a member of the 
dissertation committee who is a qualitative researcher. All participants were assigned a 
pseudonym to maintain their confidentiality.  
Sample 
 Six nurses were interviewed for this study. Saturation was assumed after four 
interviews, however, to ensure that saturation was reached, two additional interviews 
were conducted which supported repetition of categories.  Participants were asked during 
consent if they would agree to be contacted for a second interview. Five of the six 
participants agreed to be contacted; three participants participated in a follow-up 
interview, one participant did not respond to two attempts to schedule a follow-up, and 
one participant was not scheduled for follow-up because their initial interview occurred 
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after saturation had been reached. Participants were also provided with an electronic copy 
of their transcript with a member check form, sent through email, to verify and comment 
on the transcript. Three participants verified their transcripts, one participant did so by 
returning the completed member check form at the beginning of the follow-up interview 
and the other two participants agreed with the transcript through e-mail correspondence 
but did not return the form.  Of the six participants, four were recruited via purposive 
means and two through snowball sampling.  
 Data were collected from July, 2017 to January, 2018. A pause in data collection 
occurred from August to September to allow for coding and analysis. The average length 
of an interview, including the two follow-up interviews, was 68 minutes. The initial 
interviews ranged from 51 to 94 minutes, and the follow-up interviews ranged from 36 to 
60 minutes. Recruitment was conducted over a five-month period.  
Sample Description  
All participants were female, with an average age of 50.5 (30, 70), average years 
of being a nurse 24.7 (6, 50), and an average of 13.5 (6, 22) years caring for patients with 
lung cancer. Regarding education level, four (66.7%) achieved a Bachelor of Science 
degree in Nursing (BSN) or higher at the time of the interview, one had an associate 
degree (ADN) and one a diploma. All participants received their pre-licensure education 
in the Southeastern United States. Most participants, 83%, also grew up in the southeast, 
and had a family member who had lung cancer and died from the disease. One participant 
reported smoking cigarettes.  
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The following is a description of the participants. Each participant was given a 
pseudonym. Pseudonyms were based on names of the PI’s family members and 
childhood friends. 
Sylvia. Sylvia is an older nurse with over 30 years of experience; she has cared 
for patients with lung cancer for 13 years. She currently works in hospice and home 
health, and cares for patients with lung cancer in both settings. Like many of the nurses 
interviewed, she spent most of her time growing up in and received her prelicensure 
education in the Southeastern U.S. She also grew up in a household where both parents 
smoked. She had a friend that was diagnosed with and died of lung cancer.  
  Rebecca. Rebecca has been a nurse for over 20 years and has cared for patients 
with lung cancer for most of that time in both the acute care setting and as a case 
manager. She grew up and received her prelicensure education in the Southeastern U.S. 
Her paternal grandmother was a strong role model, and was a driving influence for her to 
go to nursing school. She describes her as “…she was just the matriarch of the family she 
was just such a strong woman and that you know I wanted to be like her”. Her 
grandmother died of lung cancer and continued to smoke after her diagnosis. Rebecca 
recalls her grandmother’s response to smoking cessation after her diagnosis “she wasn’t 
very old, maybe 60s, but she’s like “I enjoy it, it relaxes me…I’m not putting ‘em down.”  
 Jenny. Jenny has the least experience of the six participants; she has been a nurse 
for six years and has been caring for patients with lung cancer for the same amount of 
time in the acute care setting. She grew up in and received her prelicensure education in 
the Southeastern U.S. Both her parents smoked and her sister, she recalls, snuck 
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cigarettes from their mom to try and fit in with her friends. She was recruited into nursing 
by a hospice nurse, while she cared for her grandmothers who were dying of lung cancer.  
 Tracy. Tracy has been a nurse for 22 years and has cared for patients with lung 
cancer for the same amount of time in acute care and oncology. She grew up in and 
received her prelicensure education in the Southeastern U.S. Both of her parents smoked, 
but while her mom smoked cigarettes, her dad smoked a pipe; she relays pleasant 
memories of both her parents’ tobacco use. She experienced an entrée to nursing that is 
linked to tobacco. Her dad, a physician, took her on his rounds while he smoked a pipe 
and, she notes, this was also when nurses could smoke in the hospital. This early 
experience of nursing she describes as: “seeing the nurses and their pretty white outfits 
you know and their stockings and just looking you know so great…they seemed really 
smart…”. 
 Anne. Anne has been a nurse for 50 years and has cared for patients with lung 
cancer for 20 years. She grew up in and received her prelicensure education in the 
Southeastern U.S. An uncle died of lung cancer, and she grew up in a smoking 
environment that she describes as “…like you’re swimming in a haze…” and “really 
foggy” then continues by quipping “Lucky I was short. You know, the smoke, it kind of 
went up high at least” [laughs]. She now reflects that this smoke-filled environment 
made sense since her dad ran a tobacco farm, which helped pay for her nursing education. 
She describes wanting to be a nurse since a young age: “I never wanted to do anything 
else. As far as I can remember, I wanted to be a nurse. My mother even made me a 
nurses’ outfit…when I was six years old for Christmas.” 
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Julie. Julie has been a nurse for 10 years and has cared for patients with lung 
cancer for five years. She grew up in the Northeastern U.S. but received her prelicensure 
education in the Southeastern U.S. No one in her household smoked when she was 
growing up and no one in her family or her friends has or had lung cancer. Her earliest 
memory of cigarette smoking was from television: “…everybody on TV smoked. The 
young women, the pretty women. You hardly ever saw an ugly woman smoke. It was 
people who looked always put together. It was always young pretty people who smoked 
and they just looked cool.” 
Analytic Findings 
A qualitative narrative approach was used to explore the aims of this research. 
Thematic analysis of the transcripts yielded four themes. Some of the themes are derived 
from InVivo codes, which came from powerful narrative segments within participants’ 
experiences. The four themes are: (1) addiction in action, (2) cancer of a functioning 
organ, (3) jumping through hoops, and (4) securing the journey.   
Themes  
 The following is a description of the themes and subthemes derived from the 
analytic steps mentioned earlier in the chapter, with supporting quotes. After the first 
theme is a table, Table 2, that represents part of the analytic audit trail: a section of the 
transcript, codes, categories, and subthemes. Each theme will also have a description of 
how it is linked to one or both of the stigma theories explained in Chapter Two. Table 1 
shows the structural analysis of a narrative segment in the theme addiction in action. 
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Table 3, at the end of the explanation of themes, will also provide a summary of the 
concepts of the two stigma theories and how they relate to sections of the transcript.   
Addiction in action. The first theme, addiction in action, is derived from an 
InVivo code and represents the struggles participants had surrounding the discordance 
between what they expected of patients and what patients did or said. Fundamentally, this 
discordance, at times, highlighted a mismatch in values, knowledge, and perceptions 
between nurses and the patients they cared for. Nurses used the label of “addiction” to 
offset the potential conflict surrounding this mismatch and to help explain the irrational 
and, at times, unsafe behaviors they witnessed. Subthemes for addiction in action are 
stigma-related thoughts, struggle, and frustration. Table 2 provides an example of a 
section of the audit trail associated with the theme addiction in action which includes a 
narrative segment from the transcript and associated codes, categories, and subtheme.   
Stigma-related thoughts. While most participants expressed sympathy for 
patients who have smoking addiction they also had responses that were more 
representative of negative stereotypes of smoking and people who smoke such as 
“dumb”, “filth”, “stupid”, “smoker”, and “addict”. At times, reactions to smoking 
addiction and talking about the causes of lung cancer elicited stigma related responses 
such as when Jenny shared her reaction to lung cancer “…I mean…I guess maybe 
it’s…sometimes you think…I mean you don’t want to say you did this to yourself 
but…you know because there’s different circumstances but…I mean you think that.” 
While Jenny remarks on stigmatizing and unspoken thoughts, this form of 
judgment and blame, for Rebecca, had a logical connection to smoking and getting lung 
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cancer “…you know I think at that point they’re just really mad [people who never 
smoked] you know and I would be too… at least if you smoke and you get cancer you’re 
like…I did it to myself.” Sylvia had a similar reaction to the uniqueness of lung cancer as 
a disease linked to an unhealthy behavior, yet is simultaneously able to recognize the 
strong feelings patients have related to a disease that is linked to an unhealthy behavior  
Hmm…I would say for the most part is the… component of realizing that you did 
have a hand in it… you know some remorsefulness… there are not many other 
cancers that are that cause and effect…really…I’m trying to think of any…maybe 
some GYN cancers…so I think that would be part of it.  
 
The topic of smoking also elicited associations to other stigmatized statuses, and  
strong reactions as Sylvia and Julie describe. Sylvia:  
 
…I guess I have to say I think of it as sort of a, and I know this isn’t true, in my 
head, but I think of it as sort of…a blue collar, uneducated habit you know that if 
you really knew better you wouldn’t do it, again I know it’s an addiction.  
 
Julie recalled encounters with people who smoke and assigns intent to their 
behavior while proposing more stringent rules about where people can smoke.  
It’s just the people around me. That feel like they have to share their smoke with 
me. And I don’t like it, and I think there should be a designated spot, like a mile 
away from any building that I have to enter, or my children have to enter. So, they 
can go there and smoke. We shouldn’t have to be subjected to that. We don’t want 
to be and if they want the convenience…of having the next fix, then they need to 
walk a mile to do that. So, standing outside the door is not enough, because I have 
to go through that door.  
 
According to Link and Phelan (2001), linking a labeled group, in this case people 
who smoke, to negative attributes like other stigmatized statuses “uneducated habit” and 
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intent to provoke “feel like they have to share their smoke with me” facilitates the act of 
separation and an “us”, people who “know better” such as Julie and her children, versus 
“them”, the uneducated and people who smoke around buildings, approach which is 
illustrated in Julie’s suggestion that they have a “designated spot, like a mile away”. 
Labels, negative attributes, and separation (us versus them) are what then contribute to a 
further disadvantaged status for the group that is stigmatized.  
Sylvia and Tracy both indicated that current policies that keep people who smoke 
away from buildings and warning labels on cigarettes, do not address the issue of 
addiction. Sylvia says about this issue “I just feel like as a society, I wish we would treat 
it more as an addiction and not just ‘you can’t smoke here, you can’t smoke here’ um… 
because people still will go find places to smoke.” Tracy says the following about overall 
neglect of the issue of addiction, and the ineffectiveness of warning labels on cigarettes: 
I mean I don’t condemn or condone either way. It’s kind of a choice. But…in this 
field and what I’ve experienced personally and professionally… it’s an addiction. 
I mean these patients are addicted to this nicotine… and…just kind of makes me 
sad that…we don’t recognize that as a society… and there is a piece missing that 
should…be looked at in the fact that…how easy accessible it is. Yes, there’s 
labels and this kinda stuff, who’s gonna read a label?  
 
Struggle. The subtheme of struggle represents the problems that participants 
faced when they tried to reconcile their emotions and beliefs about addiction with their 
professional behavior. Smoking addiction was defined and described as involuntary, yet 
participants also used words that implied a voluntary behavior like “choice” “nothing 
better to do” “just something they do”. Several of the participants offered a definition of 
addiction that was medical and rational, and spoke about knowing that smoking is an 
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addiction, yet they were still “blown away”, shocked, surprised, or disappointed when 
smoking behavior continued with their patients. Sylvia offers a powerful description of 
this struggle when talking about addiction in her family: 
Because my father did quit smoking when he got heart disease but he then started 
drinking so all my life with him there was addiction behavior and so that’s a 
struggle where I know in my head what addiction does but it’s still emotionally 
like why can’t you just stop doing this… Um…It’s kind of a duality you always 
have to fight. 
 
The “duality” that Sylvia describes represents the internal struggle of the two 
identities of the “wise”, knowing the difficulties of smoking addiction from interactions 
with their patients and their families, and wanting a someone to be “normal” and not 
smoke. For Tracy, the struggle and fight became an almost literal struggle between her 
efforts to fight lung cancer with treatment and support and her patient feeding the cancer 
with smoking:  
… I try to tell them not to blame themselves and… it is what it is, let’s just deal 
with it. Let’s just go forward from here…let’s not… let’s not even think about it. 
But yet it’s very difficult to know that they’re still smoking and yet…and I tell 
them, I was like you’re feeding the cancer and I’m trying to kill the 
cancer…you’re feeding the cancer…I’m trying to kill... it’s not gonna to work.  
 
In this interaction, we also see Tracy exhibiting “wise” behaviors by helping the 
patient counteract their self-blame. Tracy also describes the difficulties of engaging her 
patients in smoking cessation when their response is “I love it.” She explains: “That’s 
pretty strong… I love it! How do I…as a nurse speak to you about… quitting when you 
love something? I find those words – I’m just like…wow, okay!”.  
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Julie presents issues related to acute care where smoking addiction is treated with 
nicotine patches that are refused by patients:  
We have had several patients who have refused the patch. And opted to take their 
IV pole with them out to the sidewalk to smoke. We have had patients on oxygen, 
whose family members will bring cigarettes in and the assumption is that they 
understand that you tell them that they could blow everybody to smithereens, if 
they have any kind of fire or flame next to that oxygen tank. Or you know, you 
assume that they understand because they appear to be intelligent people, but the 
craving, I believe, far supersedes what common sense will say. 
  
Like Sylvia, Julie includes the safety issues of smoking around oxygen, and 
brings up an assumption that patients and families understand these safety issues. This 
description of smoking addiction among patients in acute care highlights that these are 
not safe assumptions, particularly in light of the more rational definition that participants 
provide for addiction “they cannot voluntarily stop” from Julie, and as Tracy notes, there 
is an element of deception  
…the lies and the deception [of smoking addiction] is the same you know. “Are 
you smoking?” [speaking as a nurse to a patient] “Psst, no.” [speaking as the 
patient] “What are those in your pocket?” Ah! Or you can smell it on ‘em. I mean, 
it’s not like you can’t smell it and they’re like “no, I’m not smoking”. 
OK…[laughs] you know so…um the lies and the manipulation and that kind of 
stuff is exactly the same with a regular addict.  
 
However, Julie arrives at this conclusion of unsafe assumptions by the end of her 
explanation “the craving, I believe, supersedes what common sense will say.” Sylvia 
provides a similar conclusion when talking about a patient’s husband smoking in the 
same room as the patient who has a tracheostomy and feeding tube:  
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this just struck me… her husband and his friend came in and they were both 
smoking… and I just sat there thinking I’m sitting here, your wife’s got a trach 
and a G-tube seriously! You know I didn’t say anything but I just… I mean it jus- 
it is a conundrum to me how people can look at somebody sit’n there with a trach 
and a G-tube and continue to smoke so there just has to be a component that 
transcends… judgment…  
 
Relationship to theory. Goffman (1963) wrote that “normals” have “normative 
expectations” of others that can change into “righteously presented demands” when they 
encounter the stigmatized (p. 2). The theme of addiction in action reveals the overlapping 
identities of the “wise”, the “wise” as “normals” who expect their patients to behave 
rationally, and the “wise” as “wise” who have sympathy for their patients because they 
know cigarette smoking is addictive, and help them counteract self-blame. Goffman 
(1963) explained that addiction is a type of stigma that is in the category of “…blemishes 
of individual character…” (p. 4). However, when nurses struggled with empathy for 
addiction, their patients at times became their oppositional voice. Tracy talks about a 
patient who got lung cancer because her husband smoked: 
Or… second-hand smoke, like the husband smoked for 50 years and the wife gets 
lung cancer… and she’s like... “you gave me lung cancer” [speaking as the wife 
in a serious voice]. I’m thinking, “yep, he sure did!” I’m just like “Ohhh that’s 
bad! ooh, I couldn’t live with myself on that one” But yeah…they’re mad… 
 
While participants engaged in “wise” behaviors, there were limits to helping 
people who smoke not blame themselves as Tracy explained in her follow-up interview 
about the same patient “Not for the second hand one, I was like… “let em’ have it!” I just 
let her go off on him, it was awesome, I was like, “you totally deserve that and more”.  
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Addiction was partially transformed by participants from an identity with negative 
valence “weak character” to one that offered protection and engendered sympathy for 
those who suffered from it. The stigmatized label of addiction or addict, for these 
participants, was also used as a way to avoid passing judgement on irrational behavior 
such as smoking while on oxygen, smoking while receiving cancer treatment, and trading 
alcohol addiction for cigarette addiction. Participants mentioned other stigmatized 
statuses and behaviors that were associated with smoking, but the label of addiction was a 
way to discuss a health issue without delving into problems that were associated with 
greater negativity like self-harm. However, Tracy hints at this issue in her first interview 
“what I feel when my patients talk to me about it…they will say words like ‘I love it’…I 
love it’…” She continues by comparing nicotine addiction to other addictions then 
concludes with “Because it’s… “I love it?” ...and it’s killing you.” 
Frustration. Frustration was an emotional response, expressed explicitly and 
implicitly, to dealing with the irrational behaviors of addiction among their family 
members and patients. These emotions were often expressed when participants were 
struggling to reconcile their scientific rational explanation of addiction and the irrational 
behaviors they witnessed. They were also expressed when smoking cessation was 
perceived to be an urgent intervention but was unsuccessful. Sylvia talks about caring for 
a patient on oxygen who smokes:  
…it was my first patient that I was sitting in the home with…she had oxygen and 
she lit up a cigarette and I just…just the thought that you would put us all at such 
a risk… you know so I think, I think that I see people still smoking…having these 
diseases, and again I think in their minds it didn’t matter at that point, but I think 
just the…the frustration that came of seeing…addiction in action. 
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Tracy also offers a frustrating experience. This description stems from a free 
association question about cigarettes “When you hear or read the word cigarettes what 
comes to mind?” In the first interview she said “a packet of cigarettes.” In the follow-up 
interview I revisited this response and she said:  
…I guess with my role it’s just…kinda that… I almost find them to be a nuisance 
[emphasizes this word] … with the cigarette…when I think of smoking and 
cigarettes I mean that just pops into my head. And it’s almost, for me, a 
frustrating image. You know? I’m just so tired of that…and I’m tired of the…the 
bigger picture of not seeing the addiction to nicotine…and…yeah it just, it’s a 
frustrating image…yeah. Because you know I’m sitting here talking to… a forty-
four-year-old with stage four lung cancer…they’ve got a pack of cigarettes in 
their pocket [pats chest to demonstrate where the pack of cigarettes are]. I had a 
patient who actually had a CT chest scan… and in his shirt pocket, I’m not 
kidding, the image – I’m not kidding – the image came back… and I was like, 
what is that? [says this in a loud whisper]. So, I showed it to my doctor and he’s 
like, “what do you think that is?” [speaking as the physician, flatly]. And I was 
like… “I really, I don’t know”. “That’s a pack of cigarettes.” [speaking as the 
physician again]. I was like “he wore that in his CT chest scan…for staging for 
lung cancer?” He said, “yep”! I was like…just yeah…yeah.  
 
Tables. Table 1 represents the structural analysis of a narrative segment of 
addiction in action. An explanation of the structural analysis will follow. Table 2 
represents a section of the audit trail for the theme addiction in action.   
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Structural analysis. Table 1 represents the structural analysis for a narrative 
segment within the theme addiction in action. The structural analysis was conducted 
according to the components of narrative described by  Labov (1972). These components 
are (a) abstract, (b) orientation, (c) complicating action, (d) evaluation (e) result, (f) coda. 
For this narrative segment, there is no abstract. Sylvia first orients us to the people 
involved, herself and a home health patient. The situation, the patient had chronic 
obstructive pulmonary disease (COPD), helps us understand the rest of the narrative or 
why the patient was on oxygen. She provides an idea of when this happened, her first 
patient she was sitting in the home with then transitions into the complicating action, that 
the patient was on oxygen and lit up a cigarette. While she does not explicitly say that 
this was a safety risk, her point of telling this story is to illustrate a safety issue that home 
Table 1  
 
Structural Analysis of Narrative Segments According to Labov (1972) 
 
Narrative Segment Components of the narrative 
1.“but I do remember a home health 
patient… 
2. she may have had COPD  
3. but it was my first patient that I was sitting 
in the home with  
4. she had oxygen and  
5. she lit up a cigarette and 
6. I just…the thought that you would put us 
all at such a risk…  
7. so I think, I think that I see people still 
smoking…having these diseases and again I 
think in their minds it didn’t matter at that 
point but  
8. I think just the, the frustration  
9. that came of seeing um…addiction in 
action.” 
Orientation 
1. Person 
2. Situation  
3. Time 
Complicating Action 
4. she had oxygen 
5. she lit up a cigarette 
Evaluation 
6. Safety risk  
7. Irreverent patient  
Result 
8. Frustration  
Coda 
9. addiction in action 
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health nurses can encounter during their care of patients with smoking addiction, and that 
these actions may not pose much significance to the patient. The result is her response to 
this situation, frustration, although she does not provide any actions that she took. Lastly, 
she provides a clause that signals the end of the narrative, or the coda which is also her 
observation of the significance of the narrative.  
Participants described encounters that represent addiction in action and the 
associated irrational smoking behavior in different ways. Sylvia and Tracy provide 
examples of two different ways that the narrator (participant) draws in the listener in 
order to express the importance of what is happening. Sylvia does this by presenting an 
organized account of what happened; she sets the scene (time, place, people) before 
proceeding to the complicating action. By focusing on action and not dialogue, she 
quickly brings to the foreground the issue at stake, safety, a repeated theme in her 
narratives. Through the evaluation component of the narrative, she also presents a 
situational irony that represents oppositional expectations of the patient and the nurse in 
the context of a safety threat, smoking while on oxygen therapy. The patient expects to be 
able to smoke in her home and the nurse expects the patient to not smoke in front of her, 
especially while on oxygen therapy. Sylvia is shocked by the risk that the patient’s 
behavior presents “… just the thought that you would put us all at such a risk…” and 
assigns an irreverent attitude to people who smoke “…in their minds it didn’t matter at 
that point…”. Sylvia also offers the listener more of her feelings about the encounter, 
“frustration” and summarizes the event with a label “addiction in action.”  
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Tracy describes a similar situational irony. She expects her patients to forego 
smoking while receiving cancer treatment, but sees a packet of cigarettes in their pocket. 
While she describes the scenario of a patient getting a CT scan, she presents her own 
dialogue along with the physician’s to help illustrate her disbelief. In another similar 
situation in which she speaks with a patient who is smoking outside the treatment center, 
she presents her patient’s side of the encounter by relaying what he says and changing her 
voice to match that of a sheepish male patient: 
…Even with their diagnosis of lung cancer. I mean, there’s some of them who are 
still smoking outside the [hospital] …I mean that’s addiction…It’s crazy. And I’m 
like “what are you doing, Mr. so and so”? And they’re like, “oh, [draws out “oh”] 
you shouldn’t have caught me” [speaking in a deep voice] I’m like, “yeah! you’re 
right, I shouldn’t have caught you!” So that, that’s how I just…I try to take it from 
an addiction kinda standpoint. 
 
Her account is not as organized as Sylvia’s, she changes quickly from describing 
addiction to the patient encounter. Yet when she does begin describing the encounter, she 
draws the listener in quickly with presenting both people present through dialogue and 
acting out each part. Table two represents the analytic audit trail for the theme addiction 
in action.  
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Table 2 
Analytic Audit Trail for the Theme Addiction in Action. 
 
 
Narrative Segment Codes  Categories Subtheme 
…she had oxygen and she lit up a 
cigarette and I…just the thought that you 
would put us all at such a risk…so I think 
that I see people still smoking…having 
these diseases…I think just the…the 
frustration that came of 
seeing…addiction in action. Because my 
father did quit smoking when he got heart 
disease but he then started drinking, all 
my life with him there was addiction 
behavior and so …that’s a struggle 
where I know in my head what addiction 
does but it’s still emotionally like why 
can’t you just stop doing this. 
Safety  
Safety risk  
Addiction 
Addiction in 
action  
Irrational 
Frustration 
Emotional 
Struggle   
Duality  
Family  
Situational 
Irony 
Addiction 
Smoking 
Smoking 
Addiction 
Patients with 
lung cancer 
who smoke 
 
Struggle  
Frustration 
…it’s almost, for me, a frustrating image. 
I’m just so tired of that…and I’m tired of 
the …the bigger picture of not seeing the 
addiction to nicotine…and…, it’s a 
frustrating image…yeah. Because you 
know I’m sitting here talking to… you 
know a forty-four-year-old with stage 
four lung cancer. You know they’ve got a 
pack of cigarettes in their pocket I had a 
patient who actually had a CT chest 
scan… and in his shirt pocket, I’m not 
kidding, the image – I’m not kidding – 
the image came back… and I was like, 
what is that? [says this in a loud 
whisper]. So, I showed it to my doctor 
and he’s like, “what do you think that 
is?” [speaking as the physician, flatly]. 
And I was like… “I really, I don’t know”. 
“That’s a pack of cigarettes.” [speaking 
as the physician again]. I was like “he 
wore that in his CT chest scan…for 
staging for lung cancer?” He said, 
“yep”! I was like…just yeah…yeah.   
Addiction 
Frustration 
Irrational  
Addiction in 
Action  
Situational 
Irony  
Addiction 
Smoking 
Smoking 
addiction 
Patients with 
lung cancer 
who smoke  
Struggle  
Frustration  
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Participants spoke about society’s lack of recognition of smoking addiction and 
remarked that people who smoke are “left to their own devices” with regard to smoking 
cessation. They also compared smoking addiction with other drug addictions and with 
other addiction treatments. The explanations of the overall neglect by society of 
addressing smoking addiction, of how cigarettes are readily available, and the lack of 
transfer of treatment options, such as mentoring, from alcohol and overweight treatment, 
point to a disadvantaged status for smoking addiction. 
Cancer of a functioning organ. The second theme, cancer of a functioning 
organ, is also derived from an InVivo code. This theme represents nurses’ impressions 
and descriptions of lung cancer and how it impacted the people who had it, in their 
personal and professional lives. Because lung cancer invades an organ where dysfunction 
in that organ can be immediately sensed and is frightening (difficulty breathing), 
participants spoke frequently about what was needed to support this organ; they identified 
with how patients and their own family members felt when there were alterations in its 
functions. Subthemes for cancer of a functioning organ are: dyspnea, sick, intimidating, 
secretions.  
Dyspnea (difficult breathing) was described as being worse than pain, a 
significant, negative impact on quality of life, and as a ubiquitous symptom for patients 
with lung cancer. Participants frequently used the adjective “sick” to describe patients 
with lung cancer which overlaps with descriptions of how scary and intimidating it was to 
encounter the complexity of care they needed. Secretions were described as thick, 
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harrowing, loud, and having a memorable smell. While Tracy describes the smell of 
“drainage”, this experience is grouped under secretions.  
Dyspnea. Sylvia best illustrates this theme when she prioritizes lung cancer and 
the related symptoms based on the organ that it disrupts and the distress that patients 
experience:  
I mean just… the breathing and the fact that breathing becomes your focus of 
activity… I think because…fatigue and breathing begin to… be so tied up that 
they’re…because you have breathe constantly say if you had another cancer it 
wouldn’t be a cancer of a functioning organ.  
 
Jenny describes a similar focus with her grandmothers who both died of lung 
cancer and how it diminished their quality of life “It was debilitating, I mean they 
couldn’t live their lives the way they wanted to they… couldn’t breathe.” Tracy’s account 
of her grandfather’s struggle with lung cancer, again, focuses on pulmonary problems:  
…I remember his dressings, and he would keep a dressing on that area on his 
chest and…you know the, the difficulty when he started to have trouble breathing 
and the wheezing and how - I mean, he was loud [draws out this word]. You 
know…you’d sit beside him and he was just real loud. And so obviously he was 
struggling. 
 
Dyspnea, according to Sylvia, was worse than pain, and caused a great deal of 
fear and suffering near the end of life requiring aggressive symptom management, 
“breathlessness and dyspnea is probably worse than pain most people would say and so 
we’re doing a lot of modalities to… maximize their physical positioning…”. Yet she also 
notes that there is little evidence to support the therapies that are done for dyspnea calling 
the research “anecdotal” she goes on to say:  
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… just trying to keep people calm and supported as much as possible with these 
few modalities then as I mentioned there’s some secretions when people are 
terminal they can develop secretions… apparently there is a higher propensity for 
people with lung disease… but it’s distressing to families so we’re doing a lot of 
family care…and there’s often a lot of anger if the person smoked and they know 
that this is the way it ended…there might be resentment in family members so… 
we’re trying to support them as well.  
 
Here, Sylvia describes how the distress of dyspnea extends beyond the patient to the 
family and can elicit feelings of anger at the original cause of the symptom. 
Sick and intimidating. Lung cancer patients were described as sick and complex 
due to the impact that the disease and treatments had on their pulmonary and sometimes 
cardiac systems, existing comorbidities, and the struggles the patients had in adhering to 
these treatments. Because of these issues, caring for patients with lung cancer was 
initially intimidating for several nurses:  
Lung cancer patients were described as sick as Tracy succinctly states “…truly my 
lung cancer patients are sick. They can’t breathe, they’re on oxygen. I mean they are so 
sick…” Rebecca echoes this description “…and those patients were just sick… you know 
they just had a lot going on…”  
Intimidating. Jenny describes how patients with lung cancer first seemed to her 
and how difficult it was to do interventions due to fear of accidents and complications.  
…it was very intimidating. Because you could have one patient that was stable as 
far as their vital signs and their pain and they were fine and comfortable and OK 
and then you had others who still had the chest tubes, the chest tubes were 
horrifying when I first started… I, I didn’t want to touch it, I didn’t want to move 
it, I was afraid of it…and then you have those other patients that due to the 
surgery and their illness plus their comorbidities…something would go wrong 
they would go into a-fib they would develop respiratory distress God forbid pull 
out their chest tube…so lung patients were scary at first… you start off and you 
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don’t even want to ambulate your patient with their chest tube because you’re 
terrified it’s gonna come out…  
 
The complexity of the patients she cared for also made empathy a challenge 
initially:  
… I was so overwhelmed at first by all of their things that I had a harder time 
seeing the person. And as I’ve gained experience…and I’m more comfortable 
with… their tubes, lines, and all of that I can focus more on the person who’s 
going through that and who…eight times out of ten has just been diagnosed with 
this and…that’s a lot, that’s a heavy load for some people to carry. 
 
Secretions. Similarly, Tracy talks about caring for patients with lung cancer in the 
ICU. She also recalls chest tubes, but offers a more visceral description of her experience. 
Her account ends with a repeating issue in her narratives, the negative impact of smoking 
as a force that nurses have to work against to deliver their care and help patients heal. Her 
last statement returns to ambulating her patients with the chest tubes.  
I… remember the tubes…the large chest tubes that these patients had to deal 
with…all the lines and wires and… the enormous scar that they would have and 
the dressing for those scars…those were there, I remember that. I can even 
remember like the touch and the feel of it and the smell of all that serous drainage 
from those… poor incisions and all those poor patients because you know they’re 
not healing appropriately with their smoking history and… that’s what I 
remember. Yeah, walking around with those chest tubes, getting them up… 
 
Secretions and intimidating. Julie also describes caring for a patient with lung 
cancer in the acute care setting. While she starts by describing the patient’s phlegm, she 
ends by relaying how unprepared she felt to care for a patient who was so sick “on 
paper”:  
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He also had a lot of phlegm that he liked to spit on the floor. It was thick and 
yellow. And I did step in it. But I also think that he did know what he was doing. 
That was, it was, it was sad.  
 
Later she talks about the same patient, but relays more of her feelings about the 
gravity of the experience:  
And it was a scary moment. It was a scary shift. Because when I read the progress 
notes, I realized that this guy had one and a half lungs. And I didn’t expect him to 
be, for such a sick man on paper. He was really, really sick on paper. He didn’t 
seem to be so sick in person. Ambulating all over the place. Filthy mouth. Uh, 
cursed at you because he couldn’t get a cigarette. Wanting to eat when he couldn’t 
eat. Refused for you, you know, to feed him. It was scary for me, because the 
labs, everything on paper, did not match the person in the bed. Or the person 
strolling through the halls. And as a new nurse, I was thinking this is probably 
somebody who is going to die on my shift. Because this doesn’t match that. And I 
felt like I wasn’t prepared to take care of him.  
 
She talks about the patient removing his oxygen:  
But he did not get an oxygen tank on the unit, he had to stay in his room, hooked 
up to the wall. But he would take it off, he would take it off. So, these things you 
learn in nursing school that this shouldn’t happen and this can’t happen, it 
happened! 
 
Structural analysis. Three participants recall a past experience in caring for 
patients with lung cancer, two of these experiences coincided with being a new nurse, 
Jenny and Julie. Jenny and Tracy include descriptions of tubes, drainage, and 
complications in their descriptions. Julie’s narrative focuses on alternating contrasts 
between the patient’s illness “on paper”; “one and half lungs”, “labs”, with how he 
behaved in the acute care setting; “strolling through the halls”, “cursing”. She further 
contrasts this experience with what she was taught in nursing school, that patients should 
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not take off their oxygen. There is also a glimpse of other aspects of the patient that are 
not necessarily included in the paper charting and progress notes, their mood “filthy 
mouth” and the way they view their illness and treatments prescribed by the plan of care 
“Wanting to eat when he couldn’t eat.” The narrator gives very little of the patient 
perspective other than attempting to exercise his autonomy in opposition to his treatment. 
Relationship to theory. The contrasts in Julie’s narrative illustrate the differences 
between the rational expectations and plan of care in the chart with the patient’s irrational 
behavior. Information about the patient is gathered from the chart and from report, but it 
is the person, in real time, with whom the nurse engages.  The normative expectations are 
that the patient behave like the sick person on paper and that they are obedient with 
regard to routines and treatments. These normative expectations, with regard to the theme 
of cancer of a functioning organ, are best seen by contrasting Julie’s narrative with 
Rebecca’s. Rebecca describes a patient with lung cancer who had severe dyspnea and 
was dependent on oxygen:  
…she came in, she couldn’t breathe I mean…we had her on a non-rebreather, she 
couldn’t compensate…- you took the breather off for a second she’d go into the 
60’s. I mean she couldn’t move in bed she couldn’t talk…she was in a bad way 
and she was up there for a long time and I took care of her… 
 
She continues by describing restrictions placed on the patient because of her 
severe dyspnea, and a label the patient acquired, “needy”. Rebecca offers a solution to 
this conflict that she considers to be the duty of the health care professional, “meeting 
people where they are” instead of telling them how to behave and what they cannot do:  
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Yeah needy you know but… I never found her to be needy…she liked things the 
way she liked them but I didn’t find her to be needy …you know, you gotta meet 
them where they are, you gotta anticipate what they want. You know if she… 
likes to curse don’t stop her. “Don’t talk that way to me!” [says this as an 
indignant whisper – speaking as a co-worker] you know you can’t do that to 
them… 
 
She continues by recalling the conflict the staff had with this patient because she 
had a strong, no nonsense personality and was dyspneic with minimal activity  
…she’s no nonsense, you go in and try to bullshit her she’s gonna cut ya down 
she’s gonna see… right through you. She’s not gonna put up with it. You talk 
down to her she’s gonna cut ya down, you act like she’s stupid she’s gonna cut ya 
down and that’s what people were doing…they’d go in and condescend to her, or 
tell her she can’t do something or… “you can’t do that!” … if she wants to get up 
and go to the bathroom by God take her into the bathroom, she knows she can’t 
breathe…she’s not stupid she knows she can’t breathe. Bring her oxygen and go 
in there. I think it’s just funny ‘cause so many people just… think they know 
best…and a lot of health care professionals think they know best. We don’t know, 
we don’t… 
 
Jumping through hoops. The third theme, jumping through hoops, is derived 
from an InVivo code. This theme represents the collaborative actions that nurses took to 
ensure that their patients with lung cancer received fundamental and key aspects of their 
care, and the complicated, and at times, unnecessary, barriers they faced when doing so. 
Fundamental standards that nurses worked to execute included calling the doctor for pain 
medication, obtaining a portable oxygen compressor for patients who were physically 
unable to manage a regular sized oxygen tank, and getting an order for adequate amounts 
of morphine for end of life care. The last scenario is what Sylvia describes as a “gold 
standard” of care, yet she still encountered barriers.  Subthemes for jumping through 
hoops are: push back, attitude barriers, and system level barriers.   
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Push back is a subtheme that is similar to attitude barriers but can be distinguished 
as an active process of negative displacement when nurses are engaging in advocacy. The 
negative displacement is psychological in the sense that the nurse perceives they are in a 
less effective position after the push back than before; they then must expend additional 
time and effort to make the advocacy effective. Negative attitudes are described by nurses 
not as an active thing but as a type of passive barrier they have to work around or deal 
with. System level barriers were obstacles in the system, such as insurance requirements 
and scheduling logistics, that were between the nurse’s assessment of what was needed 
for the patient and providing the care to the patient.    
Push back and attitude barriers. Jenny describes caring for a postoperative 
patient who had low blood pressure:  
… probably a couple of years ago… I had this super sweet patient that had come 
in earlier on day shift, I came in at seven was about to start my shift, blood 
pressure was a little low you know he’s fresh post op so all this stuff is going 
on…so I call early in the night and I’m like hey this is the situation, I get orders 
for the blood pressure, he’s OK pain-wise… has his PCA doing that every now 
and then once the blood pressure comes back up… get him up to the chair like 
I’m supposed to at six in the morning…he’s hurting still he doesn’t want to use 
the pain medication because now he’s afraid it’s gonna make his blood pressure 
drop. I try to explain you know ‘If you’re hurting it’s, it’s OK we can do 
something about your blood pressure it’s OK I don’t want you to be in pain and 
I’ve got these other things I can give you if you want, I think I had Tylenol it was 
like a standard order… patient says to me well I don’t usually take Tylenol 
because I’ve had liver issues or whatever it was I usually take Ibuprofen and it 
works, that’s what works for me and that’s all I would need right now. So, I paged 
the physician, on call physician, and I’m like all I need is an order for what -  how 
much ever ibuprofen you wanna give me. And I just, I mean I just get it, I mean 
he’s yelling, he’s asking me why don’t you wanna give your patient pain 
medicine like didn’t even remember this is the same patient I’m calling about 
earlier in the shift his blood pressure was in the 60s…I don’t think – maybe the 
narcotics aren’t a good idea which is what I said you know maybe the IV 
narcotics aren’t such a good idea because the blood pressure was low at the 
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beginning of the shift I don’t really want to do that to day shift and all he wants is 
an ibuprofen and I have to get that order from you unfortunately I have to call you 
at 6:30 in the morning I do apologize. It’s just situations like that, you know, 
um…where you get push back when you try to do the right thing…  
 
Jenny offers another explanation that shows that negative attitudes from 
physicians is not an uncommon barrier:  
Ah…surgeons, the attitudes…the attitudes the um…’why are you calling me’ you 
know kind of thing especially working night shift oh my goodness um…and you 
know…sometimes it makes you not want to call or not want to reach out or not 
want to say anything…because nobody likes to be yelled at or made to feel 
incompetent that’s not what we’re there for but it still happens. 
 
Structural analysis. Jenny uses the words ‘push back’ after describing a situation 
where she is advocating for her patient and doing patient centered care, and the physician 
shifts the focus away from the patient, towards Jenny and insubordination. She has to 
take additional time to try to shift the focus back to the patient and re-emphasize urgent 
issues like blood pressure and poor pain control. Jenny also talks about the attitudes of 
physicians and sees this as a deterrent to intervening on behalf of the patient, yet with this 
knowledge, she continues to “do the right thing” as her first account illustrates. Her 
emphasis, at the beginning of the narrative and throughout, of her relationship with the 
patient “super sweet patient” and early efforts to ensure good post-operative care, 
provide a sharp contrast to the way the physician reacts “I mean I just get it, I mean he’s 
yelling”. With this contrast and build-up in the narrative, push back almost becomes too 
bland of a description for the verbal abuse that occurred.  
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Sylvia also describes stigma-related, negative attitudes that are damaging and 
interfere with caring for patients at the end of life: 
I think there’s still um…I think there still is….thought about ‘you’ve done this to 
yourself’…I do still hear residents or physicians or people higher up the process, 
with comments like well you know ‘what do you expect they smoked’ you know 
they’re not gonna do any different…so I do think that is still a mindset at a 
different point on the healthcare continuum…where people are young and healthy 
and don’t have these habits are very easy to dismiss the struggles that people 
might have.  
 
I asked her if these attitudes impacted her ability to deliver care to her patients and she 
said:  
I mean sure ‘cause if you gotta go back to the doctor for orders…it does still exist 
where… they would never say it, but I think there is some kind of a punitive 
mindset…there’s this big divide  between hospice and non-hospice when it comes 
to so many things including pain management…because people who don’t do 
hospice pain management, they’re going ‘oh they just want drugs’ or ‘oh they’re 
just addicts’… and in hospice… it’s completely a neutral tool…with lung disease 
and lung cancer morphine is the gold standard for dyspnea so trying to get 
someone who doesn’t understand that, doesn’t have that liberality of thought that 
a hospice nurse would have to treat dyspnea with free amounts of morphine… I 
mean if you’re at a certain point in your disease, that’s what you need…trying to 
get that across to a physician that’s a huge block…  
 
Rebecca describes a slightly different attitude barrier, that nurses are not taken 
seriously by physicians which leads to problems communicating important assessment 
findings and delays in treatment. She describes caring for a patient with a significant leak 
from his postoperative wound. The patient had soaking wet linens every four hours and 
skin break down. This pattern had been occurring for several days with repeated calls to 
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the physician. Rebecca was finally able to apply an ostomy bag hooked to a Foley 
catheter to measure the drainage. She evaluates the situation this way: 
I felt horrible for him because it didn’t make any sense why he’d been laying like 
this for days…but they eventually took him back to surgery. It took days…but 
you know it was one of those things too I think…but for him [this particular 
patient] it took being able to measure, quantify the amount before the surgeon 
would do anything. I think you had to quantify the amount of drainage he had - 
say “look, he’s had four liters out in the last 24 hours.” Do something! Because 
we were saying ‘change dressing, pads wet.’ I don’t think it clicked in the 
surgeon’s mind how much this man was actually draining. Until you could 
quantify it into a number and then they were like “Oh crap!” you know “That’s 
crazy!” and then they did something when they could quantify it and see it 
because I don’t think they take nurses seriously a lot of the times… 
 
System level barriers. While Rebecca does not describe push back or negative 
attitudes, she notes the multiple, complex, and seemingly unnecessary steps to obtain 
portable oxygen, a common and critical therapy for patients with lung cancer:   
… making sure they’re getting their oxygen…fight’n for oxygen which is crazy 
but…most of my patients were Medicare patients so…they’re carrying around 
that huge oxygen tank…to go to the store, or go to the doctor’s office and trying 
to get them the portable tanks the… little…concentrator so that they could go to 
the store without carrying that heavy tank…’cause a lot of em are in a walker and 
carrying a tank and they can’t do it…they cannot do it and…it’s heart 
breaking…and you would not believe the hoops you have to jump through to get 
them a concentrator. She goes on to describe the hoops:  …you would have to get 
the doctor, the doctor has to fill out all this paperwork they have to have 
pulmonary function tests, they have to have… go through PT to get evaluated to 
be able to get a portable concentrator.  
 
Then she describes the reason for the hoops:  
…the insurance won’t pay for the… small regulator, the small concentrator. The 
home ones they’ll do but not the portable…It’s awful I’ve, I’ve spent a lot of time 
trying to get those things taken care of trying to get the pulmonary function tests 
and the PT evaluation and stuff ‘cause they… I mean truly they cannot walk with 
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a walker and manage an oxygen tank, you can’t do it. I mean it’s hard for us to do 
it while we’re walking patients can you imagine trying to do it by yourself. She 
goes on to describe the process but it’s getting there ‘cause it’s not like the doctor 
signing orders for a concentrator they have to write pretty much a dissertation 
why this patient needs it…so much work for them that you can see why they’re 
hesitant to do it for everybody…because it’s a whole lot more work… they have 
to write up why, and that’s why they need the pulmonary function and they need 
physical therapy to say they can’t carry around that oxygen tank and so everybody 
has to sign off on it. But they’re agreeable they just - it’s a pain in the butt…they 
make it hard.  
 
Rebecca describes a situation where the patient, with the advocacy efforts of the 
nurse, has to prove a certain level of diminished physical and pulmonary capacity in 
order to obtain a critical therapy that will also allow them to participate in their care, 
travel to doctor’s appointments, and perform activities of daily living, such as going to 
the store.   
Tracy recalls a long-term struggle with system level barriers when trying to 
coordinate a multidisciplinary clinic for patients with lung cancer. In order to have a 
successful clinic, everyone needs to be present, however:  
…my surgeons sometimes will… not come to clinic when they have patients 
because they either have an emergency or whatever…and there’s no backup plan. 
And I have begged for a backup plan for…five years? So…and…I’m just kind 
over them not having a plan so I went to my manger and I was like…we need to 
kind of have higher up management talk to these guys and…we all need to come 
together and have a plan. 
 
She continues by explaining the impact on the patient when physicians do not 
attend: 
And when they [the surgeons] don’t come it…does kind of mess up and kinda 
spoil the plan…the patients are already stressed out enough, they don’t need to be 
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called to rearrange an appointment they’re like ‘Ahhhh! I wanted to come and talk 
to a doctor and see what this is in my chest!’  [speaking as a patient under stress]  
 
In her follow-up interview she says that when the surgeon attends the clinic they 
can provide input about whether a surgical intervention can be done. When the patient 
only sees the oncologist and not the surgeon: “if we had not had the multi-disciplinary 
clinic, if he had just gone to see the oncologist, or just seen Radoc…he would’ve been 
delayed in his care. And that would have been horrible for him.” She ultimately attributes 
the difficulty in organizing this clinic to “…the mechanics and logistics don’t work as 
well as they do at these other places.”. 
Relationship to theory, structural discrimination. When nurses spoke of jumping 
through hoops to care for their patients they frequently mentioned that they did so from a 
disadvantaged status. In Link and Phelan’s (2001) framework for stigma, structural 
discrimination is posited to have negative consequences for those who have a disease that 
carries stigma, yet the people who advocate for them often work in the same system that 
has the discriminatory practices. Tracy offers a direct account of this issue:  
… I think the adequacy of staffing is poor…um…obviously they’re trying to get 
away with… throwing as much… on a nurse as possible…when in…in reality, I 
mean nursing is not medicine. We work together because we understand the same 
language, but we have our own science, we have our own… protocols and 
guidelines…and they have theirs. I think that the miscommunication with the 
physicians and nurses, it’s a hierarchy and if you’re not okay with being down 
here, when you’re getting orders… then you’re gonna buck the doc or buck the 
physician’s assistant…that’s not gonna go well, well it’s not gonna go well for the 
patient, that’s really at the bottom line…I think an emphasis on… nursing is 
important…our things that we provide for our patients…I don’t think that that’s 
really utilized and…I’m sad about that…I don’t like the fact that we are kind 
of…dismissed… 
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This miscommunication echoes Jenny’s account of a physician shifting the focus 
of care away from the patient to the nurse when she called for pain medication. Tracy 
also describes the issue of the lack of emphasis on nursing as a current problem that has 
not been resolved, however, she also does not propose a solution to this issue. Rebecca 
provides a similar description of nurses intervening on behalf of patients from a 
disadvantaged status:  
…and nurses do get the short end of the stick because you can tell a doctor 
umpteen times what’s going on and they don’t see it. Unless they walk in and 
actually see it you know they don’t understand. So, nurses kind of get the short 
end of that a lot of times but that’s the way of the world. 
 
Nurses, in this description, have acquired a stereotyped label as a group that 
should not be taken seriously. The consequences of this stereotype are that nurses repeat 
themselves and are not heard until they translate what they are saying into something the 
physician can understand. Rebecca indicates that this stereotype and the subsequent 
disadvantaged status has become “taken for granted as being just the way things are” 
(Link & Phelan, 2001, p. 367) or “the way of the world”.  
Securing the journey. The fourth theme is securing the journey. One participant 
referred to lung cancer as a journey directly, however, other words and descriptions were 
used that alluded to this concept such as “leading down a path”, “next steps” and 
“where they are in the process”. There were also descriptions of how nurses tried to 
ensure the best trajectory for their patients by providing education, empowerment, and 
support beyond their prescribed roles, and they were always looking beyond their own 
care encounters to what the patient would need next or long term.  
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Participants cared for patients with lung cancer in different settings and at 
different times along their cancer journey. While the setting that they worked in and the 
roles they performed within these settings informed the ways they approached providing 
quality care and helping patients achieve quality of life, they often desired connections 
beyond what was prescribed by their practice setting and worried about patients being 
lost in the health care system. All of the nurses interviewed saw patients with lung cancer 
as a particularly vulnerable group that needed a unique kind of connection, care, and 
empathy. Patients occupied their thoughts outside of their care settings when they 
problem-solved ways to improve difficult patient care situations, and when they worked 
to maintain connections with patients. The narrative segments that describe additional 
ways in which they formed deeper connections with patients draw in the recipients of 
these narratives in a way that magnifies the importance of what they did, what they 
thought, and how they felt about it. Subthemes for securing the journey are progressing, 
following, connecting, challenges to connecting, and challenges in the journey.  
 Progressing. In the acute care setting, Jenny and Rebecca repeatedly mention the 
importance of progressing patients so that when they return home they can “…start living 
the way or as close to the way they could before they came in the hospital that’s, that’s 
the best scenario.” Rebecca frequently commented on aspects of acute care, including 
progression, that were “hands on” which was more gratifying than educating patients 
over the phone:  
…when you’re working in acute setting… you can do the dressing change, you 
can do the incentive spirometer, you can walk ‘em, you can talk to ‘em, but in 
case management you’re just educating… and you hang up the phone.  
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Following. Sylvia and Rebecca both reflected on why following patients with 
lung cancer is so important, however Sylvia indicated that patients can be lost to follow-
up from inability of the health care system to keep track of patients because of the 
potential for self-blame among patients who smoke. She explains these two issues:  
I do remember another home care patient…just this really salty lady and we hit it 
off…she came on the service with lung cancer and when I read her files she had 
been lost to follow up and this was in the probably gosh 80s or 90s and maybe it’s 
not as easy to get lost any more…in some ways I see it as even more likely… it’s 
like with the more information we have the less…people actually do follow up, 
but I remember just being broken hearted because by the time they did catch up 
with her again she had metastatic disease and she had been diagnosed as just a 
spot…I don’t know how much that is still an issue but…following people or 
maybe more aggressive [screening]…and then if they do have an earlier stage 
identified… that they do have a way to keep tabs on people…because…I don’t 
think it’s a stretch to say…if someone has such an unhealthy behavior it may be 
easier without a follow up to say well I deserve this and I did this to myself…  
 
Rebecca also talked about the importance of following patients to makes sure they 
have the right resources when they leave the acute care setting, however her perspective 
comes from working in acute care and case management and realizing that some patients 
struggle with basic disease self-management like taking medications, which can lead to 
them acquiring the label ‘noncompliant’.  
I think it [case management] gives me an appreciation for what these people are 
coming from... ‘cause they come into the hospital and…we say noncompliance 
and yeah it’s noncompliance but it’s not really because they don’t want to it’s 
because they can’t and I think it gives a whole new perception of let’s find out 
what they need for when they go home. And again…yes that falls on nurses but I 
think hospital case managers, they need to be right there following these people 
and finding out what happened that they came into the hospital, what can we do to 
keep you from coming back.  
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 Relationship to theory. Rebecca mentions that patients can acquire the label 
“noncompliant”. She also talks about the implied negative stereotype associated with it 
“they don’t want to.” While she does not explicitly say that patients are not followed 
because of this label, she hints at the risk that the label implies for being able, as a health 
care professional, to understand and continue to anticipate the needs of the patient.  
Connecting. Connecting means being involved with the patient’s care beyond 
and at a deeper level than the initial professional encounter. Re-connecting with patients 
after acute care encounters allowed nurses to witness patients as people in a different part 
of their cancer journey, that of healing and improving. Equally important was hearing 
from patients again which allowed nurses to feel like they had made an impact and to 
know that the patient and family were doing well. When patients returned to the acute 
care setting to see the nursing staff this was a positive experience as Jenny describes 
“Seeing patients that come back and say “Oh OK I just celebrated my six-month 
anniversary…had my follow up chest CT and I’m good and…I’ve gained weight!” and 
it’s yeah, it’s amazing.” 
 Rebecca offers a description that is at the core of the connecting subtheme: 
 … the most positive thing for me is hearing from them again. Seeing them… 
making sure they’re OK or being able to connect with them after they leave me in 
some form or fashion… ‘cause I think it…for nurses, it lets nurses know you 
impacted somebody’s life you didn’t just do your shift and keep ‘em alive until 
7:05…you did more than that…you’ve made a difference and I think for nurses 
that goes a long way…especially… in the hospital when you just…do so much 
and you feel so much and you’re just trying to get it all done.  
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This is particularly important for Rebecca because in her description of how 
nursing has changed she recalls that she went from believing she was going to “change 
the world” to “…putt’n a Band-Aid on a lot of people and…you give ‘em education and 
pat ‘em on their back and send ‘em out…” For Rebecca, connecting also meant being 
physically close to patients with lung cancer in order to make an impact because the 
beginning of their trajectory, diagnosis, is a very emotional time for them: 
They just wanna know if they’re gonna live. You know so I think it’s…different I 
think you just need to listen to them and hold their hand and you know sit down, I 
mean, and I think that’s a lost art, you know… sit on the bed with ‘em listen to 
them talk and I do that, I still do that… I’ll sit down…sit in the chair, sit in the 
bed and listen to them and I think that’s more important than anything else you 
can do. I just listen to them and let them talk and let them cry, and you know ask 
them what they’re thinking about doing because that way it empowers them to 
know what they wanna do, to have a plan and kinda start going that way. 
 
Tracy echoes the emphasis on physical connection and listening:  
I’m probably… more sympathetic than empathetic – I mean… I did have 
somebody who had lung cancer in my family but…I truly feel like they need…an 
ear, they need to vent, they need just to know somebody’s there… I can give them 
my card and they can call me directly. And that is a connection and they latch 
onto that…and I’m the one that gives the hugs. I had a patient bring in her mom 
and her sister, I hadn’t met them yet. And I saw her, and I just adore this woman, 
she’s been through a lot. I came up and gave her a hug, she goes “oh my hug” and 
she introduced me she’s like ‘mom the lady that gives me the hug every time I 
come!’ I’m like that’s me, totally that’s me. Um...You know, I try to encourage 
them, I’m their cheerleader…but yet I try to be as honest as I can and…you know 
say yeah… that’s probably gonna happen next. 
 
However, as Rebecca and Tracy both assert, there is a wrong way to connect with 
patients and that is by sharing a story of someone you know who survived lung cancer 
and by saying you know how the patient feels: 
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I do know people who tell stories… ‘well my grandmama had…’ and I just think 
that is so the wrong way to go ‘cause they don’t care…they only care about 
what’s happening right now to them, and they don’t wanna hear that your 
grandmama lived.  
 
Tracy says about this issue:  
…I don’t think they want to hear that, I think they just want the support… saying 
to somebody I know what you’re going through… um…I don’t think they wanna 
hear that. I know I don’t think I would wanna hear somebody say that to me. No, 
you don’t know what I’m going through. I just wanna support you and encourage 
you to make the best decision for you. And it may not be chemo, it may be 
palliative. Let’s make you comfortable. You know, what are your goals? What do 
you want to do with your… six months? 
 
Challenges to connecting. For Sylvia and Tracy, securing the patient’s journey 
included palliative and end of life care and planning. This made connecting a psycho-
emotional challenge because they were aware of a poor prognosis while engaging with a 
hopeful patient, an emotionally stressful experience as Sylvia describes:  
I do have a homecare patient right now and…she was sharing how she had just 
stopped smoking she has got a head and neck and…lung cancer diagnosis…but 
she had told me that she had smoked and drank heavily and she had quit and she 
was going to church and… but because of smoking and the drinking she had 
gotten head and neck…she had an ostomy, a trach that was capped, and a G-tube 
because she can’t eat enough… but she’s doing immunotherapy and she’s very 
upbeat about her chances, however it is metastatic and… I read her chart…and the 
immunotherapy that she’s taking isn’t making a difference, she thinks it is but it’s 
not, she feels better and… a lot of it is probably placebo which is fine… but she’s 
getting out and is more upbeat, but I know it’s not gonna end well and it’s just 
really hard to sit there and… just try to be where she is right now and encourage 
her and say that’s great and what do you wanna do she just went to the beach with 
her friends you know and how was that but I know when I see her again… it’s 
gonna be not in a great place and that’s just you know sadly so many that you’re 
gonna see at these stages and I think my [family member] the [profession] that 
smokes you know she’ll say she has the same experience with her patients that 
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come in at different points and you know so I think that’s a hard thing to know 
you’re gonna see that.  
 
Tracy offers a sharp juxtaposition of the challenges of caring for patients with a 
serious and terminal illness by saying that it is “nice but it’s also very hard.”  
... the oncology part it’s, it’s nice but…it’s also very hard because lung cancer 
patients die. I mean… they do… and you get a bond with them, you get a bond 
with their family and then when they start to… not do well the family is 
panicking…the patient is panicking, you’re panicking…and there’s just not a lot 
of hope that you can give and you’ve gotta transition ‘em to… palliative and 
hospice care and… I mean that’s so stressful for everybody and then you’re 
getting calls from Uncle Bob who lives in New York and you know, Aunt Sally in 
Texas and trying to educate and you know and talk about next steps and… they’re 
like ‘you’re giving up’ [speaking as the patient] some of ‘em are like, you’re 
giving up or some of ‘em are like pfft it’s my time, it’s, I can’t do this anymore 
kinda thing so it, this part is you get a little, a little bit more of attachment with 
these patients and…it’s you know it’s just hard to see them not do well… 
 
Coping mechanisms were used that helped nurses maintain connections when 
they witnessed psychological and emotional stress among their patients as Anne explains: 
“…I don’t want to say later you get cold to it, but you have to… you have to kinda buck 
up and… be strong for them.” 
Challenges in the journey. Lung cancer is a disease that presented significant 
challenges to the resources of patients and their families. The main tangible resources 
included money, transportation, and physical energy. The less tangible resources included 
abilities to cope with psychological, social, and emotional stressors. Participants describe 
patients experiencing: “financial devastation” related to treatment costs and being 
“scared they can’t afford everything…transportation that sort of thing”.  
138 
At times these costs lead to interruptions in care as Tracy explains “I’ve had one 
to stop treatment, with immunotherapy, it still works… for a while after you stop so one 
patient stopped actually for a while…got scans…I think for about six months stopped, 
just financially couldn’t do it anymore.”  
Patients also had difficulties overcoming the shock of their diagnosis, and 
emotional turmoil during treatment related to uncertainty about their trajectory and about 
their caregivers. Anne describes talking with patients and their caregivers:  
their primary care giver… it’s really amazing the husbands and/or wives that 
come in with…the patient and they’re trying to be all positive and… say how he 
felt today, or how he didn’t feel so good today and… their prognosis is really kind 
of bad but they’re trying to be so upbeat, and they look so worn out…and…you 
just gotta feel for ‘em. Yeah, you gotta feel for ‘em…physically, you can look at 
‘em…tearful sometimes… like I said, just their physical, emotional 
appearance…even the patient will comment, he or she is just working themselves 
to death, she needs help, I know I’m being a burden… 
 
Patients experienced different emotional challenges based on their smoking status 
and their age. Jenny recalls a frequent saying among her patients who smoke “I wish I 
would have never started” yet she also expresses a juxtaposition regarding smoking 
behavior and a lung cancer diagnosis: “I think a lot of people…tend to think ‘oh well this 
just happened all of a sudden’ you know, when how many ever years they’ve put 
themselves at risk…” she continues by contrasting people who never smoked with people 
who do:  
…people who never smoked I think have a little bit harder time with it, with 
answering the why because then you have other people who have seen all the ads 
and know they’ve smoked however long in their lifetime and well here we are you 
know it kinda it almost seems like it’s in the back of their minds but they still 
have this thing that they’re doing that they don’t need to be doing…um… it’s a – 
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I hate to say almost expected but…more than expected than someone that never 
smoked.  
 
 Tracy recalls a female patient who spent a long time trying to find the cause of 
her cancer, but she starts with a common perception among her patients: Oh! I mean 
you… you only get lung cancer if you smoke, right? Right, that’s what they’re thinking. 
She goes on to talk about the reaction of her patients who have never smoked: 
…but they are completely shocked. And… it takes a while for them to digest it. 
And the questions that they have – I mean they’re very angry…a lot of mine that 
are diagnosed with lung cancer are like “well I did it to myself” I’m like 
“well…let’s not blame ourselves but…you gotta quit smoking. This is why you 
got lung cancer. And the…ones that never smoked are like, “what did I do wrong?  
 
She continues by talking about the struggles of a specific patient who did not smoke:  
You know, one of them actually said that to me, ‘what did I do wrong?’ And she 
tested her house for radon…and she did all these things and…she’s like - it took 
her, it took her like a year to really be like… “OK”. She’s like – she just kept on 
blaming herself – ‘what did I do wrong, what did I do wrong’? And I was like, 
you didn’t do anything wrong. It’s just a bad, nasty cancer.   
 
This, Tracy explains, is a frustrating experience for both her and the patient.  
Structural analysis. Tracy alternates between the perceptions of people who 
smoke and have lung cancer “well I did it to myself” and those who never smoked “what 
did I do wrong?”, “shocked”, and “angry”.  These two types of patient are in a virtual 
side by side position as she explains the different reactions to a lung cancer diagnosis, yet 
she provides a story about a woman who never smoked and her search for the cause of 
her diagnosis, while the brief description of the person who smoked indicates that this 
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person already has their answer to the question “what did I do wrong?” Tracy’s response 
to this question involves personifying lung cancer “it’s just a bad, nasty cancer”.  
Relationship to theory. Tracy talks about psychological consequences of her 
patients with lung cancer who smoke and who never smoked. While she does not 
mention the ongoing consequences of self-blame for patients who smoke, her efforts to 
counteract their self-blame and refocus the issue to smoking cessation indicates that she 
does not think self-blame is a productive line of thinking. Her narrative of the patient who 
was diagnosed with lung cancer and who never smoked illustrates the negative effects 
that a label and associated negative stereotypes: “I mean you… you only get lung cancer 
if you smoke, right? Right, that’s what they’re thinking” and …but they are completely 
shocked. And… it takes a while for them to digest it. And the questions that they have – I 
mean they’re very angry…” have on people with a disease, lung cancer, that carries a 
stigma self-inflicted, and a “bad, nasty cancer”.  
Older patients seemed to take their diagnosis “in their stride” and were on more 
of an “even keel”. Younger patients had unique struggles according to all participants 
because they had kids, and were “not ready”. Anne talks about the emotions of her 
younger patients:  
They’re just stressed…it’s so much their life now…it’s every day…insurance, 
what they’re not paying… you know, “I’m worried I can’t get this medicine, 
they’re not paying this, I’ve gotta work with them - the doctors are working with 
me to get it, but if I don’t get it...I’m wondering how long will I last?” It is so 
much, they’re just…they’re thinking about it all the time, they’re asking questions 
about it all the time… it’s question after question after question - not that they 
don’t still do this over with the navigators, with the oncologist the radiologist... 
their radiology/oncologist. But it’s forever on their mind. Worrying about their 
families… 
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Various forms of support were mentioned as important during the patient’s 
journey such as family support, financial support, and support groups. Family support 
could be beneficial and problematic when they dominated or contrasted with the goals of 
the patient. Nurses worked to fill the gaps in support as Anne, Tracy, and Jenny describe. 
Anne notes that even when patients block support initially, it is important to check on 
them later: And that happens sometimes… they don’t want to hear it, they’ve heard it 
before…they know it’s not gonna get ‘em anywhere, they know the ending is gonna still 
be the same… She goes on to explain how she responds: “…sometimes I even say I’m 
gonna – and I do, that I’m gonna give you a call later, in a couple - few days, check on 
you…and I do.”.  Tracy says: “I help them fill out SCAT applications to get here, 
Medicaid, transportation I’m always on the phone calling to get help for these patients.” 
Jenny describes how her unit pitched in to help a patient and her family: 
I guess she was like in her 70s, 60s, 70s and had complicated lung cancer she was 
keeping her two grandchildren her husband was out of work so they were the sole 
responsibility of their grandkids, he was out of work so like the unit got together, 
we fund raised we got them a thanksgiving dinner, Christmas dinner, toys I 
mean…and that’s all from…our hearts to them so we do a very good job at that… 
going above and beyond. 
 
Similar to Anne’s observations about patients being emotionally distressed 
enough to shut down and block support, Tracy notes the struggles she has had organizing 
a support group for patients with lung cancer, something she notes is key to their journey: 
…there’s support groups that are out there but my patient population just doesn’t 
go. We have worded it differently, we have…reached out… and we are just so 
unsuccessful in getting a support group for those patients ‘cause they don’t want 
it.  
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While she believes that this is because their various invasive therapies leave them 
exhausted, solutions to poor attendance focused on offering support through smoking 
cessation or one on one support.  Other cancer diagnoses do not have this same issue: 
Like prostate… they’ve got a great group. GI…they have a great group. Breast 
cancer, has like five groups… the young… the old… the you know, I mean they 
have…you know a ton. Which is great but…we even have like we call like ‘living 
with cancer’, which would be basically my patient population. And not interested 
in that. We have…worded kind of funny to try to get our patients in. I can’t even 
remember what that group is called, but… they’re absolutely not interested. 
There’s flyers everywhere, we send them out… when it’s lung cancer awareness 
month, which is November, you know we are just trying to push this information. 
And I think that they don’t understand that. This is a journey. And really, we’re 
here to support you and your family. 
 
Other support that participants thought patients with lung cancer needed was 
similar support and public recognition as breast cancer, represented in Table 3, more 
integrated cancer care early in their diagnosis, and more timely education about their 
diagnosis.  
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Table 3 
 
Relationship of Sections of Transcript to Stigma Theory 
 
Sections of Transcripts Theoretical Concept  
 “smoker”, and “addict” “noncompliant” 
“cause and effect” disease [lung cancer] 
Labels/Labeling (Link & Phelan, 
2001) 
“dumb” [person who smokes] 
“filth” [cigarettes] 
“stupid” [people who smoke in front of patients] 
Stereotyping (Link & Phelan, 
2001) 
“I would say for the most part is…the component 
of realizing that you did have a hand in it some 
remorsefulness there aren’t many other cancers 
that are that cause and effect…”  
Separation “us” versus “them” 
(Link & Phelan, 2001) 
“…I mean…I guess maybe it’s…sometimes you 
think…I mean you don’t want to say you did this to 
yourself but… because there’s different 
circumstances but…I mean you think that.”  
“… I mean it’s always this thing about breast 
cancer, breast cancer, breast cancer. And that’s 
fine …but it’s never that much about lung cancer.”  
Status Loss (Link & Phelan, 
2001) 
“there is a piece missing that should…be looked at 
in the fact that…how easy accessible it is. Yes, 
there’s labels and this kinda stuff, whose gonna 
read a label?”  
Structural Discrimination (Link 
& Phelan, 2001) 
“…you can’t blame people, people can’t blame 
themselves. We all make poor decisions. We all 
make decisions that are gonna affect our health 
later on um…and I think as a nurse taking care of 
those patients you just have to…look beyond that 
and meet their patient wherever they are…”  
“Wise” Thoughts 
“...they would give anybody anything, especially 
my dad’s mom…she would give the shirt off her 
back to a stranger…and she smoked all her life, 
from the time she was like eleven… and just the 
path that it led her down… it didn’t mean she was 
a bad person, it just meant she made some bad 
choices” 
“Wise” Experience and “Wise” 
Logic 
“…I’ll say things like you know I’ve never smoked 
but I understand it’s very hard to give up…” 
“Wise” Actions (Goffman, 1963) 
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Table 3 summarizes the relationship of what participants said to the different 
concepts in one of the two stigma theories discussed in Chapter Two. The concepts 
presented in the table are labeling, stereotyping, separation, structural discrimination, and 
the “Wise”. The first row shows examples of labels that are associated with people who 
smoke, people who have an addiction, and people with lung cancer or the disease lung 
cancer. These labels overlap with the concept of stereotyping because “addict” is both a 
label that matters socially and is a cognitively expedient way to describe a person who 
has an addiction, yet it also summarizes their identity in a negative way. The second row 
provides examples from the transcripts of participants responses to the free association 
questions at the beginning of the interview and other stereotypes that were mentioned 
throughout the interview. The word “dumb” for example, is a negative stereotype that is 
imputed from knowing that people still smoke in the presence of widely known health 
risks. The third row provides an example of how patients with lung cancer are separated 
and distinguished from other cancers as the “cause and effect” cancer. This separation 
also contributes to status loss or a “you did this to yourself” type of cancer, and less 
comparative public support than breast cancer.  Structural discrimination is represented 
by the neglect that participants noted with regard to adequately addressing and treating 
smoking addiction or nicotine addiction either among people who smoke in general or 
people with lung cancer who smoke.  The last three rows of the table represent the 
thoughts, experience, logic, and actions of participants considered to be components of 
“Wise” persons who have intimate knowledge of persons with a stigmatized disease and 
show empathy and help to counteract stigma.  
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Summary  
The purpose of this study was to understand the experiences of nurses who care 
for patients with lung cancer and how these experiences relate to the stigma associated 
with lung cancer. The four themes were: addiction in action, cancer of a functioning 
organ, jumping through hoops, and securing the journey. Smoking addiction was an issue 
among patients with lung cancer that nurses struggled with and was both a stigmatized 
label and used to understand the irrational behaviors that nurses witnessed among their 
patients. Other struggles included attitude and system level barriers that became “hoops” 
that nurses had to jump through, from a disadvantaged status. The pulmonary issues 
associated with having lung cancer was a repeated concern and differentiated lung cancer 
form other types of cancer. Lung cancer was a referred to as a journey in which patients 
experienced financial and psychological stress. Nurses helped patients during their 
journey by mobilizing support and resources, and initiating and maintaining strong 
connections, which at times was challenging. 
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CHAPTER V 
DISCUSSION 
The purpose of this study was to explore the experiences of nurses who had at 
least six months of cumulative experience caring for patients with lung cancer, had been 
registered nurses for at least two years, and who were practicing in the Southeastern 
United States. A secondary aim of this study was to explore how these experiences are 
related to the stigma associated with lung cancer. This chapter is organized by the themes 
in Chapter Four: addiction in action, cancer of a functioning organ, jumping through 
hoops, and securing the journey. Within the discussion of each theme will be 
recommendations for nursing practice or future research.  
Addiction in Action 
Smoking, in this study, was described both as an addiction and as an implied 
behavioral choice. Addiction was described as involuntary and something that yielded 
deceit, such as when patients denied smoking when there were signs that they were 
smoking. Smoking cessation was perceived to have very low success rates and be a 
challenge when patients said things about smoking like “I love it”. This study provides 
additional context surrounding the empathy toward people who smoke that stems from 
knowing that it is an addiction; yet the nurses did not fully understand addiction.  Nurses 
in this study have dealt with smoking addiction multiple times in their careers and in their 
families. So, while they have empathy, they still struggle with their patients’ smoking 
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addictions, particularly because as nurses they are strongly invested in the health and 
well-being of their patients. Other than frustration and shock at the smoking behaviors of 
their patients, it is unknown what the long-term effects are for the nurse regarding this 
repeated cycle of frustration and shock for caring for patients with smoking addiction; 
potentially, this can wear away at empathy and lead to burnout. Burnout might be 
exacerbated if the nurse is not educated in effective evidence-based smoking cessation or 
if there is no evidenced-based framework within the work setting that can be applied to 
the care of the patient with lung cancer who has smoking addiction.   
Additionally, nurses’ descriptions of smoking and smoking addiction revealed a 
lack of full understanding of addiction as a chronic disease that requires multiple 
interventions and follow-up by health care professionals. Nurses spoke of smoking as a 
habit that could be voluntarily stopped, and often did not acknowledge the likelihood of 
multiple relapses before a lasting quit attempt. This can lead to frustration for nurses in 
trying to help patients quit and may result in perceiving the problem to be unsolvable. 
Nurses had a fragmented understanding of smoking addiction that contributed to their 
difficulties in witnessing smoking behaviors, and frustration with effectively addressing 
smoking cessation. This fragmented understanding allows for the continuation of extant 
negative stereotypes and labels in the health care setting. For example, the stereotypes 
that a person who smokes or the act of smoking is “dumb,” and that smoking is a 
“choice,” highlights a gap in understanding that addiction is a chronic disease where 
addictive substances “…hijack brain circuits that exert considerable dominance over 
rational thought, leading to progressive loss of control over drug intake in the face of 
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medical, interpersonal, occupational and legal hazards” (Dackis & O’Brien, 2005, p. 
1431). 
Research on the neurobiology and pathology of addiction indicates that the person 
has very little control or “choice” regarding the behaviors surrounding the addiction.  
Labeling certain health behaviors to be a “choice” might be a way of coping for nurses 
because it indicates a certain level of control over oneself, and places the majority of 
responsibility for health maintenance on patients. This is not to say that patients have no 
responsibility for their health, but that too much responsibility may be placed on them too 
early in their disease trajectory. There was no mention, by participants, of what they did 
to address ambivalence about quitting or patients in the precontemplation stage of 
change; although they described interacting with patients in these stages of change. 
Nurses should also have simulation practice and training in not only the five As of 
smoking cessation (ask, advise, assess, assist, arrange follow-up) but the five Rs 
(relevance, risks rewards, roadblocks, repetition) which are used when a patient is not 
interested in quitting (Fiore et al., 2008). The five Rs are based on the principles of 
motivational interviewing (MI) which can help health care professionals who are 
performing smoking cessation to “roll with resistance” (Fiore et al., 2008, p. 57). 
 Education about addiction would help nurses to not frame smoking behaviors as 
a choice but as an addiction, and addiction as a chronic disease. The chronicity of 
addiction means that the judgment of people who have it, with regard to safety and their 
own health, can be overridden repeatedly by the pathways in the brain that support 
continued and regular use of the substance. Therefore, nurses should expect to have to 
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reemphasize safety issues with patients frequently and firmly. They will also need the full 
support of their practice areas in maintaining a culture of safety for their patients, 
themselves, and the patient’s family.  Participants expressed dissatisfaction with current 
policies to deter smoking such as smoke-free areas around buildings and warning labels 
on packages, indicating that they see a need for change. Having comprehensive 
knowledge of smoking addiction in addition to a desire for better deterrents from 
obtaining cigarettes and better treatment for addiction would also allow nurses to be more 
effective advocates for increased support for smoking cessation for patients both in their 
practice areas and with regard to local, state, and national policies.    
Participants described the care they gave as episodic because it occurred during a 
shift or during a home or office visit. Care that is designed around brief encounters can 
generate frustration when addressing a chronic and intractable health issue like smoking 
addiction. During these brief encounters, where there is limited time to make an impact or 
do an intervention, nurses and other health care professionals may be disappointed when 
they do not see immediate results such as they might when they perform other more 
specific tasks like changing a dressing or ambulating a patient.  Participants also 
described the acts of being able to “fix” and have resolutions to patient problems as 
important to them. If patients express ambivalence or lack of readiness regarding 
smoking cessation, part of their care can appear to be an open-ended issue with no 
foreseeable resolution, and a potentially disappointing experience for nurses, particularly 
if they have no evidenced-based framework to apply to these issues. 
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This study revealed that it is possible to know stereotypes of people who smoke 
and smoking-related illnesses and also have empathy, and that stereotypes or judgements 
do not necessarily translate into action. However, “wise” people who are also “normals”, 
or people who do not smoke and do not have cancer, had expectations of their patients 
that included not smoking in their presence or while receiving treatment. However, 
nurses’ encounters with patients who smoke while receiving treatment or lying about 
smoking reveals that it is not the people they are frustrated with, but the more troubling 
behaviors that are associated with smoking addiction. 
Nurses, although sympathetic, encountered difficulty with not viewing lung 
cancer as a self-inflicted “you did this to yourself” disease and smoking as a “habit” that 
if a person “knew better” they would not do it, a “choice”, and a “dumb” behavior. This 
finding is somewhat similar to a cross-sectional study of nurses in China which revealed 
that nurses assigned more blame to lung cancer than any other cancer, but less blame than 
they assigned to obesity (Wang et al., 2015). One nurse in this study remarked that 
HIV/AIDS is more stigmatized than lung cancer; something she witnessed while working 
because people, family and staff, were afraid to touch people with this disease. Several 
nurses in this study compared different addiction behaviors like food addiction, alcohol 
addiction, and illegal substance addiction with smoking addiction but they generally did 
not offer comparisons on stigmatized diseases. However, knowing that smoking is an 
addiction is supported in another study to be associated with more empathy toward 
people who smoke (McCool et al., 2013).
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Although nurses in this study had stigma-related thoughts but did not describe 
stigma-related actions, education surrounding stigmatized diseases and the impacts they 
have on the patients who have them would help nurses re-frame their thinking toward 
what the patient is saying and experiencing, and away from common negative stereotypes 
and labels. Although it is not explicitly hypothesized in either Goffman’s or Link and 
Phelan’s stigma theory, in order to advocate for people with stigmatized diseases the 
“wise” or any advocate would need to have comprehensive knowledge of the processes 
of stigma. More research is needed on an organizing framework to help nurses assess and 
intervene with patients who have lung cancer who experience self-stigma or perceived 
stigma.  
In addition, all health care professionals would benefit from in-person dialogue 
with patients, in a small group educational setting, that would allow the patient to 
describe their struggles, what it is like to be a patient, and the negative and positive 
impact that health care professionals have on patient experiences. This experience could 
also include a reflection exercise and discussion about ways to improve care for patients. 
Stigma researchers have proposed using a continuum model to approach reduction of 
stigma related attitudes (Schomerus et al., 2014) by thinking of oneself as a person 
somewhere on a wellness-illness continuum, that everyone will be closer to the illness 
end of the continuum at some point and that everyone has unhealthy habits.  
A smoking related illness may be considered by health care professionals to be a 
“wake-up” call that can provide most of the motivation for smoking cessation for all 
patients who smoke. A cancer diagnosis, however, is not maximized as a “teachable 
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moment” by health care professionals, often because they do not know how to use 
effective smoking cessation interventions (Gritz et al., 2006). Health care professionals, 
according to this study, may believe that the diagnosis of lung cancer is enough of a 
wake-up call and continued motivational stimulus for the patient and their family, and 
does not necessitate additional or advanced interventions. Moreover, a perceived lack of 
interest from the patient may deter the practitioner or nurse from further engagement with 
the patient on smoking cessation.  
At times, the perspectives of clinicians regarding smoking cessation interventions 
for patients were described by nurses as being in conflict with current evidence-based 
guidelines.  This conflict stemmed from the belief that nicotine withdrawal and cravings 
are short term and that nicotine replacement therapy (NRT) only prolonged the problems 
with withdrawal.  These discrepancies can confuse the patient, since they may receive 
conflicting education from different clinicians which undermines smoking cessation 
interventions, leading patients to conclude, as one participant observed, that they are “left 
to their own devices” for quitting smoking.  Chart audits are a potentially useful way to 
evaluate adherence to clinical procedures and protocols. Low adherence can be addressed 
through online educational modules or one-on- one coaching.   
Participants acknowledged negative stereotypes linked to smoking such as “filth”, 
and to smokers such as “blue collar” and “uneducated”; the negativity of these 
stereotypes were attenuated by saying “I know it’s an addiction”. Nurses may care for 
patients with smoking addiction who have low SES and low education attainment, but 
may not realize that smoking is potentially higher in this group because efforts to 
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denormalize and reduce smoking did not reach all demographics to the same degree 
(Garrett, Dube, Babb, & McAfee, 2015; Graham, 2012). Key aspects of decreased 
smoking prevalence such as public, workplace, and household smoking bans and absence 
of tobacco company advertising may be less readily adopted and enforced in low SES 
communities (Garret et al., 2015). People in these communities can experience more 
financial stress and have less access to adequate smoking cessation services, making 
quitting more difficult (Centers for Disease Control and Prevention, 2015; Garret et al., 
2015). Indoor smoking bans may not be as prevalent in low SES households as they are 
in higher SES ones  (King, Hyland, Borland, McNeill, & Cummings, 2011) or in places 
where individuals with low SES work like casinos (Centers for Disease Control and 
Prevention, 2015).  
Although smoking prevalence has declined overall, there are still high smoking 
rates among people who have low income and low education attainment, mental illness, 
and among certain ethnic minorities like American Indians and Alaska Natives (AI/AN) 
(Jamal et al., 2015). These demographics are also potential stigmatized statuses described 
by Conlon et al. (2010) as “stacked stigmas” or “co-occurring stigmas that can be linked 
to the primary stigma event” (p. 100). Education about stacked stigmas and the impact of 
smoking denormalization on different demographic groups would help nurses and all 
health care professionals counteract negative stereotypes within themselves and those that 
are expressed in the workplace and in their communities. All health care professionals 
should learn about the social determinants of health that contribute to smoking initiation 
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and addiction, to better understand the diverse needs and circumstances of the 
communities they serve.  
Smoking cessation for these groups may also be a unique challenge because they 
may come from micro communities where smoking is considered normal. One participant 
recalled that different generations in the same family were observed to have smoking 
addiction and develop lung cancer. Nurses who work in home health may go to these 
communities to care for people and encounter dangerous situations, such as a patient 
smoking while on oxygen or other people in the household smoking near oxygen, 
whereas nurses in acute care may have less exposure to smoking near oxygen due to a 
highly regulated environment. Smoking was viewed not only as detrimental to health but 
as capable of threatening the safety of the patient, the patient’s family, and health care 
professionals. Thus far in the literature, smoking addiction and people who smoke have 
not been labeled and stereotyped as dangerous, like people with mental illness (Link & 
Phelan, 2001). Extant theories of stigma and attribution support that danger or “peril” 
(Jones, 1998, p.65) are stereotypes associated with some stigmatized conditions, and the 
threat of harm they contain contributes to negative identities, isolation, and negative 
emotions and actions on the part of “normals” (Jones, 1988, Weiner, 2006). Smoking 
behavior presented uncertainty for nurses with regard to safety. People who smoked were 
expected to have smoking addiction, but not to let that addiction threaten the safety of 
others.  
Participants remarked on how ineffectual the current policies of banning smoking 
in certain areas and warning labels on cigarettes are at deterring smoking in the absence 
   
155 
 
of recognition and proper treatment of smoking addiction. These policies stem largely 
from influential groups of nonsmokers who saw second-hand smoke as a threat to the 
general public and assigned people who smoke the label of dangerous. While this strategy 
has decreased smoking prevalence, it has been at the cost of further marginalizing already 
vulnerable groups.  
 Part of the evidence-based guidelines for tobacco cessation includes follow-up 
with patients who are planning to quit and supporting them through the cessation process. 
This may be somewhat unrealistic for clinicians, however, one participant observed that 
patients who have a partner have a better success rate in quitting smoking than those who 
do not. Conceivably, a partner can provide the support and follow-up that bridges the gap 
in the smoking cessation trajectory, something that is not emphasized in the guidelines. 
Health care professionals should include the family in smoking cessation, particularly if 
the patient lives with someone who smokes even if the patient does not smoke, or the 
reverse. 
Although participants spoke about lung cancer in a way that negatively 
distinguishes it from other cancers, a “you did this to yourself” type of disease, there 
were no descriptions of actions or intentions toward speaking out against the stigma 
associated with lung cancer. Very little has been studied about how the wise advocate for 
the stigmatized, however a recent study using latent class analysis found that the “wise” 
fall into two categories: active “wise” who endorse challenging stigmatization, and 
passive “wise”, who do not (Smith, 2012). As “wise” persons, nurses helped to 
counteract patients’ expressions of self-blame, an active process. However, the literature 
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and theory still lack clarity as to who initiates challenges to stigma and under what 
circumstances. Lung cancer patients would likely have difficulty challenging 
stigmatization if they are (a) too sick to do so and (b) engaging in their own self-blame or 
self-stigmatization, so they may rely more on the “wise” and other advocates to help 
enact positive changes to their care.  
Public Support and Status Loss  
Table 3 in Chapter Four summarizes the relationship of what participants said to 
the different concepts in one of the two stigma theories discussed in Chapter Two. One 
participant indicated that there is greater support for breast cancer than lung cancer. Poor 
awareness and public support for lung cancer is frequently mentioned in studies of 
patients and clinicians who care for this population (Chapple, 2004; Conlon et al., 2010; 
Rohan et al., 2016; Tod & Joanne, 2010). Other scholars have attributed this to better 
survival rates for breast cancer, and other solid tumor cancers, which have allowed 
patients to engage in their own successful lobbying and advocacy for more funding (Gritz 
et al., 2007; Gulyn & Youssef, 2010) which “…translated into important budget earmarks 
and research emphases” (Gritz et al., p. 860).  
This has occurred over the last two decades because advocacy groups that lobby 
for specific diseases to the U.S. Congress have been able to shift the focus from the 
general public and science being the recipients of the benefits of funding to specific 
people with the disease, which allowed members of Congress to make judgements and 
decide the moral worthiness of diseases and the people who have them; stigma became a 
deciding factor in how money should be spent (Best, 2012). In addition, according to 
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Best, who studied medical research funding of 53 diseases over 18 years, diseases that 
had high mortality rates and were associated with deviant behaviors such as liver and 
lung cancer, received less funding over this time instead of more or the same amount.  
Results of the Best (2012) study indicate that poor public support and funding are, 
in part, due to the stigma associated with lung cancer as a self-inflicted disease. While 
nurses may think that increasing public support for lung cancer is out of their reach, they 
can use a stepwise approach to bridging the perceptual barrier between patients with lung 
cancer and clinicians and the public by starting with the areas in which they practice and 
their local communities. Patients with lung cancer or families of patients can be invited to 
various educational meetings of health care professionals to tell their story of what it is 
like to be a patient and a person with lung cancer. Nurses can be politically active by 
contacting their local or state representative and telling them about this patient population 
in a way that is more nuanced and personal than statistical information.    
Cancer of a Functioning Organ 
Patients with lung cancer have a myriad of distressing symptoms that have been 
reported in other studies such as pain, cough, dyspnea, and weight loss (Conlon et al., 
2010; Hamann et al., 2013). Dyspnea was described as a prominent symptom that 
interfered with quality of life, and the complexity of multiple symptoms and 
comorbidities was summarized with the description “sick”.  The negative impact of 
symptoms like dyspnea on quality of life has been reported by clinicians in another study 
(Conlon et al., 2010). When compared to patients with other cancers, patients with lung 
cancer have been rated by clinicians as having the poorest quality of life and more 
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distressing symptoms such as weight loss (Hamann et al., 2013). However, when 97 
patients with stage IIIb or IV lung cancer in a longitudinal study reported and ranked 
their own symptoms, moderate or severe dyspnea and fatigue were two of the most 
frequently reported symptoms which persisted throughout the time they were followed, 
whereas cough and appetite problems were reported closer to the end of life (LeBlanc et 
al., 2015). Clinicians may potentially be focused on symptoms or signs that they deem 
serious, such as weight loss, while the patient and family have different concerns such as 
dyspnea and fatigue. According to participants who also had the perspective of a family 
member of someone with lung cancer, family members are also negatively impacted by 
distressing symptoms such as loud breathing, secretions, and seeing their loved one 
struggle to breathe. Symptoms were given hierarchical importance, for example, dyspnea 
was ranked higher than pain.  
Lung cancer was observed to be often diagnosed at a late stage, which may mean 
that more symptoms are present and the disease is more advanced, leading to more 
aggressive treatments. Cancer care to date has mostly been focused on stopping the 
progression of the disease, and less on physical symptoms and psychosocial components 
(Greer, Jackson, Meier, & Temel, 2013). Palliative care is one way to ensure that both 
physical symptoms and psychosocial problems are addressed while improving quality of 
life (Greer et al., 2013; Smith et al., 2012). Assessments done by health care 
professionals should be combined with patient and caregiver or family concerns to drive 
the plan of care. Palliative care, by a palliative care clinician or a team trained in 
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palliative care, should be combined with standard oncology treatment early in the 
patient’s trajectory (Greer et al., 2013).  
Complexity of care and the sickness of patients was reported to be a stressful 
aspect of caring for patients with lung cancer. Due to the complexity of care of patients 
with lung cancer, novice nurses need to be mentored in care of the physical aspects of 
their care such as tubes, drains, and lines, and in seeing the patient as a person. This can 
be done in a simulation setting where the patient has a complex plan of care and also 
sociocultural background information that helps the student or novice nurse to keep the 
care person-centered instead of task-centered. Post clinical discussion can include how 
student nurses distinguish the patient “in the chart” from the patient in the room, from the 
person, who happens to be a patient.   
Jumping Through Hoops 
Nurses spoke of “hoops” they had to jump through to secure basic therapies for 
their patients with lung cancer. One such therapy was a portable oxygen compressor that 
allows the patient to perform activities of daily living such as going to the store or to 
doctor’s appointments.  Being able to perform activities of daily living, maintaining 
independence, sleep, and decreasing fatigue were rated very important or important to 
maintaining quality of life by 90% of participants in a cross-sectional study of 660 
patients with lung cancer (Gralla, Hollen, Msaouel, Davis, & Petersen, 2014). Some of 
the tests required to obtain a portable oxygen compressor, such as a pulmonary function 
test, can be difficult or exacerbate fatigue for patients with lung cancer. Not having 
portable oxygen could further tether them to their home and potentially interfere with 
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traveling to medical appointments.  Removing some of the barriers to accessing 
important therapies could facilitate the ability of patients to engage in activities of daily 
living and help maintain their quality of life. However, more research should be done on 
patients with lung cancer and their caregivers to determine the impact of system level 
barriers on their quality of life.  
Actions that nurses took to care for their patients came from what they perceived 
to be a disadvantaged status of being “dismissed” as nurses and not being taken 
seriously. The status of nurses in the hierarchy of health care professionals has not been 
mentioned in the literature on stigma and lung cancer.  Further research needs to be done 
that explores the mechanisms, conflicts, and perceptions that contribute to nurses not 
being taken seriously, being dismissed, and having to spend additional time and energy 
refocusing care interventions so that care is delivered to the patient in a timely and safe 
manner. If nurses perceive themselves to have a disadvantaged status in the healthcare 
team, or when they experience repeated push back or negative attitudes when they carry 
out interventions during patient care, they are at risk for burnout and leaving their 
workplace or even the profession. Moreover, the patient is at risk for poor outcomes if the 
nurse hesitates or is reluctant to call the physician when orders are needed, or if nurses 
think they need to design care around the needs of the physician instead of the patient.  
Case studies of situations similar to what participants described can be developed and 
reviewed in multidisciplinary educational meetings, conferences, or through online 
modules that can help clinicians see the potential detrimental impact of negative attitudes 
and unproductive communication that shifts the focus of care away from the patient. 
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Leadership training in conflict resolution and listening to understand can provide 
guidance in these situations. Also, the nurse can reorient any conflict situation back to the 
goal of care and the patient at the center of the care, particularly when communication 
starts to become unfocused or unprofessional.  
Securing the Journey 
The theme of securing the journey revealed the importance of and challenges to 
connecting with patients with lung cancer and the witnessed challenges that patients 
faced. Labeling of patients as “noncompliant” was thought to misrepresent patients’ 
abilities versus their intentions, “they can’t” versus “they don’t want to”; one being the 
patients’ actual identity and the other a stereotype of their virtual identity. Saying that 
patients are noncompliant, according to Huffman (2010), is “…labeling [that] fosters a 
belief that the individual has refused to cooperate with instructions or guidance” (p. 246). 
While it was not said explicitly that patients did not receive follow-up from healthcare 
professionals because of this label, there is an implied risk that the health care 
professional will be less able to understand and continue to anticipate the needs of the 
patient because of the stereotype associated with the “noncompliant” label. In a study of 
student physicians, patients that had addictions that contributed to their illness or who 
were noncompliant elicited cynical reactions and disrespectful humor (Wear et al., 2006). 
Labels like “noncompliant” and “needy” require discussion and reflection among health 
care professionals regarding the potential damage that they do to patient care, because the 
former label places the entire responsibility of behavior change on the patient, and the 
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latter requires the patient to behave in a way, “not needy”, that suits the health care 
environment.  
Self-blame was mentioned hypothetically as a psychological barrier to follow-up; 
this is supported by responses of patients with lung cancer in qualitative studies (Hamann 
et al., 2014) and as a barrier to diagnosis of lung cancer (Scott et al., 2015). Self-blame 
and self-stigma has also been reported by clinicians who care for patients with lung 
cancer (Tran et al., 2015). However, studies to date of lung cancer have not investigated 
the long-term effects of self-stigma on disease trajectory. A recent longitudinal 
randomized controlled trial of people with mental illness supported that people who had 
more self-blame at baseline had greater difficulty coping after one year than people who 
reported less self-blame (Oxele et al., 2017). Similar longitudinal studies should be done 
with patients who have lung cancer. Since palliative care is an essential aspect of cancer 
care, therapies to counteract the negative effects of self-blame and self-stigma as well as 
feelings of regret, remorse, and shame can be incorporated into the palliative care model.  
Nurses reported that patients who do not smoke had a difficult time answering the 
question of why they have lung cancer, which is consistent with the literature (Conlon et 
al., 2010; Hamann et al., 2014; Tod & Joanne, 2010). Difficulty with answering the 
“why” question, in this study, was also attributed to a stereotype that a participant 
explained as “you only get lung cancer if you smoked”. The literature however has not 
provided long term consequences of this initial difficulty, which a participant in this 
study described as a protracted process. A person who spends a year trying to find the 
cause of their cancer may be distracted from engaging in disease self-management and 
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may have delayed coping with the diagnosis.  More research should be done on how 
patients with lung cancer initially cope with their diagnosis, how their coping changes 
over time, and what impact it has on their trajectory. This can also be assessed during 
care encounters by the nurse or the palliative care team.  
“Meeting patients where they are” was an important empathic approach as a part 
of “connecting” mentioned by two participants that involved understanding the patient’s 
perspective in order to provide patient centered care. This approach helped nurses to keep 
their care centered on what was important to the patient, versus the perceived rationality 
or irrationality of the patient’s behaviors. This approach can be modeled to new nurses 
and other staff who are struggling to provide care to the patient because of perceived 
inappropriateness of the patient’s behavior.  
While participants talked about lung cancer being a particularly emotional and 
difficult diagnosis for younger patients because they have children, this assumption may 
be problematic in situations where older patients are the sole caregivers of their 
grandchildren. Moreover, families were frequently noted to be an important part of the 
patient’s cancer journey and were at risk for becoming overwhelmed or exhausted from 
providing care and support for the patient. Healthcare professionals should assess not 
only the patient’s financial resources but their supportive roles in their families or social 
lives; they should not assume that older patients do not have similar familial caregiver 
roles as younger patients, just because they are older.  
 In this study, there was a lack of knowledge about why participants did not attend 
support groups, although potential reasons such as fatigue were offered. Problems with 
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support groups for patients with lung cancer have been found in one other qualitative 
study (Conlon et al., 2010). These problems included the introduction of smoking stigma 
during the groups by patients with lung cancer who did not smoke when they indicated 
they did not deserve lung cancer and, passively, that people who smoked did deserve it. 
Also, people who smoked avoided the support groups because they felt like they would 
have to lie about their smoking status in order to be accepted in the group.  
This issue needs to be studied from the patient perspective to determine how 
support can be provided to patients with lung cancer and what prevents them from using 
certain support services.  Nurses should assess the social and emotional support their 
patients currently have, and help the patient determine additional support needed, if any, 
and what will work best for the patient. Some patients may prefer less formal settings, or 
one on one interactions, to give and receive emotional support. It could potentially be 
beneficial to invite patients who have attended support groups or who have advice on 
giving and receiving emotional support to multidisciplinary clinics as a way to help 
patients understand the benefits of this form of support from someone who has used it.  
Limitations 
 All of the participants were women, which is consistent with other qualitative 
studies of nurse’s perceptions of diseases that carry stigma (Aranda et al., 2014; Brown & 
Thompson, 2007). Most of the participants were also Non-Hispanic White, had over 15 
years of experience as nurses, and were older, which, along with gender, limits the 
diversity of perspectives presented in this study. Some of the follow-up interviews 
occurred months after the initial interview, meaning participants may have had trouble 
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recapturing their original thoughts. However, participants were mostly consistent from 
one interview to the next. Participants were, at times, talking about events that occurred 
several or many years ago, so this recall represents their reflection of events and their 
memory of how they felt at the time. They were also telling their perspectives to another 
nurse, this could have impacted the way they expressed themselves and what they chose 
to say. 
Purposive sampling was done through social media and through nursing 
organizations, therefore the sample is limited to people who access social media on a 
regular basis and are in the network of the principal investigator, to people who are 
members of and read organization newsletters and publications, and the extent to which 
the recruitment message is disseminated.  
  Transferability of the findings is limited because of the setting of the study, the 
Southeastern United States. Both the region of the U.S. where the nurse is from and 
where she practiced during the time she cared for patients with lung cancer can be a 
factor in their perspectives of both the disease and the associated behavior. For example, 
North Carolina is historically a tobacco state, meaning that the commerce surrounding 
tobacco production and sales was important to local economies (Fallin & Glantz, 2015). 
The way people perceive tobacco related diseases in North Carolina may be different 
than in a region or country where the historical ties to tobacco are less strong. In addition, 
there may be other cultural aspects that are revealed that may or may not be useful to 
people who read the study. However, in these cases, it is important for the researcher to 
try and give context to the culture of the people being studied when appropriate.  
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Conclusion 
Nurses’ experiences, communicated through narratives, further informs the 
identity of “wise” persons so that these qualities can be known and taught in nursing. 
Maintaining integrity of the nursing profession requires in-depth knowledge of how 
nurses embody these expectations and when they struggle to do so, or when they see the 
struggle of other health care professionals. 
A narrative approach provided a richer understanding of how nurses as “wise” 
persons think and what actions they take to counteract stigma in their patient encounters, 
which has been missing from the lung cancer and stigma literature to date. Their stories 
of smoking addiction and lung cancer in their families provides some understanding of 
the roots of their empathy and advocacy; yet negative stereotypes were still present in 
their experiences with people who smoke and people with lung cancer. Nurses enter the 
profession with experiences of health and illness from their sociocultural background and 
can reflect on and draw from these experiences. While the exact frequency of 
encountering smoking addiction among lung cancer patients, especially when they smoke 
in clinical setting, is not clear, for these nurses, these encounters were significant.    
The two stigma theories presented in Chapter Two posit that stigma occurs at the 
macro and micro levels and that the people involved in the stigma process have 
overlapping identities with extant and emerging statuses that promote or prevent a 
downward social trajectory related to a stigmatized condition. People who are “normals” 
or “wise” may also have a stigmatized condition, however their status in society can 
determine how easily they can conceal their stigmatized condition and what they can do 
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to counteract the stigma (Goffman, 1963). For health care professionals, their status as a 
professional engenders assumptions that they are empathic, impartial, social justice 
activists and advocates, which may cloak their personal judgements and attitudes about 
what is normal while simultaneously informing their more “wise” approach to care.  
At the micro level, in Goffman’s theory, nurses are considered to be “wise” 
persons who have knowledge of the difficulties of people who have a stigmatized illness 
and are positioned to help the stigmatized counteract stigma, but the “wise” are also 
“normals”.  This study added a more nuanced understanding of the experiences of nurses 
as the “wise” and nurses as “normals”, and the actions they take to help deal with 
struggles they have when caring for patients with smoking addiction, and lung cancer.  
Addiction, as a stigmatized condition, was partially transformed by the “wise” to 
a label that could protect the patient from further judgement. How the “wise” behave and 
think as such is not clearly described by Goffman’s theory. This study potentially adds 
another way in which nurses as “wise” persons counteract stigma by reducing the 
negative valence around labels and stereotypes. However, nurses demonstrated a 
fragmented understanding of smoking addiction that contributed to their difficulties in 
witnessing smoking behaviors, and frustration with effectively addressing smoking 
cessation. This fragmented understanding allows for the continuation of extant negative 
stereotypes and labels in the health care setting.  The “wise thoughts” and “wise actions” 
they had and did can be used to build a framework for approaching patients with a 
stigmatized disease, and it also provides guidance for what additional research needs to 
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be done. For example, the need to study those who engage in “wise” actions on a larger 
scale beyond patient care encounters to understand their stories of advocacy.  
At the macro level, Link and Phelan’s (2001) theory was a helpful framework for 
seeing and interpreting labels and stereotypes and how they are used to provide quick 
solutions to patient problems such as the labels “noncompliant” and “needy”, and how 
they have become part of the background in health care. Separation, status loss, and 
structural discrimination are still components of smoking stigma and lung cancer stigma. 
Nurses reported a diminished status among health care professionals; the “wise” may, at 
times, advocate for people with a stigmatized disease while dealing with their own 
stigmas that they cannot hide because they emerge in their care of patients. These 
problems can be addressed by continually working to professionally resolve conflicts and 
keep the focus of care on the patient and not on interprofessional and intraprofessional 
conflicts. However, space and time should be set aside to address these conflicts so that 
they are not emerging during patient care. 
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APPENDIX A 
DEMOGRAPHICS FORM 
1. What year were you born?  
 
___________ 
 
2. What is your gender? 
 
______ male    ______ female ______________________Prefer to self-describe (please 
specify)  
 
 _________Prefer not to say 
 
3. Where did you grow up?  
 
______________ 
 
4. In what state did you receive your pre-licensure nursing education? 
 
__________________ 
 
5. How many years have you been a registered nurse? 
 
_________  
 
 
6. What is the highest education level you have obtained? 
 
_____Associate Degree 
_____Diploma 
_____Bachelor’s degree 
_____ Master’s degree.  
_____ DNP 
_____ PhD 
 
7. What type of clinical setting do you currently work in? 
 
______ Oncology Inpatient 
______ Oncology Outpatient 
______ Home Health 
______ Hospice  
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______ Palliative Care 
______ Telemetry 
______ Medical Surgical 
______ Step-down 
______ ICU 
 
_______________________Other – please write in 
 
8. What type of setting did you care for patients with lung cancer? 
 
________________________________________________________ 
 
9. How many years have you cared for patients with lung cancer? 
 
____________ 
 
10. When caring for patients with lung cancer what is a typical shift that you have 
worked? 
 
______________________ 
 
11. Do you currently use tobacco products? 
 
_____ Yes 
 
_____ No 
 
12. If “yes” what type of tobacco product do you use? 
 
___________________ 
 
13. Have you ever smoked or used tobacco products?  
 
_____ Yes 
 
_____ No 
 
 
14. What type of tobacco product did you use?  
 
________________ 
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15. Has a family member or close friend ever been diagnosed with lung cancer? 
 
_______Yes                  ________No 
 
 
16. Has a family member or close friend ever died of lung cancer? 
 
________Yes               __________No 
 
 
17. Have you ever been diagnosed with cancer? 
 
_________Yes            __________No  
 
18. If so, what type of cancer? 
 
____________________________ 
 
19. Which race/ethnicity most closely describes how you identify yourself? 
 
_____ Caucasian or White 
 
_____ Black/African American 
 
_____ Hispanic/Latino 
 
_____ American Indian/Alaska Native  
 
_____ Asian/Pacific Islander  
 
_____ Other 
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APPENDIX B 
 
INTERVIEW GUIDE 
 
Free Association 
• When you hear the word healthy what comes to mind?  
• When you hear or read the word smoker what comes to mind? 
• When you hear or read the word cigarettes what comes to mind? 
• When you care for a patient who smokes the first thing you think is…? 
• What are your thoughts on why people start smoking and why they continue to 
smoke?  
• What has been your experience with people who smoke? How has this impacted 
the way you care for people who smoke or used to smoke?  
• When I am assigned a new patient with lung cancer the first thing I think is…? 
How are these thoughts different from other patients to which you are assigned?  
Biographical Narrative Questions  
• What is your first memory of or what was your first experience with lung cancer?  
• What is your first memory of or what was your first experience with smoking? 
• Tell me about how you got into nursing?  
• How has your perspective of nursing changed since you first started as a nurse? 
• Tell me about when you started to care for patients with lung cancer (what was it 
like for you)? 
• Describe how your perspective may have changed about lung cancer since you 
first started to care for patients with lung cancer?  
Semi-structured Interview 
• Describe your work environment and some of the things you do to care for/help 
patients with lung cancer. 
o How are you supported in your role of caring for patients with lung 
cancer? 
o What support is needed for care of patients with lung cancer? 
• What have you noticed about how people talk about lung cancer? 
• What are some common words, phrases, or progress notes used to describe 
patients with lung cancer when you are working?  
• How do you use empathy in your communication with patients with lung cancer? 
• When is it a challenge to use empathy?  
• What are some common things that patients and family members say about lung 
cancer? 
o How do you respond and/or feel about what is said? 
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• How do you advocate for your patients with lung cancer? 
o What facilitates this advocacy? 
o What barriers to advocacy do you encounter? 
• Describe any differences you have noticed between  
o Your patients with lung cancer and your patients with other cancer 
diagnoses. 
o Your patients with lung cancer who are older and those who are younger. 
o Who currently smoke and those who do not.  
• What are some of the challenges that arise when caring for patients with lung 
cancer? 
• What are some of the positive experiences you have noted when caring for 
patients with lung cancer? 
• Recall a time when caring for a patient with lung cancer when the care or 
treatment went well… 
o Describe what happened during this time. 
o What was the outcome and why do you think it was good? 
o What was the reaction of the patient, family, and professionals who 
provided care for this person.  
o What feelings did you have regarding this event? 
• Recall a time when caring for a patient with lung cancer when the care or 
treatment did not go well… 
• Describe what happened during this time. 
• What was the outcome and why do you think it was not good? 
• What was the reaction of the patient, family, and professionals who 
provided care for this person? 
• What feelings did you have regarding this event? 
 What are your thoughts on the stigma associated with lung cancer?  
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APPENDIX C 
MEMBER CHECK FORM 
This form is designed for the participant (you) to comment on the accuracy of the 
transcript. This is only your data that you are seeing. Please answer the following 
questions about this transcript. 
Please indicate, by circling AGREE OR DISAGREE, whether you agree or do not agree 
with the transcript.  
I AGREE with the transcript. 
I DO NOT AGREE with the transcript.  
Please indicate WHY you AGREE or DO NOT AGREE with the transcript AND/OR 
offer any comments you have about the transcript.  
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APPENDIX D 
RECRUITMENT FLYER 
 
RESEARCH PARTICIPANTS NEEDED 
 
My name is Sarah Abrams and I am a Registered Nurse and a graduate student pursuing 
my PhD at the University of North Carolina at Greensboro School of Nursing. My 
dissertation research is on the experiences of nurses who care for patients with lung 
cancer. Much of the research on people with lung cancer has been done from the 
perspective of the patient, so not much is known about the perspective of nurses.  
 
PURPOSE: A qualitative study to describe the care of patients with lung 
cancer from the perspective of Registered Nurses who care for 
them.  
 
PROCEDURE: Participants will be interviewed no more than twice by the 
principal investigator (Sarah Abrams). The first Interview will 
take approximately 90 minutes and will be audio-recorded.  If 
a second interview is needed it will be no more than 30 minutes 
and will be audio-recorded.  
 
ELIGIBILITY:                        • Must be a registered nurse caring for or have cared for 
patients with lung cancer and are practicing in the 
Southeastern United States.  
• Must have at least two years of nursing experience. 
• Must be caring for or have cared for patients with 
lung cancer for at least 6 months of your career. 
 
*** If you know someone who meets these criteria, please 
SHARE on social media or direct them to/show them/send 
them this flyer ***  
If you need a copy of the flyer please send a request to 
siabrams@uncg.edu  
*****Please DO NOT POST THIS FLYER ANYWHERE 
WITHOUT PERMISSION i.e. the place where you work 
****** 
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COMPENSATION: Participants will receive a gift card compensation for their time.  
CONTACT: For more information please contact the principal investigator 
 Sarah Abrams RN, MSN, PhD 
student at the University of North 
Carolina at Greensboro 
 siabrams@uncg.edu  
  
                                    
 
 
 
